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ABSTRACT 
Constitutive heterochromatin in mammalian cells is present at repeat regions of telomeres, 
centromeres and at pericentric regions of the chromosome. This work focuses on centromeric and 
pericentric heterochromatin. Chromatin compaction keeps these genomic domains transcriptionally 
inert. How the compaction of chromatin is achieved is not completely understood. Dysregulation of 
heterochromatin organization leads to severe diseases and developmental defects (Hahn et al. 2010). 
Therefore it is important to understand the mechanisms that establish, regulate and maintain 
pericentric heterochromatin. Another function of pericentric heterochromatin emerged during the last 
few years. Centromeres are flanked by large blocks of heterochromatin, which, in S. cerevisiae (Folco 
et al. 2008; Kagansky et al. 2009) and D. melanogaster (Olszak et al. 2011), are required for the 
establishment of functional centromeres. It is currently not clear whether the compact structure of 
pericentric heterochromatin abolishes the integration of the centromere specific H3 variant CenpA. 
Heterochromatin might be important to define the border to centromeric regions and therefore ensures 
centromere identity. Furthermore heterochromatin-associated proteins might play direct roles at 
centromeres. Pericentric and centric chromatin are both composed of satellite repeat sequences and 
carry characteristic histone modifications (H3K9me3 and H4K20me3) (Martens et al. 2005). We 
identified M18bp1, a protein involved in ‘priming’ centromeric chromatin for CenpA deposition, in a 
peptide pulldown enriched with the heterochromatin mark H3K9me3. M18bp1 co-localizes with 
CenpA and is recruited to pericentric heterochromatin in wild type mouse fibroblasts. We propose a 
novel mechanism explaining the recruitment of M18bp1 to centromeres. M18bp1 is recruited to 
centromeres via direct interaction of a central region in M18bp1, containing a conserved SANT 
domain, with the C-terminus of CenpC (Dambacher et al. 2012). Furthermore this study shows that the 
recruitment of M18bp1 to pericentric heterochromatin occurs in an HP1-dependent manner. M18bp1 
directly binds HP1 isoforms in vitro and in vivo. Together the data provide first evidence, that 
components of heterochromatin, like HP1 proteins, have functions at centromeric chromatin.  
M18bp1 is crucial for mouse development as mutant embryos die very early in the blastocyst stage 
(E3.5). Blastocyst cells show mitotic defects and enter apoptosis. Inducible M18bp1 knockout 
fibroblasts show proliferation defects, which is the consequence of two major phenotypes: a) 12h after 
induction of the deletion severe mitotic defects like decondensed mitotic chromosomes, misalignment 
in metaphase plate, lagging chromosomes and anaphase bridges probably lead to cell death. b) 3-5 
days after depletion, CenpA levels are reduced. Conditional knockout mice with specific deletion of 
M18bp1 in germ cells show cyst formation in female ovaries and reduced testis size in male mice 
compared to control mice. We provide the first characterization of a M18bp1 knockout mouse and 
provide first evidence that M18bp1 is essential for development. 
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The characterization of proteins involved in the establishment of repressive histone modifications is 
the second part of this thesis. Three enzymes are involved in the modification of histone H4 on lysine 
20. PrSet7 introduces the monomethylation in a replication-dependent manner, while Suv4-20h1 and 
Suv4-20h2 establish the di- and trimethylation mark. How these enzymes are regulated in establishing 
the marks is not clear. It has been proposed that PrSet7 monomethylates newly synthesized histones, 
which then serve as substrates for Suv4-20h enzymes to be converted into di- and trimethylation. 
Suv4-20h enzymes indeed show higher activity on nucleosomal arrays with monomethylated H4K20, 
providing first evidence for a sequential methylation pathway. Additionally, a novel interaction 
between PrSet7 and Suv4-20h2 was identified in GST pulldown experiments. The direct interaction of 
PrSet7 and Suv4-20h2 indicates a mechanism for interdependent regulation of H4K20 specific 
methyltransferases, which has to be further validated in subsequent studies. 
Suv4-20h2 plays important roles in ensuring the compact chromatin structure, important for gene 
silencing at pericentric heterochromatin. As a scaffold protein it provides multiple binding sites for 
HP1 proteins and tethers the mobile HP1 proteins to heterochromatin. Chromatin structure is more 
accessible to MNase upon loss of Suv4-20h2 and shows extended nucleosomal repeat length, both 
indicating that Suv4-20h2 mediates chromatin compaction. Furthermore Suv4-20h2 is crucial for the 
recruitment of cohesin to pericentric heterochromatin. Based on this experiments the histone 
methyltransferase Suv4-20h2 is defined as a major structural constituent of heterochromatin that 
mediates chromatin compaction and cohesin recruitment. 
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1. INTRODUCTION 
1.1 Heterochromatin in mammalian cells 
The interphase nucleus of eukaryotic cells comprises chromatin with different levels of compaction. 
Based on this observation, chromatin was first divided by Heitz 1928 (Heitz E.; Das Heterochromatin 
der Moose’) in less condensed euchromatin and highly condensed heterochromatin (Huisinga et al. 
2006). Different kinds of heterochromatin have been defined: facultative and constitutive 
heterochromatin. The repressive state of facultative heterochromatin is reversible and dependent on 
the cell type and differentiation state. In contrast constitutive heterochromatin is stable and endues the 
major portion of repressive chromatin in the nucleus. It is present at telomere regions of the 
chromosome and at the centromeres (Brown 1966) (Figure1.1). 
 
Figure 1.1. The chromatin landscape (Martens et al. 2005). Heterochromatin defines important genomic 
regions on the chromosome. Constitutive heterochromatin is present at highly repetitive regions like telomeres, 
minor and major satellite repeat regions.  
The centromere represents the constricted region of the chromosome, which is important for ensuring 
chromosome inheritance. During mitosis kinetochore assembly occurs at the centromeres. The 
kinetochore complex serves as the platform for spindle-microtubule attachment in order to create the 
adequate force required for proper chromosome segregation. Together these mechanisms ensure the 
delivery of one copy of every single chromosome to each daughter cell during cell division. While the 
function of the centromere is evolutionarily conserved, the DNA sequence and the protein network 
present at centromeres are rapidly evolving. Two types of repetitive DNA sequences can be identified 
around centromeres in the mouse genome. The minor satellite repeats consist of 120 bp units and form 
a stretch of 600 kb, whereas the flanking major satellite repeats (6 megabases of 234 bp units) form 
the pericentric regions (Choo 2001; Martens et al. 2005; Bulut-Karslioglu et al. 2012) (Figure 1.2.). 
Together centric and pericentric heterochromatin form characteristic highly condensed clusters in 
interphase nuclei termed chromocenters. These compact chromatin structures can be easily visualized 
by DAPI staining. 
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Figure 1.2. The centromeric region of the chromosome. A) Centromeres are at the constriction site of 
chromosomes. Minor satellite repeats are the underlying DNA at centromeric chromatin. They are flanked by 
major satellite repeats which form pericentric heterochromatin. B) Characteristic for centromeric chromatin is 
the Histone H3 variant CenpA. CenpA nucleosomes are interspersed with H3 containing nucleosomes. 
The lack of a conserved DNA sequence provoked the hypothesis that epigenetic mechanisms 
determine the identity of centric and pericentric heterochromatin. Pericentric heterochromatin 
comprises repressive marks like hypoacetylation, DNA methylation and histone modifications like 
H3K9me3 and H4K20me3, which are typically associated with transcriptional silencing. In contrast 
centromeric chromatin collates heterochromatic and euchromatic characteristics. Kinetochores 
assemble on distinct chromatin regions that contain the histone H3 variant CENP-A and interspersed 
nucleosomes dimethylated on H3K4 (H3K4me2). The active mark H3K4me2 has been shown to be 
important for the recruitment of HJURP, the CenpA specific chaperone and the subsequent deposition 
of CenpA (Bergmann et al. 2011). Also other active histone modification marks are present at minor 
satellite repeats like H3K4me1 or H3K36me2, me3. Moreover ChIP experiments in mouse embryonic 
fibroblasts revealed that hypoacetylation (Honda et al. 2012), DNA methylation (Chen et al. 2003; 
Yamagata et al. 2007), and histone methylation (H3K9me3, H4K20me3) marks, which are 
characteristic for heterochromatin, are features of minor satellite repeat regions (Guenatri et al. 2004; 
Martens et al. 2005). Additionally proteins, characteristic for heterochromatin, like heterochromatin 
protein 1 (HP1) have been shown to localize to centromeric regions in metaphase (Hayakawa et al. 
2003; Gopalakrishnan et al. 2009). According to that centromeric and pericentric heterochromatin 
share several common properties in mammalian cells. Studies in S.cerevisiae (Folco et al. 2008; 
Kagansky et al. 2009) and D. melanogaster (Olszak et al. 2011) suggest that heterochromatin is even 
crucial for the establishment and maintenance of functional centromeres. Heterochromatin in these 
organisms defines the border of centromeric chromatin (Pidoux and Allshire 2004; Sato et al. 2012). If 
this regulatory mechanism is conserved in higher organisms is completely unknown. However both 
centromeric and pericentric chromatin are important genomic regions which have to be tightly 
regulated. Any perturbation of the epigenetic balance can cause severe abberations like genomic 
instability, which can lead to cancer and other severe diseases (Shen 2011). Therefore it is very 
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important to learn more about the function and regulation of the complex system termed 
heterochromatin. 
1.2 Formation of centromeric chromatin 
Centromeres are crucial for proper chromosome segregation. Chromosome segregation defects may 
lead to loss or gain of one or more chromosomes, a condition known as aneuploidy which is a 
hallmark of malignant cells (Holland and Cleveland 2009). Thus cells have to strictly control the 
number of centromeres per chromosome. Chromosomes lacking a functional centromere show severe 
segregation defects (Amato et al. 2009), while in contrast chromosomes, which harbor more than one 
functional centromere face chromosome breakage due to asymmetric tension (Sato et al. 2012). 
CenpA loading onto chromatin is thought to be the crucial process to create a functional centromere, 
as CenpA is not present at inactive centromeres (Earnshaw and Migeon 1985). The loading itself is a 
very complex procedure, which can be separated in three different steps (Figure1.3): 
a) Priming of centromeres for CenpA deposition 
One central question in the context of centromeres is how centromere identity is achieved. 
Experiments revealed that HJURP, the chaperone incorporating CenpA into centromeric nucleosomes, 
requires the Mis18 complex consisting of Mis18alpha, Mis18beta, M18bp1 and RbAp46/48 proteins, 
for its recruitment to centromeres (Fujita et al. 2007). What could be possible mechanisms that drive 
the Mis18 complex to create a permissive chromatin state prone for CenpA deposition? Chromatin 
structure can be modified by specific epigenetic marks to allow incorporation of CenpA. One 
possibility to achieve an open chromatin state would be histone acetylation. Indeed several 
observations suggest that histone acetyltransferases may be required for functional CENP-A assembly 
and subsequent de novo kinetochore formation (Nakano et al. 2003; Okamoto et al. 2007; Ohzeki et al. 
2012). In line with this the acetyltransferases p300 and PCAF have been found to both localize to 
functional, but not to inactive centromeres (Craig et al. 2003). Furthermore, upon depletion of Mis18 
complex members, integration of newly synthesized CenpA is abrogated. Surprisingly this can be 
rescued by treating the cells with HDAC inhibitors like TSA or overexpression of HATs like p300 or 
PCAF (Fujita et al. 2007). According to this, an increase in centromeric H3 acetylation can be seen in 
G1 phase when M18bp1 is present at centromeres suggesting that M18bp1 recruits some HAT 
activity, which has not been identified yet. Interestingly mouse embryonic fibroblasts depleted for 
Mis18alpha show, apart from increased H3 acetylation, a decrease in H3K4me2, H3K9me2 and 
H3K9me3 as well as the loss of HP1 and a reduction of DNA methylation at minor satellite repeat 
regions. Direct interaction of DNMT3A and DNMT3B has been shown between Mis18 alpha (Kim et 
al. 2012) and CenpC (Gopalakrishnan et al. 2009). This interaction might be sufficient to recruit 
DNMT activity to centromeric chromatin. Furthermore it is currently unclear which 
methyltransferases are active at centromeres and how they are recruited. One possibility might be a 
HP1 mediated recruitment of centromere specific chromatin modifiers. 
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Figure 1.3. Cell cycle dependency of CenpA deposition. CenpA is diluted during DNA replication in S-phase 
as the existing amount is distributed equally onto both daughter strands. Highest levels of CenpA synthesis can 
be detected in G2 phase of the cell cycle, while newly synthesized CenpA is loaded much later in G1 phase. The 
CENP-A assembly machinery like the Mis18 complex is poised for activation throughout the cell cycle but kept 
in an inactive noncentromeric state by Cdk mediated phosphorylation during S, G2, and M phases. Cdk1/Cdk2 
activity drops in anaphase and allows de-phosphorylation of M18bp1. In anaphase/telophase M18bp1 is 
recruited to centromeric chromatin and prepares chromatin for subsequent CenpA integration. In early G1 phase 
HJURP the CenpA specific chaperone deposits CenpA into chromatin, a process, which is error prone as CenpA 
deposition occurs also outside the centromeric regions. Therefore specific control mechanisms evolved to 
remove mis-integrated CenpA from non-centromeric regions while correctly integrated CenpA is maintained at 
centromeric regions in a process requiring M18bp1 and the small GTPase MgcGacGap. 
b)  Deposition of CenpA 
In higher organisms CenpA deposition occurs in a replication independent manner. While in S phase 
the already existing CenpA nucleosomes are divided onto both daughter strands, the deposition of 
newly synthesized CenpA occurs only in early G1 phase by the histone chaperone HJURP (holiday 
junction recognition motif). This implicates that all proteins involved in this process have to be cell 
cycle regulated, which is ensured by an orchestrated cyclin/CDK network. Throughout G1 and S phase 
cyclins accumulate (increased CDK activity); at G2/M transition maximum CDK activity is necessary 
to guarantee that the majority of CDK substrates is phosphorylated. The CDK levels stay high until bi-
orientation of all chromosomes at the metaphase plate is controlled by the spindle assembly 
checkpoint (SAC). After SAC is satisfied cyclins get rapidly degraded by the APC complex and the 
cell progresses to G1 with low CDK levels. Silva and colleagues could show (Silva et al. 2012) that 
CenpA deposition is regulated by the activity of Cdk1 and Cdk2. M18bp1 is phosphorylated by Cdk 
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proteins, which precludes its association with centromeric chromatin. Silva and colleagues proposed 
the following: After anaphase onset CDK activity drops, dephosphorylated M18bp1 is then able to 
associate with the centromere and recruits proteins, which are necessary for the CenpA loading. 
Interestingly they could also show that inhibition of Cdk leads to misintegration of CenpA outside of 
G1. This is an indication that Cdk regulated phosphorylation of M18bp1 is the major timing factor for 
CenpA deposition. Chromatin condensation efficiently performed by condensin complexes in mitosis 
is also suggested to be one criterion for CenpA deposition (Ribeiro et al. 2009; Samoshkin et al. 2009). 
Two independent affinity purification approaches in human cells using tagged CenpA (Dunleavy et al. 
2009; Foltz et al. 2009) identified the prenucleosomal complex. HJURP, H4, Nucelophosmin1 
(NPM1) as well as subunits of the CAF1 (H3.1 chaperone) and the HIRA complex (H3.3 chaperone) 
were found to be associated with CenpA. However it is still in question what the crucial steps in 
regulating the deposition of CenpA are. 
c) Maturation and maintenance of centromeric chromatin 
Newly synthesized CenpA is incorporated into chromatin by its chaperone HJURP- but this deposition 
is in a first place not fully specific for centromeric regions. After overexpression of CenpA, 
incorporation of CenpA occurs at kinetochore regions but also at genomic regions outside of minor 
satellite repeats, like the chromosome arms (Van Hooser et al. 2001). Therefore it was proposed that 
mechanisms exist which on the one hand remove misincorporated CenpA and on the other hand 
stabilize CenpA at centromeric regions or protect it from being removed by certain control 
mechanisms. The subunits of the remodeling and spacing factor (RSF) complex, Rsf1 and SNF2h 
interact with CenpA chromatin in mid-G1 phase and seem to be required for the maintenance of 
CenpA as HeLa cells depleted for Rsf1 show loss of CenpA (Perpelescu et al. 2009). Another study in 
HeLa cells (Lagana et al. 2010) revealed that the small GTPase MgcRacGap, Ect2, the small GTPases 
Cdc42 and Rac are important for stabilizing newly synthesized CenpA. MgcRacGap localizes to 
centromeres in late G1 phase of the cell cycle when CenpA loading is largely completed. Together 
with Ect2, MgcRacGap regulates the activity of the small GTPase Cdc42 in mitosis (Oceguera-Yanez 
et al. 2005). MgcRacGap is present at centromeres during late G1 phase and directly interacting with 
the licensing factor M18bp1, which in turn recruits Cdc42. As siRNA mediated knockdown of Cdc42 
or Rac results in significant lower levels of CenpA at centromeres, it has been proposed that 
MgcRacGap-M18bp1-mediated Cdc42 activity is necessary to somehow modify CenpA. Either by 
adding or by removing a modification a separate identity for CenpA is generated, which marks it 
discriminably from old CenpA as a stable component of centromeric chromatin.  
1.3 The complex network of centromere proteins 
Once the centromere basis is established, a complex network of centromere proteins (more than 80 
proteins have been identified until now) are recruited (Gascoigne and Cheeseman 2011) to form the 
kinetochore. The structural core of the kinetochore is composed of the KMN network consisting of 
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KNL-1 protein (Blinkin), the Mis12 complex and Ndc80 (Cheeseman and Desai 2008). Removal of 
any of the components of the KMN network leads to disruption of binding scaffolds for microtubules 
at outer kinetochore plates (Kline et al. 2006). To ensure proper chromosome alignment at the 
metaphase plate, each chromosome establishes bipolar attachments through its sister-kinetochores to 
microtubules protruding from opposite poles of the mitotic spindle (Tanaka 2008). The process of 
spindle attachment is a rather stochastic event and therefore error-prone. In order to control this crucial 
step eukaryotic cells have evolved a quality control mechanism: the spindle assembly checkpoint 
(SAC). SAC detects inappropriate kinetochore-microtubule attachments during chromosome 
congression from prometaphase to metaphase. Upon activation, additional control mechanisms are 
induced, which lead to delay of mitotic exit, allowing sufﬁcient time for error correction and 
chromosome bi-orientation. During the early stages of mitosis (prometaphase), unattached 
kinetochores catalyze the formation of the mitotic checkpoint complex (MCC) composed of BubR1, 
Bub3, Mad2 and Cdc20. This leads in turn to inhibition of a downstream target of the SAC the 
anaphase promoting complex (APC/C). The APC/C is a E3 ubiquitin ligase that targets several 
proteins for proteolytic degradation, including mitotic cyclins (McLean et al. 2011) and therefore 
contributes to the strict cell cycle regulation and timing, crucial for proper chromosome segregation. 
Another important regulator of kinetochore assembly is the chromosomal passenger complex (CPC) 
consisting of Incenp, Borealin, Survivin and the kinase AuroraB. Importantly the CPC promotes 
chromosome bi-orientation by specifically destabilizing erroneous kinetochore attachments like 
syntelic and merotelic attachments by allowing the stabilization of correct bipolar attachments (Tanaka 
et al. 2002; Hauf et al. 2003; Lampson et al. 2004). Apart from its function in destabilizing incorrect 
attached spindle-microtubles, this complex comprises various other important functions in mitosis 
(Ruchaud et al. 2007; van der Waal et al. 2012). During cytokinesis the CPC localizes at the midbody 
where Aurora B initiates an abscission delay when two daughter cells are connected by a chromosome 
bridge. This mechanism protects the cells from tetraploidization (Steigemann et al. 2009). Altogether 
the CPC complex is an important factor in controlling cell division in spatial and temporal manner. 
1.4 The functions of M18bp1 at centromeres 
M18bp1 was first discovered in a temperature sensitive screen performed in fission yeast for mutants 
that mis-seggregated their chromosomes (Hayashi et al. 2004). In a subsequent study Mis18alpha and 
Mis18beta were identified to be present in a complex with M18bp1 (KNL2), RbAp46, RbAp48 (Fujita 
et al. 2007). Fujita and colleagues could show that upon siRNA knockdown of either Mis18alpha, 
Mis18beta or M18bp1 in HeLa cells the deposition of newly synthesized CenpA is impaired. 
Independently a study in C. elegans showed that the homologue of M18bp1 is required for the 
centromeric localization of CenpA (Maddox et al. 2007). The human M18bp1 localizes to centromeres 
at anaphase just before HJURP is present and remains there until mid G1 phase, suggesting a tightly 
cell cycle dependent regulation. MgcRacGap has been shown to directly interact with M18bp1 during 
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G1 phase (Lagana et al. 2010). Together with Ect2, MgcRacGap regulates the activity of the small 
GTPase Cdc42 in mitosis (Oceguera-Yanez et al. 2005). This interaction is crucial for the recruitment 
of active Cdc42 that somehow modifies CenpA leading to its maintenance at centromeric chromatin. 
A very recent study characterized the function of Mis18alpha in a mouse knockout model (Kim et al. 
2012). Mis18alpha deficiency in mice leads to lethality at early embryonic stage (E6.5-E7.5). Further 
analyses of Mis18alpha knockout blastocysts and fibroblasts displayed severe defects like improper 
microtubule attachment to chromosomes, inappropriate chromosome condensation, mis-alignment in 
prometaphase, anaphase bridges, lagging chromosomes in telophase resulting in fragmented 
chromosomes. These results suggest that the Mis18 complex is required for proper chromosome 
segregation. The M18bp1 knockout in mice has not been analyzed yet and it is still unclear what the 
functions of M18bp1 at centromeres are and how M18bp1 is recruited to centromeric regions. 
1.5 The sequential pathway to establish pericentric heterochromatin 
Pericentric heterochromatin flanks the centromeric chromosome regions. Heterochromatin displays a 
highly compacted chromatin structure consisting of repetitive elements (major satellite repeat regions), 
which are kept in a transcriptionally inert state. The compact structure is achieved by specific 
chromatin modification patterns like DNA methylation, hypoacetylation and repressive histone 
modifications like H3K9me3 and H4K20me3, which provide a binding platform for specific sets of 
heterochromatin effector proteins. The heterochromatin organization differs in distinct cell types; 
correlating with the diffentiation state and varies due to the developmental stages (Probst et al. 2010). 
But how is heterochromatin established? Pericentric heterochromatin is established in a sequential 
pathway. Suv39h enzymes methylate chromatin at lysine 9 of histone H3 (H3K9me3). This creates a 
binding site for the recruitment of HP1 proteins to heterochromatin. In turn the presence of HP1 
recruits more Suv39h enzymes leading to more H3K9me3 and further HP1 recruitment. Apart from 
Suv39h enzymes, HP1 directly binds to other important histone lysine methyltransferases (HMTs), 
Suv4-20h1 and Suv4-20h2, which introduces an additional repressive mark on histone H4 - 
H4K20me3 (Schotta et al. 2008) (Figure 1.4.). The accumulation of repressive marks and the potential 
of HP1 proteins to form homo- and heterodimers is thought to result in a chromatin cluster visible as 
dense chromocenter structures (Schwarzacher 1964; Bartova et al. 2002). Nevertheless a concrete 
mechanism leading to the specific heterochromatin structure is still under heavy debate. Cells lacking 
Suv39h enzymes loose both H3K9me3 and H4K20me3. Additionally due to the lack of H3K9me3 
HP1 proteins are not recruited to pericentric heterochromatin (Peters et al. 2001). However Suv39h 
DKO cells still show chromocenter structures in the nuclei. As Suv39h DKO cells still show 
compacted chromatin, there might be additional proteins important for the structural integrity of 
heterochromatin. 
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Figure 1.4. The sequential pathway to establish pericentric heterochromatin (adapted from (Schotta et al. 
2004)). In a pathway, which is somehow regulated by ncRNAs the CAF1-HP1a-Setdb1 complex is recruited to 
pericentric heterochromatin. Setdb1 mono-methylates histone H3 at lysine 9 and provides a substrate for Suv39h 
enzymes. Suv39h1 and Suv39h2 are recruited to heterochromatin in an HP1 dependent manner and convert the 
monomethylation at H3K9 into trimethylation. Further HP1 molecules are recruited to pericentric 
heterochromatin and bind to H3K9me3. The high concentration of HP1 proteins recruits other HMTases like 
Suv4-20h proteins. Suv4-20h introduce the trimethylation of histone H4 at lysine 20. Additionally Suv39h 
proteins recruit DNA-methyltransferases (Dnmts), which modify major satellite repeats sequences. Additional 
proteins might contribute to the sequential pathway. 
Chromocenter organization is maintained throughout the cell cycle with one exception during mitosis. 
This continuous presence of heterochromatin at major satellite repeats actually requires re-
establishment of heterochromatin features after each round of replication. Pericentric heterochromatin 
as a rather closed and transcriptionally inert chromatin has to be reorganized during mitosis but also 
opened for the repair machinery to bind upon DNA damage (Goodarzi and Jeggo 2012). Therefore 
chromatin cannot be static. But in order to prevent cells from genomic instability it has to follow 
certain rules in protecting critical genomic regions from being transcribed at the wrong time. How this 
flexibility is ensured is not clear. There is some evidence that HP1 proteins might play important roles 
in the rearrangement of heterochromatin upon DNA damage (Ayoub et al. 2008; Ayoub et al. 2009; 
Baldeyron et al. 2011). Furthermore a recent study identified transcription factors that sequence- 
specificly recognize major satellite repeat regions and then recruit the required effector proteins 
(Bulut-Karslioglu et al. 2012), suggesting that regulation of heterochromatin comprises epigenetic and 
genetic aspects, which have to be further analyzed. 
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1.6 Regulation of histone lysine methylation 
Heterochromatin displays a compact chromosomal structure with distinct histone and DNA 
modification patterns, important to control the transcription of repetitive elements. The characteristic 
methylation patterns at pericentric heterochromatin consisting of H3K9me3 and H4K20me3 are 
established by specific histone lysine methyltransferases (HMTs). Characteristic for nearly all histone 
lysine methyltransferases is the enzymatic domain, the SET domain (Tschiersch et al. 1994; Jenuwein 
et al. 1998; Trievel et al. 2002; Yeates 2002). Several proteins have been identified to methylate 
histone H3 at Lysine 9: G9a (Tachibana et al. 2002) and GLP (Tachibana et al. 2008) form dimers, 
which have been shown to introduce mono- and di-methylation at H3K9. Setdb1 (ESET) also 
possesses activity to methylate H3K9 (Yang et al. 2002). In a complex with HP1a and CAF1 it has 
been shown to be responsible for the monomethylation of H3K9. Monomethylated H3K9 serves as a 
substrate for Suv39h1 and Suv39h2, which convert the monomethylation into di- and trimethylation 
states at pericentric heterochromatin (Loyola et al. 2009). Suv39h enzymes are recruited to pericentric 
heterochromatin in a HP1- dependent manner (Rea et al. 2000). Three histone methyltransferases have 
been identified to methylate H4K20: PrSet7 (Nishioka et al. 2002), Suv4-20h1 and Suv4-20h2 
(Schotta et al. 2004). PrSet7 (Setd8) introduces the monomethylation of H4K20 in a replication 
dependent manner. During replication, ‘old’ histones are distributed equally on both daughter strands 
and newly synthesized histones are incorporated into the nucleosomes. The monomethylation of newly 
synthesized H4 at lysine 20 is introduced in S-phase in close connection to the replication fork (Tardat 
et al. 2010). The expression of the PrSet7 protein is tightly regulated during cell cycle. Protein levels 
peak during G2/M and early G1 phase of the cell cycle (Oda et al. 2009). Various post- translational 
modifications have been identified including phosphorylation, sumoylation and ubiquitinylation 
(Abbas et al. 2010; Centore et al. 2010; Oda et al. 2010; Tardat et al. 2010; Spektor et al. 2011). 
PrSet7 has also been shown to interact with PCNA via a conserved PIP (PCNA interacting peptide) 
domain also called ‘PIP degron’ (Jorgensen et al. 2007; Huen et al. 2008; Havens and Walter 2009). 
This interaction is on the one hand crucial for the recruitment of PrSet7 to the replication fork, on the 
other hand it is important for the function of PrSet7 in DNA damage response and its cell cycle 
dependent regulation (Abbas et al. 2010; Centore et al. 2010; Oda et al. 2010). PrSet7 is a direct target 
for the E3 ligase complex CRLCdt2, which causes ubiquitin dependent degradation of its substrates. 
CRLCdt2 activity is dependent on the interaction of PrSet7 with PCNA via its PIP degron. 
Suv4-20h1 and Suv4-20h2 have been characterized as histone methyltransferases possessing specifc 
activity towards H4K20 methylation. Suv4-20h enzymes differ in their activities to induce either 
H4K20 methylation states as H4K20me2 is reduced in Suv4-20h1 knockout cells, whereas MEFs 
knockout for Suv4-20h2 almost loose H4K20me3. As different HMTases have been identified to 
methylate H3K9, Suv4-20h enzymes are the only methyltransferases, which show specific activity in 
introducing H4K20me2 and H4K20me3. They act downstream of Suv39h enzymes in a sequential 
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pathway (Schotta et al. 2004), as mouse fibroblasts depleted for Suv4-20h enzymes loose both 
H3K9me3 and H4K20 di- and trimethylation. Suv39h enzymes introduce H3K9 trimethyaltion, which 
in turn is bound by HP1 proteins. HP1 proteins recruit Suv4-20h enzymes to pericentric 
heterochromatin for establishing the trimethylation mark on H4K20. How the enzymatic activity of 
Suv4-20h enzymes is regulated is not known.  
1.7 HP1 isoforms recruit multiple proteins to chromatin 
HP1 was first discovered in D. melanogaster as a protein, which associates with pericentric 
heterochromatin. In mammals three isoforms have been identified HP1alpha, HP1beta and HP1 
gamma. The proteins consist of three domains: The N-terminal chromo domain (CD) targets HP1 to 
heterochromatin as it allows direct binding to H3K9me3 (Lachner et al. 2001; Nielsen et al. 2002)A 
flexible hinge domain (Badugu et al. 2005) is implicated in the regulation of protein/RNA/DNA 
interactions. The C-terminal chromo shadow domain (CSD) is involved in homo- and 
heterodimerization of HP1 isoforms and mediates the binding to other proteins through a pentapeptide 
motif PxVxL (Thiru et al. 2004). HP1 proteins possess multiple functions at chromatin. It has been 
originally identified in Drosophila as a chromatin binding protein, which induces transcriptional 
repression at heterochromatin (Eissenberg et al. 1990). Additionally it plays a role in telomere 
maintenance (Canudas et al. 2011; Jiang et al. 2011), replication (Maison and Almouzni 2004) and 
DNA repair (Dinant and Luijsterburg 2009). HP1 is also present in euchromatic regions, but the 
mechanism for the recruitment of HP1 proteins to transcriptionally active chromatin is not clear as 
H3K9me3 is not present in these regions (Kwon and Workman 2011).  
Figure 1.5. The interaction network of HP1 
proteins adapted from (Kwon and Workman 
2011). HP1 proteins interact with various 
proteins. Chromatin proteins, as well as proteins 
with described functions at centromeres have 
been identified to interact with HP1. Due to the 
complex interactome of HP1 isoforms they 
might serve as a hub to recruit different sets of 
proteins and complexes to specific loci and 
therefore regulate various functions. 
 
As versatile as the functions are also the proteins that have been identified to directly interact with 
HP1, which rises the question how specificity is assured and how HP1 proteins are regulated. One 
suggestion would be that different HP1 isoforms or homo- heterodimers favor specific mechanism in 
the cell, e.g. all isoforms can be recruited to pericentric heterochromatin but HP1 gamma has been 
shown to be enriched with euchromatic regions. It has also been shown that localization of the 
different isoforms varies during cell cycle (Hayakawa et al. 2003). Additional levels of specification 
can be introduced by posttranslational modifications, proposed as ‘HP1-mediated subcode within the 
histone code’ (Lomberk et al. 2006). Detailed modification analyses could show that HP1 proteins are 
INTRODUCTION 	   20	  
hyperphosphorylated (Shimada and Murakami 2010) and sumoylated at the hinge domain (Maison et 
al. 2011). Several proteins have been identified to interact with HP1 proteins, which either are 
chromatin associated or non-chromatin proteins (Figure 1.5.). The diverse interaction partners of HP1 
isoforms suggest that the protein might mediate several independent functions at chromatin and might 
even function as chromosomal hub for the recruitment of different effector proteins to specific 
chromosomal regions.  
1.8 The function of cohesin at pericentric heterochromatin 
Cohesin is a multi-subunit complex consisting of Smc1, Smc3, Scc1 (Rad21) and Scc3 (SA) 
responsible for sister chromatid cohesion in mitosis	   (Losada	   et	   al.	   1998;	   Toth	   et	   al.	   1999). ChIP 
experiments revealed that the presence of the complex correlates with genomic loci, which are 
occupied by CTCF. Cohesin and CTCF work together to mediate the long-range interactions that 
deﬁne the topology of a number of essential loci (Parelho et al. 2008; Wendt et al. 2008; Sanyal et al. 
2012). The activity of the cohesin complex is highly cell cycle regulated. Initial recruitment of cohesin 
to chromatin occurs in telophase to G1 phase of the cell cycle. During S phase the cohesion between 
sister chromatids is established, a process dependent on Sororin, Esco1, and Esco2. With onset of 
prophase the bulk of cohesin is eliminated from the chromatin arms. Several proteins have been 
identified to contribute to the active removal process like Plk1, AuroraB, Condensin I, or Wapl. 
Exclusively pericentromeric cohesin remains and is protected from global removal by Shugoshin 
(Sgo1) and PP2A. Finally at metaphase to anaphase transition, separase is activated by the APC/C and 
cleaves centromeric cohesin as well as residual cohesin on chromosome arms, a process crucial to 
finally allow sister chromatid separation (Peters et al. 2008). In ﬁssion yeast, pericentromeric 
heterochromatin is directly responsible for the sister chromatid cohesion (Bernard et al. 2001). 
However Koch and colleagues could not show an interaction of Cohesin with HP1 proteins in higher 
organisms (Koch et al. 2008), although independent studies point towards a connection between 
cohesin and pericentric heterochromatin (Gartenberg 2009). Heterochromatin protein 1 has been 
shown to interact with Shugoshin (Yamagishi et al. 2008). As Shugoshin is known to preserve 
pericentromeric cohesin from active removal, heterochromatin might be involved in this protection. 
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Figure 1.6. Cell cycle dependendent regulation of cohesin (Peters et al. 2008). Cohesin loading occurs in 
telophase/early G1 phase of the cell cycle, while cohesin establishment is mediated by Sororin and Esco1/Esco2 
in S-phase during sister chromatid cohesin. Bulk cohesin is removed from chromosome arms and is protected at 
pericentromeric regions by Shugoshin proteins (Sgo1).  
The Roberts-SC phocomelia syndrome is another example for a possible interdependency of cohesin 
and heterochromatin. This disease is an extremely rare genetic disorder caused by the mutation of the 
ESCO2 gene on 8th chromosome. Esco2 is involved in establishment and activation of cohesin and 
localizes to pericentric heterochromatin exclusively during S phase (Whelan et al. 2012). Esco2 
deficiency in mice causes mitotic defects (railroad chromosomes), which abolish development in very 
early stages. This phenotype is based on reduced Cohesin acetylation, improper sororin recruitment 
and the subsequent mis-localization of Cohesin at chromosomes causing defects in chromatid 
cohesion. Despite of some evidence predicting a correlation of Cohesin and heterochromatin it is 
currently unclear how Cohesin is recruited and maintained at heterochromatin. Additional studies 
failed to identify known heterochromatin factors like HP1 proteins to be responsible for the 
recruitment of Cohesin to regions of pericentric heterochromatin (Koch et al. 2008; Serrano et al. 
2009). Therefore additional work is necessary to identify factors mediating the recruitment of Cohesin 
to pericentric heterochromatin. 
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AIMS OF THE THESIS 
Pericentric and centric chromatin are important regions of the genome that have to be tightly 
controlled. A complex system of chromatin modifications combined with a complex network of 
protein interactions is necessary to guarantee identity and functionality of centromeres and pericentric 
heterochromatin. This enormous effort is necessary because any alteration in the structure causes 
severe phenotypes based on mitotic defects leading to genomic instability and resulting in cancer or 
other diseases. Although centromeres and pericentric heterochromatin have to be tightly controlled- 
they are permanently challenged to provide a system that is able to react to cell cycle dependent 
chromatin rearrangements and environmental changes. Therefore the chromatin has to be in a dynamic 
equilibrium and under permanent adaptation involving specific chromatin modifications and the 
dynamic recruitment of specific effector proteins and complexes. Centromeric and pericentric 
heterochromatin are tightly compacted structures, which ensure transcriptional inaccessibility. The 
mechanism by which this structural regulation is achieved and modulated throughout mitosis is 
completely unclear.  
Our lab is interested in how centric and pericentric heterochromatin is established and regulated. In 
order to unravel the complex system responsible for the regulation of heterochromatin the interaction 
network of the H3K9me3 marks should be investigated. Therefore peptide pulldown approaches and 
subsequent high sensitive mass spectrometry analyses were performed to identify novel 
heterochromatin regulating proteins. From this initial peptide pulldown screen one protein especially 
draw our interest. M18bp1 (C79407, KNL-2) was specifically enriched with the trimethylation of 
H3K9. The fact that a protein with known functions in centromere establishment and maintenance 
somehow associated with the heterochromatic context was rather surprising.  
A) Therefore I started the functional characterization of M18bp1 addressing the following questions:  
How is M18bp1 recruited to centromeric regions?  
M18bp1 was identified as a protein present at centromeric regions in a cell cycle dependent manner 
but it is unclear how it is targeted to this specific regions. 
What are the functions of M18bp1 at chromatin?  
Described as a protein involved in the priming of centromeres it was unclear what the precise function 
of the M18bp1 at centromeres is. Especially as M18bp1 was enriched with H3K9me3, a mark present 
in heterochromatin, it was obvious to ask for a potential function of M18bp1 at heterochromatin. 
What happens to a cellular system or an organism when M18bp1 is missing? 
The characterization of a mouse knockout model was basis for the functional characterization of the 
protein in the mammalian system. 
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B) Another aim was to characterize known key players involved in the establishment of pericentric 
heterochromatin like the HMTases Suv4-20h1 and Suv4-20h2 as well as HP1 proteins. Until now it is 
not clear how the compact structure at heterochromatin is established and maintained. HP1 dimer or 
multimeric complexes are suggested to be responsible for the structural features, but the concrete 
mechanism is not known.  
How is the compact structure in heterochromatin achieved?  
Suv4-20h2 has been reported to be tightly associated with heterochromatin, which was rather 
surprising for an enzyme. From this the hypothesis arose that Suv4-20h2 might display additional 
functions affecting the chromatin structure.  
Histone H4 lysine 20 methylation is established in a sequential pathway. Dependent on the presence of 
H3K9me3 and HP1 proteins the HMTases (Suv4-20h1 and Suv4-20h2) are recruited to 
heterochromatic regions (Schotta et al. 2004). The monomethylation of H4K20 is mediated by PrSet7, 
which is a tightly cell cycle regulated enzyme. Up to now it is unclear how the enzymatic activity of 
Suv4-20h enzymes is regulated to induce either H4K20me2 or H4K20me3. It has been hypothesized 
that PrSet7 in a replication dependent manner monomethylates newly synthesized histone H4 at lysine 
20, which is then converted to di- and trimethylation by the Suv4-20h enzymes. We aimed to question 
this hypothesis and asked: 
How are H4K20 specific histone methyltransferases regulated? 
 
 
 
 
 
 
 
 
 
 
 
 
 	   24	  
2. RESULTS 
2.1 The proteome of the histone H3 lysine 9 trimethylation mark in embryonic stem cells 
The N-terminus of histones is a target for diverse posttranslational modifications like phosphorylation, 
acetylation, sumoylation and methylation. These modifications index the chromatin as part of the 
epigenetic control of gene expression and recruit specific sets of effector proteins. The trimethylation 
mark H3K4 localizes to promoter regions of actively transcribed genes, whereas repressive histone 
modifications are the hallmark of heterochromatin. Two histone modifications have been described to 
be associated with pericentric heterochromatin: H3K9me3 and H4K20me3. Proteins recognizing the 
different histone modification marks have conserved domains like Bromodomain, PHD finger or the 
Royal family domains (Tudor, PWWP, MBT and Chromodomain), which are a structurally related 
group of domains (Yap and Zhou 2010). While the bromodomain exhibits affinity to histone 
acetylation marks (Hassan et al. 2007), PHD finger and chromodomain have been shown to be 
associated with methylated histone tails (Musselman and Kutateladze 2011). 
 
Figure 2.1. Binders of H3K9me3 and their possible functions. Overview of effector proteins identified for the 
H3K9 trimethylation mark, the interaction domain and the implicated function of the characterized interaction. 
The trimethylation of H3K9 is recognized by HP1 proteins, which harbor a chromodomain (CD) and a 
chromoshadow domain (CSD). While the chromodomain directly interacts with the methylated H3K9, 
the CSD allows homo- or heterodimerization and binding to other effector proteins. In addition to HP1 
proteins, also other mouse chromodomain proteins are reported to bind H3K9me3, some examples are 
depicted in Figure 2.1. The goal of this thesis was to reveal novel insights into the biological roles of 
histone methylation marks, which have been implicated in diverse biological processes ranging from 
regulation of pluripotency and development to cancer progression.  
Starting point of this study was a peptide pulldown screen, which was performed using biotinylated 
peptides derived form the N-terminus of histone H3. As other studies (Bartke et al. 2010; Vermeulen 
et al. 2010) used similar approaches in a cancer cell line (HeLa cells) the focus here was the proteome 
of a pluripotent cell line. Therefore a protocol was established to prepare nuclear extracts from mouse 
embryonic stem cells (mES cells) (Figure 2.2.A). These cells are derived from the inner cell mass 
(ICM) of the pre-implantation embryo. ES cells are pluripotent, as they can give rise to all tissue 
lineages of the three primary germ layers. 
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Additionally, ES cells display a very interesting proteome containing ‘stemness factors’ like Oct4 or 
Nanog, which can be exclusively studied in this cell system.  
 
Figure 2.2. Peptide pulldown approach. A) Scheme of the peptide pulldown approach. mES cells were 
harvested and spinned through a Ficoll gradient to remove the cytoplasmic fraction and to isolate the nuclei. The 
DNA was digested with MNase and chromatin-associated proteins were extracted with high salt buffer. The 
resulting nuclear extract was then incubated with the biotinylated peptides immobilized on a streptavidine resin. 
Upon extensive washing steps to reduce unspecific binding proteins were separated on a SDS page. B) Silver gel 
of proteins bound to H3K9 unmodified and trimethylated peptide. C. Western blot probed with HP1a antibody. 
Extracted ES cell proteins were precipitated with specific peptides, separated on a SDS page and 
visualized by silver staining (Figure 2.2.B). A well characterized protein with affinity for H3K9me3 is 
HP1. Therefore western blot with a HP1 antibody was performed to test for the quality of the nuclear 
extract and the washing conditions of the peptide pulldown (Figure 2.2.C). Several independent 
peptide pulldowns have been performed to guarantee reproducibility of the experiments. Depicted in 
Figure 2.3.A is a representative silver gel of an H3K9me3 peptide pulldown. Proteins, enriched with 
the H3K9me3 peptide compared to the unmodified control were identified by mass-spec analysis.  
 
Figure 2.3 Interactome of histone H3 lysine 9 methylation 
mark. A) Silver stained SDS page of a representative peptide 
pulldown experiment. Individual lanes were cut in 10 pieces. 
Peptides from tryptic digest were analyzed in LC MS/MS. B) 
LC MS/MS analysis of silver gel samples after peptide 
pulldown. Mascot files were analyzed using Scaffold 
proteomics software to compare independent spectra. 
Numbers presented in the table are unique spectra found in 
peptide pulldown sample. 
 
 
 
A list with the top hits is shown in Figure 2.3.B (a full list of identified proteins can be found in 
appendix table I.). All three HP1 isoforms were enriched with the H3K9me3 peptide confirming the 
western blot data and the specificity of the assay. Additionally, Trim28 (Kap1) was the top hit on this 
list of the proteins enriched with H3K9me3. Kap1 is a very complex protein involved in the genetic 
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silencing of repetitive genomic elements and acts as a scaffolding protein binding to several interactors 
like e.g. HP1 proteins (Iyengar and Farnham 2011). Interestingly aside of Kap1 many other proteins 
binding to H3K9me3 are known interactors of HP1 like Atrx and PogZ. Mass-spec analysis identified 
also several zink finger proteins like Zfp828, Zfp462, Zfp280c. Dnttip2 (ERBP; ERalpha binding 
protein) is a rather uncharacterized protein, which was enriched with the modified H3K9 peptide.  
In summary, the H3K9me3 peptide pulldown screen resulted in a long list of potential binding factors 
for the different modifications. From these data however it was impossible to judge whether the 
association is based on a direct interaction of the candidate protein with the histone methylation mark 
or whether other proteins present in the nuclear extract mediate the interaction. Further analyses were 
necessary to characterize this association and to test for a possible function of these candidates at 
heterochromatin. As all proteins were precipitated with a modification characteristic for 
heterochromatin, they should be recruited to heterochromatin regions. Therefore localization studies in 
wild type mouse embryonic fibroblasts were performed using a set of candidate proteins. The cDNA 
was expressed from a mammalian expression vector containing an EGFP-tag. HP1b, a well 
characterized protein localizing to heterochromtic foci in the nucleus was transfected as a control. 
Both C2H2 zink finger proteins Zfp828 and PogZ showed a rather broad nuclear staining only 
excluding nucleolar regions. Importantly, some of the tested proteins showed clear heterochromatic 
localization like M18bp1 and Dnttip2, which were comparable to the localization of HP1b. Dnttip2 
was additionally present in the nucleoli (Figure 2.4.). 
 
Figure 2.4. Localization of candidate proteins in mouse fibroblasts. Cellular distribution of different EGFP-
tagged candidate proteins overexpressed in wild type mouse embryonic fibroblast cells. Scale bar is 5µm. 
In a next step it was questioned whether the localization to heterochromatin is dependent on the 
H3K9me3 mark. Therefore localization studies were conducted in two knock-out cell lines: Suv4-20h 
DKO cells are depleted for Suv4-20h enzymes and therefore lack H4K20me3. Suv39h DKO cells are 
devoid of both H3K9me3 and H4K20me3, as the establishment of the H4K20me3 mark occurs in a 
sequential pathway and is therefore dependent on H3K9me3.  
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Figure 2.5. The localization of different candidate proteins is dependent on H3K9me3. Localization study 
of different EGFP-tagged candidate proteins overexpressed in wild type, Suv39h DKO and Suv4-20h DKO MEF 
cell lines. Scale bar is 5µm. 
The localization of HP1b as a well-characterized H3K9me3 binder was clearly dependent on the 
presence of H3K9me3. HP1b was enriched at heterochromatic foci in wild type and Suv4-20h DKO 
cells but showed diffuse nuclear signal upon loss of H3K9me3. Interestingly a similar localization 
pattern could be observed in the case of two other candidate proteins: M18bp1 and Dnttip2. Cells 
overexpressing Dnttip2 showed EGFP signals in nucleoli and at regions of pericentric heterochromatin 
in wild type and Suv4-20h DKO mutant cells. Interestingly in cells lacking Suv39h enzymes Dnttip2 
was still present in nucleoli but completely absent from heterochromatin. M18bp1 localized to 
heterochromatin in wild type and Suv4-20h DKO cells and showed diffuse nuclear EGFP signal in the 
Suv39h mutant fibroblast cells (Figure 2.5.). 
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2.2 The functional characterization of M18bp1 
2.2.1. The function of M18bp1 at centromeres 
M18bp1 was published as a protein, which is involved in ‘priming’ centromeric chromatin for CenpA 
deposition (Fujita et al. 2007). Confocal analysis of M18bp1 transfected mouse fibroblasts revealed 
that M18bp1 not only localized to pericentric heterochromatin but was also enriched at small foci in 
the nucleus (Figure 2.6). The small M18bp1-EGFP foci co-localized with centromeres, which were 
stained with an antibody specific for the centromere-specific histone H3 variant CenpA. But how is 
M18bp1 targeted to centromeric chromatin?  
 
Figure 2.6. Centromeric localization of M18bp1 in mouse embryonic fibroblasts. Localization study of 
EGFP-tagged M18bp1 protein overexpressed in wild type mouse fibroblasts. Centromeric regions were stained 
with a specific antibody recognizing CenpA. 
In order to identify proteins, which facilitate M18bp1 targeting to centromeres we tested several 
centromere proteins for interaction with M18bp1. In collaboration with Wen Deng in the group of 
Heinrich Leonhardt several Cenp proteins were tested for its interaction with M18bp1 in an F3H 
(fluorescent three-hybrid) interaction screen (Zolghadr et al. 2012). This assay allows an in vivo 
interaction test as a fluorescently labeled bait protein is tethered to a fixed location in the genome and 
analyzed for co-localization with a fluorescent prey fusion protein (Figure 2.7.A). In total 16 
centromere proteins were tested for their binding affinity to M18bp1. CenpA as a prey protein was not 
recruited to the nuclear focus. Instead CenpC localized to the M18bp1 focus and showed strong 
interaction with M18bp1 (Figure 2.7.B). 
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Figure 2.7. F3H interaction screen for M18bp1 interaction partners. A) Schematic drawing of the principle 
of a F3H assay. The F3H assay is an in vivo interaction assay based on a BHK cell line possessing a lac operator 
(lacO) repeat array stably integrated in the genome and fused to the EGFP binding protein (GBP). This cells line 
was further transfected with expression vectors encoding for the lac repressor (lacI), the bait protein (GFP-
M18bp1) and different RFP/pmcherry tagged prey proteins (Cenp proteins). The lacI binds directly to the lac 
operator sequence and forms a LacI-GBP fusion protein. GBP recruits the EGFP-tagged M18bp1 to the lacO 
focus, which appears as green spot in the cell nucleus. Interactions of the tested prey proteins with M18bp1 are 
measured by the red/green ratio and are used as an indicator for the strength of the tested interaction B) 
Examples of microscope analysis of F3H assay. CenpA as prey protein did not localize with the lacO array 
binding M18bp1 but CenpC was recruited to the M18bp1 nuclear focus. C) Overview of tested Cenp proteins. 
Assay was performed by Wen Deng in the group of Heinrich Leonhardt. Scale bar is 5µm. 
12 other Cenp proteins were tested in the F3H assay for interaction with M18bp1 but non of them was 
found to interact (Figure 2.7.C). Based on the initial F3H interaction screen, CenpC was identified to 
bind M18bp1. But which part of M18bp1 is required for the interaction with CenpC? M18bp1 is 
conserved in higher organisms and harbors two conserved domains, the SANT domain in the more C-
terminal part of the protein and a SANTA domain located in the middle of the protein.  
The SANT domain, initially identified as a 50-amino-acid motif that is present in nuclear receptor co-
repressors, was subsequently found in the subunits of many chromatin-remodelling complexes. It was 
named after the first proteins, which were found to have such a domain: switching-defective protein 3 
(Swi3), adaptor 2 (Ada2), nuclear receptor co-repressor (N-CoR) and transcription factor (TFIIIB) 
(Boyer et al. 2004). Sequence analysis revealed a strong similarity to the DNA-binding domain (DBD) 
of Myb-related proteins (Aasland et al. 1996). Many vertebrate proteins harboring a SANT domain 
possess also a SANTA (SANT Associated) domain, which has been identified based on a motif search 
(Zhang et al. 2006). The function of the SANTA domain is not characterized. To test if SANT and 
SANTA domains are participating in the interaction with CenpC several truncations of M18bp1 were 
generated and tested for interaction in the F3H assay (Figure 2.8.A). The N-terminus (M1 aa1-440) 
was not able to bind to CenpC while the C-terminus (M2 aa441-998) was sufficient to mediate an 
interaction with CenpC, suggesting that the SANTA domain alone is dispensable in this context. The 
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central region (M3 aa325-800) containing SANTA and SANT domain as well as a shorter fragment 
(M4) in which only the SANT domain was present showed clear interaction with CenpC, again 
suggesting that the SANTA domain is not crucial for the interaction (Figure 2.8.B). 
 
Figure 2.8. Mapping of the M18bp1 domain that interacts with CenpC. A) Scheme of the M18bp1 protein 
and conserved domains. Several truncations were derived: the N-terminus (M1), the C-terminus (M2), a central 
fragment containing both conserved domains (M3), a shortened M3 fragment lacking the SANTA domain (M4) 
and the SANT domain alone (M5). B) Microscopy analysis of the tested EGFP tagged M18bp1 fragments 
against RFP tagged CenpC. C) Statistical analysis of the interaction screen, based on automated quantification in 
several hundred cells per construct through red/green intensity values as a measurement of the strength of the 
tested interaction. Assay and analyses were performed by Wen Deng in the group of Heinrich Leonhardt. Scale 
bar is 5µm. 
To test if SANT and SANTA domains are participating in the interaction with CenpC several 
truncations of M18bp1 were generated and tested for interaction in the F3H assay (Figure 2.8.A). The 
N-terminus (M1 aa1-440) was not able to bind to CenpC while the C-terminus (M2 aa441-998) was 
sufficient to mediate an interaction with CenpC, suggesting that the SANTA domain alone is 
dispensable in this context. The central region (M3 aa325-800) containing SANTA and SANT domain 
as well as a shorter fragment (M4) in which only the SANT domain was present showed clear 
interaction with CenpC, again suggesting that the SANTA domain is not crucial for the interaction 
(Figure 2.8.B). Statistical analysis of the interaction screen, based on automated quantification in 
several hundred cells per construct through red/green intensity values provided additional information 
concerning the strength of the tested interaction (Figure 2.8.C). In the case of M4 the average 
red/green signal ratio was rather low although in confocal imaging 73% of the analyzed cells showed 
co-localization with CenpC. One explanation for the discrepancy might be that the expression level of 
RFP CenpC is lower in cells co-expressing EGFP M4, compared to the other truncations. Based on 
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these results it seemed that the SANT domain somehow facilitates the interaction and therefore a small 
fragment containing solely the SANT domain was tested. This short truncation (M5) failed to interact 
with CenpC leading to the conclusion that apart form the SANT domain other regions of the protein 
are necessary to mediate the interaction. From this analysis it can be concluded that a central region of 
M18bp1 is needed to mediate a stable interaction with CenpC.  
The interaction of M18bp1 and CenpC was further characterized in co-immunoprecipitation 
experiments. HEK cells were co-transfected with EGFP-tagged CenpC and myc-tagged M18bp1. 
CenpC was purified using nuclear extract with GFP-trap affinity resin. M18bp1 clearly co-
immunoprecipitated with CenpC providing further evidence that M18bp1 and CenpC can interact in a 
different in vivo system (Figure 2.9.). 
Figure 2.9. Co-immunoprecipitation of CENP-C and M18bp1. 
HEK293FT cells were transfected with expression plasmids for 
EGFP-CENP-C and myc-M18bp1. Nuclear extracts from these 
cells were incubated with agarose beads (control) and GFP-Trap 
affinity beads to enrich for EGFP-CENP-C and interacting bound 
proteins. Western blot analysis shows the nuclear extract (Inp), 
proteins bound to agarose beads (mock) and proteins that were 
enriched with GFP-Trap agarose beads (IP). An empty lane is 
indicated by “-”. EGFP-CENP-C and myc-M18bp1 were detected 
using antibodies against GFP and myc, respectively.  
CenpC is a conserved centromeric protein, whose very N-terminus has been shown to bind the Mis12 
complex (Screpanti et al. 2011), a complex which together with Knl1 and Ndc80 is part of the (KMN) 
network forming the inner and outer kinetochore. The central region of CenpC is responsible for its 
direct binding to CenpA (Moree et al. 2011; Dambacher et al. 2012). Chromatin binding and 
dimerization activity has been shown for the C-terminus containing the cupin domain (Trazzi et al. 
2002; Trazzi et al. 2009). A study in X.laevis (Moree et al. 2011) could show that the very C-terminus 
of CenpC is crucial for the interaction with the M18bp1 homologue. Therefore the goal was to define 
the region in CenpC crucial for its interaction with M18bp1. The cDNA of CenpC was divided into 
three constructs feasible for in vitro translation (Figure 2.10.A.). These sub-fragments were tested for 
their interaction with GST-tagged M18bp1 truncations (M1-M5). In vitro interaction studies showed 
that the N-terminal and the middle part of CenpC do not mediate the M18bp1 interaction. The N-
terminal region of M18bp1 was also not required for the binding to CenpC. In contrast the C-terminus 
and a central region of M18bp1 showed direct interaction with the C-terminal fragment of CenpC. 
From the direct binding assay the C-terminal region of CenpC was identified to be required for the 
direct interaction with a central region of M18bp1 (Figure 2.10.B.).  
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Figure 2.10. In vitro interaction studies of M18bp1 and CenpC. A) Scheme of the domain structure of mouse 
CenpC and the truncation constructs that were used in this assay. B) Recombinant GST-tagged M18bp1 
truncations (M1-M5) were incubated with in vitro translated myc-tagged CENP-C truncation proteins and bound 
to GST beads. The bound CENP-C protein truncations were detected using myc antibody. 
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2.2.2. The characterization of M18bp1 knockout mice 
To learn more about the in vivo functions of M18bp1, knockout mice provided by the EUCOMM 
project (Ayadi et al. 2012) were analyzed. Exon 4 of the M18bp1 gene was flanked by loxP sequences 
(Nagy 2000) and additionally a bGal cassette flanked with FRT sides was inserted into the locus. The 
targeting strategy results in a knockout first allele, which produces a beta-galactosidase (bGal) under 
control of the endogenous M18bp1 promoter (Figure 2.11.A). The heterozygous M18bp1+/bGal mice 
were phenotypically normal without showing any obvious defects in development, fertility or 
behavior. Intercrosses of M18bp1+/bGal mice were set up to obtain full mutant mice, however no living 
M18bp1 ko mice were observed, suggesting that M18bp1 is essential for viability (Figure 2.11.B.).  
 
Figure 2.11. Genomic locus of M18bp1 and knockout strategy. A) Schematics of the M18bp1 ko strategy. 
The bGal allele carries an integration of a b-galactosidase gene, leading to a mutant allele. FRT-mediated 
recombination converted the bGal into a flox allele, which carries loxP sites around exon 4. Excision of exon 4 
using Cre recombinase results in the loss-of-function delta allele. B) Intercrosses of M18bp1bGal/+ mice revealed 
the early lethality of M18bp1 mutants.  
To narrow down the time when these embryos die, embryos at different time points after fertilization 
(E7.5, E11.5, E13.5) were isolated. Genotyping revealed that not a single M18bp1 mutant embryo was 
generated after E7.5. These data clearly demonstrate that M18bp1 is an essential factor for early 
embryogenesis.  
Notably, in the blastocysts (E3.5) from M18bp1bGal/+ intercrosses, M18bp1bGal/bGal mutant embryos 
were detected, however, even these early embryos were developmentally retarded and displayed 
noticeable apoptotic bodies. Strikingly these early mutant embryos already showed developmental 
abnormalities while control blastocysts showed normal shapes and cellular structures. Individual cells 
showed an abnormal chromatin structure and the formation of apoptotic bodies (arrowhead) indicating 
ongoing cell death. Only a few mitotic cells could be monitored, which displayed segregation defects 
like misalignment of the metaphase plate (Figure 2.12.). Furthermore the generation of ES cell lines 
from these blastocysts failed suggesting that the outgrowth of the ICM, which gives rise to ES cells is 
also perturbed (data not shown). The malformation of the blastocyst implicates that the knockout of 
M18bp1 is lethal in the embryo at very early developmental stages at around E3.5.  
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Figure 2.12. Phenotype of M18bp1 mutant blastocysts. Confocal section of an immunofluorescence analysis 
of control and M18bp1bGal/bGal blastocysts. The mutant blastocyst displays developmental retardation, reduced 
CenpA staining and the appearance of apoptotic bodies (arrowhead). Scale bar is 6µm. 
To analyze whether defects in centromere organization might contribute to these developmental 
defects in the M18bp1 mutant blastocysts immunofluorescence analysis for CenpA was performed. 
While CenpA foci were well detectable in control blastocysts, mutant blastocysts showed reduced 
CenpA levels (Figure 2.12. middle). From these data it can be concluded that M18bp1 is essential for 
early embryogenesis through ensuring proper chromosome segregation by mediating CenpA 
incorporation into centromeric chromatin. As the straight knockout causes very early lethality 
conditional knockout mice were generated. For this purpose FLP recombination was used to remove 
the bGal cassette and to convert the M18bp1bGal allele into a flox allele. The resulting flox allele allows 
expression of a full length M18bp1 protein and can then be converted into a M18bp1 delta allele using 
Cre recombinase. Cre-mediated recombination truncates the genomic sequence of M18bp1 from exon 
3 onwards and leads to the expression of a short transcript, which could only give rise to a truncated 
non-functional protein. Dependent on the specific expression profile of the promoter driving the Cre 
recombinase expression, mutant alleles can be generated in a time- and tissue-specific manner. 
Expression data (biogps.org) describe M18bp1 as highly abundant in embryonic stem cells, 
hematopoietic stem cells and testis. As M18bp1 is highly expressed in testis, tissue-nonspecific 
alkaline phosphatase (TNAP) Cre recombinase (Lomeli et al. 2000) was used to generate a conditional 
knockout allele specifically in germ cells. Germ cells are defined as cells, which give rise to the 
gametes. Primordial germ cells (PGCs) cells in female mice enter into the prophase of the first meiotic 
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division in the ovary to become oocytes. In the testis of male mice PGCs become mitotically arrested 
to become prospermatogonia (Nakatsuji and Chuma 2001). M18bp1 was efficiently depleted in 
M18bp1fl/fl, TNAP Cre mice obtained by crossing M18bp1fl/fl with M18bp1fl/fl, TNAP Cre mice. The 
genotype of the offspring was comparable to the expected mendelian ratio. Mutant mice were born and 
did not show any obvious phenotype. Controlled matings revealed that female and male mice were 
still able to breed but breeding took longer as compared to wild type crossings.  
 
Figure 2.13. IHC analysis of ovaries and testis of M18bp1fl/fl, TNAP Cre mice. A) Ovaries of M18bp1fl/fl, 
TNAP Cre mice show ovarian cysts. B) Testis from control (M18bp1+/fl, TNAP Cre) and mutant (M18bp1fl/fl, 
TNAP Cre) mice show differences in size. C) Testicular histology was performed on material of 4 weeks old 
mice. H&E staining of control and mutant tissue as paraffin sections. Histology was performed by Alexander 
Nuber. 
The effect of the M18bp1 depletion was investigated in ovaries and testis, as TNAP Cre specifically 
deletes in germ cells. Ovaries were isolated from adult female mutant mice. Whereas the overal 
morphology looked comparable to control ovaries, M18bp1 mutants showed ovarian cysts (Figure 
2.13.A). Furthermore testes were dissected from mutant and control males. Compared to control mice 
the testes of mutant mice were severely reduced in size (Figure 2.13.B). Testicular histology was 
performed with material from 4 weeks old male mice. Male mice were fertile at 5-7 weeks. Paraffin 
sections of the 4 weeks old mice were stained with Hematoxylin and Eosin (H&E staining) to 
visualize structural tissue details. Stainings revealed that control mice showed the characteristic 
structural features of wild type tubles. In mutant mice some tubles showed normal structure while 
others were abnormally shaped with completely degenerated inner tuble structures (Figure 2.13.C). 
RESULTS 	   36	  
 
Figure 2.14. Testis phenotype of M18bp1fl/fl, TNAP Cre mice A) Cellular composition of a seminiferous 
tuble, structures were visualized with H&E staining. B) Detailed histological analysis of H&E stained paraffin 
section of control and M18bp1fl/fl, TNAP Cre mutant mice. Histology was performed by Alexander Nuber. 
In the outer rim of the testicular tubles spermatogonia and Sertoli cells are present. Spermatogonia 
(spermatogonial stem cells) are germ cells, which in the mitotic (proliferative) phase undergo either 
self-renewal or differentiation into spermatocytes. In contrast Sertoli cells are not germ cells and have 
regulatory functions in spermatogenesis. Spermatocytes undergo two meiotic divisions and give rise to 
spermatids accumulating in the centre of the tubles (Figure 2.14.A). Detailed analysis of these paraffin 
sections revealed that the severely affected tubles lost spermatogonia, spermatocytes and spermatids 
completely and only Sertoli cells are still present at the outer rim of the structure. Sertoli cells as non-
germ cells are not depleted for M18bp1 as TNAP Cre is not expressed in these cells. From these data it 
can be concluded that the loss of M18bp1 is essential for the survival of all germ cells and the lack of 
M18bp1 leads to total failure in spermatogenesis in most testis tubles. (Figure 2.14.B). 
Due to the early embryonic lethality it was impossible to obtain primary mouse embryonic fibroblasts 
(pMEFs), which are normally isolated from E13.5 embryos. Therefore an inducible system was used, 
by combining the floxed allel with an inducible Cre recombinase. This Cre recombinase (Cre ERT2) is 
fused with the ligand-binding domain of the estrogen receptor. This fusion protein is constitutively 
expressed but localizes to the cytosol.  
 
Figure 2.15. Deletion rate upon induction of the M18bp1 knockout using Tamoxifen. A) Endpoint PCR on 
genomic DNA from pMEFs of control (M18bp1+/fl; Cre ERT2) and mutant (M18bp1fl/fl; Cre ERT2) with specific 
primers detecting wt, floxed and delta allele in uninduced (- 4-OHT), control (EtOH) and Tamoxifen-induced (+ 
4-OHT) cells. B) Quantitative PCR on genomic DNA of uninduced and induced mutant cell lines with specific 
primers detecting the floxed allele. 
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Upon treatment with tamoxifen (4-OHT), the Cre recombinase can enter the nucleus and converts the 
M18bp1 floxed to a deleted allele. MEFs were isolated from E13.5 embryos from intercrosses of 
M18bp1fl/fl; Cre ERT2 mice. Cells were cultivated under low oxygen conditions and induced with 
Tamoxifen. Extensive titration experiments were necessary to adjust the Cre ERT2 system, as the Cre 
recombinase in control cells already caused some mitotic defects. Therefore the system was adjusted 
to a concentration of 4-OHT, which did not affect the control cells. The analysis of the cells was 
performed 12-24h after application of Tamoxifen. Genomic DNA was isolated to determine the 
deletion rate in mutant cell lines in standard endpoint PCR and qPCR (Figure 2.15.). Deletion after 24 
hours was rather efficient as no flox allele was detected and the deletion rate was calculated to >95% 
from qPCR data. Additionally protein levels and turnover were analyzed comparing uninduced vs. 
induced mouse fibroblast extracts in western blot. For this purpose a M18bp1 specific antibody was 
raised in rabbit against peptides (see Materials and Methods). The antibody recognizes a protein band 
above 100kDa and an additional band at around 90kDa. The calculated size of M18bp1 is 113kDa, 
which matches with the upper band on the blot. This was confirmed as the band at >100kDa 
disappears upon induction of the deletion, suggesting a high turnover of M18bp1 (Figure 2.16.A). 
 
Figure 2.16. M18bp1 cko cells show proliferation defects upon induction of the deletion. A) Western blot of control and 
induced M18bp1fl/fl; Cre ERT2 pMEFs (two cell lines) with a M18bp1 specific antibody. B) Proliferation curve of control 
and M18bp11fl/fl; Cre ERT2 pMEFs after 4-OHT induction. 
Proliferation rate of the cells was measured for up to six days after applying Tamoxifen. As the control 
cells show continuous proliferation, M18bp1fl/fl; Cre-ERT2 fibroblasts grew considerably less well and 
stopped proliferation after day3 (Figure 2.16 B). Microscopy was used to further analyze the cellular 
phenotype upon deletion of M18bp1. The control cells exhibited characteristic morphology of wild 
type primary mouse fibroblasts while the mutant cells displayed severe changes in the nuclear 
structure 12h after Tamoxifen treatment. Two phenotypes could be observed in M18bp1fl/fl; ESR Cre 
cells: an early phenotype visible 12h after depletion as M18bp1 ko cells show severe mitotic defects 
(Figure 2.17.) and a late phenotype appearing after 3-5 days of deletion when M18bp1 mutant cells 
show reduced CenpA levels. (Figure 2.18.) The early phenotype results in cells exhibiting anaphase 
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bridges, lagging chromosomes, micronuclei, blebbing of the nuclear lamina as well as less defined 
chromocenter structure. Furthermore many cells showed di- or multi-nucleation (Figure 2.17.). 
 
Figure 2.17. Mitotic defects upon M18bp1 depletion. Confocal analysis of pMEFs isolated from intercrosses 
of M18bp1+/fl x M18bp1fl/fl;Cre ERT2. Deletion was induced by Tamoxifen treatment for 24h, when cells were 
fixed and DAPI stained. 
High-resolution microscopy also revealed defects in chromosome condensation during mitosis. As 
M18bp1 was reported as a factor important for CenpA integration, CenpA levels were tested 12h and 
3 days after depletion in control vs. mutant cells using a specific antibody. CenpA levels in M18bp1 
mutant cells were well detectable 12h after depletion and comparable to control cells (data not shown). 
Interestingly 3 days after depletion, CenpA was hardly detectable in M18bp1 ko fibroblasts (Figure 
2.18.). 
  
 
Figure 2.18. CenpA levels decrease upon 
M18bp1 depletion. Confocal analysis of pMEFs 
isolated from intercrosses of M18bp1 wt/fl x M18bp1 
fl/fl ESR Cre. Mutation was induced by Tamoxifen 
treatment for 24h. Cells were fixed and stained with 
anti CenpA antibody. Scale bar is 5µm. 
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From these data it can be concluded that M18bp1 is involved in different cellular mechanisms: On the 
one hand M18bp1 may be directly involved in the regulation of mitosis and on the other hand M18bp1 
is required for facilitating the deposition of newly synthesized CenpA onto centromeric chromatin in 
primary mouse fibroblasts. 
M18bp1 ko fibroblasts show severe proliferation defects which are caused by failures during mitotic 
chromosome segregation. In order to detect alterations in the timing of mitosis M18BP1 ko fibroblasts 
expressing H2B-EGFP as nuclear marker were analyzed in live cell imaging. This method is a 
frequently used tool to monitor changes in the nuclear chromatin structure in living cells without 
compromising nuclear and chromosomal structures (Kanda et al. 1998).  
 
Figure 2.19. Time-lapse microscopy of M18bp1 knockout fibroblasts. Control and M18BP1fl/fl; Cre ERT2 
pMEFs which stably express H2B-EGFP were imaged for around 6 hours. Shown are time-series of selected 
mitotic cell divisions. 
Upon induction with Tamoxifen aberrant cell divisions could be observed in M18bp1 mutant cells. 
Preliminary timescale analysis of cells revealed no obvious delay in mitotic progression, but further 
statistical analyses are necessary to conclude this observation (Figure 2.19.). 
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2.2.3 The interaction network of M18bp1 
The depletion of M18bp1 results in a dramatic phenotype in mice as well as on the cellular level- but 
what are the precise molecular functions of M18bp1? One possibility could be that M18bp1 influences 
proteins, which are involved in centromere regulation. To identify potential candidates, a knock-in ES 
cell line was generated. Advantage of this system is, that the tagged M18bp1 is expressed under the 
control of the endogenous promoter and therefore protein levels are not altered in the cell (Figure 
2.20.).  
 
Figure 2.20. Knockin strategy for M18bp1FLAGES cells. Modification of the M18bp1 genomic locus in 
M18bp1 knock-in ES cells. These cells express a FLAG-tagged M18bp1 from the endogenous promoter. 
Importantly no changes in proliferation rate or morphology in comparison to wild type ES cells were 
observed, suggesting that the integration of the targeting cassette did not cause any cellular defects. 
Six rounds of FLAG-immunoprecipitation experiments in wild type vs. M18bp1-FLAG cells were 
performed. Bound proteins of the immunoprecipitation (IP) experiments were separated on SDS page 
and silver stained (Figure 2.21.A). The efficient precipitation of the M18bp1-FLAG was tested in 
western blot using a FLAG- specific antibody (Figure 2.21. B).  
 
Figure 2.21. Immunoprecipitation of FLAG-tagged M18bp1 from ES cells. A) FLAG tagged M18bp1 was 
purified from knock-in ES cell nuclear extract with FLAG M2 antibody. As a control, wt ES cell extract was 
used to detect unspecific binding to the M2 antibody. Proteins were separated on SDS page and visualized by 
silver staining. B) Western blot analysis to check for successful precipitation of the tagged proteins with anti 
FLAG antibody. 
Mass spectrometry analysis of proteins precipitated with FLAG- tagged M18bp1 revealed 446 
enriched proteins. Some interesting clusters could be identified among these various proteins. Known 
interactors like Mis18alpha and Mis18beta, which have been proposed to form a stable complex with 
M18bp1 underline the cell line as a valid tool for the identification of interacting proteins. Importantly 
CenpC was also specifically enriched with M18bp1 confirming interaction data. Additional proteins, 
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which have been suggested to be associated with M18bp1 (Rbbp4 and Rbbp7), were present in the list 
of precipitating proteins. Moreover the small GTPase RacGap1, which was also described to be crucial 
for the regulation of M18bp1 has been identified (Lagana et al. 2010). Furthermore a number of novel 
putative interaction partners were identified.	  Two groups of proteins were particularly interesting in 
this context: On the one hand a class containing chromatin-associated proteins and on the other hand a 
class of proteins having functions at the centromere (Figure 2.22.).  
 
 
Figure 2.22. Interaction network of M18bp1 in knock in ES cells. Heat map of proteins identified in six 
independent FLAG-IP experiments from M18bp1FLAG knock-in ES cells and wt ES cells as control. Proteins are 
clustered in chromatin proteins and centromere proteins.  
The group of centromere proteins showed HJURP as the chaperone responsible for CenpA deposition 
onto chromatin and several centromere proteins associated with M18bp1. Apart from CenpC other 
Cenp proteins were present in the protein list, like CenpT, CenpO, and CenpV. CenpV was especially 
interesting as overexpression of CenpV causes hypercondensation of pericentromeric heterochromatin 
(Tadeu et al. 2008; Honda et al. 2009). CenpO was described as an important factor to prevent 
premature sister chromatid separation and is crucial for proper kinetochore function (Hori et al. 2008). 
Interestingly also other mitotic checkpoint proteins, like components of the chromosomal passenger 
complex (CPC), Aurora B, Incenp and Borealin, as well as Bub3 and Mad2 were present in this 
dataset. 
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Within the cluster of proteins having functions on chromatin, the three isoforms of HP1 (HP1alpha, 
beta and gamma) were abundant hits. HP1 proteins are well characterized in the context of 
heterochromatin. Importantly it has been reported that HP1 isoforms associate with centromeric 
chromatin in a cell cycle dependent manner (Hayakawa et al. 2003). The heterochromatin cluster of 
M18bp1 interacting proteins revealed also several histone variants like macro H2A.1 and macro 
H2A.2 and H2A.Z. Furthermore chromatin-modifying proteins like the DNA methyltransferases 
Dnmt1, Dnmt3a, HDAC1, the HAT Myst2 (Kap7) and the HMTases specific for H3K9me3, Suv39h1 
and Suv39h2, have been identified. Interestingly Hells (Lsh) was also found in the list, which is a 
crucial factor for normal embryonic development and closely associated with pericentric 
heterochromatin (Muegge 2005). Lsh deficiency leads to abnormal heterochromatin organization, a 
loss of DNA methylation, and an altered pattern of histone-tail acetylation and methylation (Yan et al. 
2003). In summary, M18bp1 interacts with both chromatin associated and centromere associated 
proteins, suggesting multiple functions of M18bp1, which have to be further analyzed. 
2.2.4. The function of M18bp1 at pericentric heterochromatin 
M18bp1 was one of the proteins specifically enriched with the H3K9me3 peptide in several 
independent experiments. Initial confocal analyses revealed that it localizes to chromocenters upon 
overexpression in mouse fibroblasts. In M18bp1-transfected cells the chromatin structure was altered 
extensively and looked rather compacted compared to non-transfected cells. Interestingly upon 
overexpressing the EGFP-tagged M18bp1 protein in Suv39h knockout MEFs the heterochromatic 
localization was lost showing a broad nuclear staining, but still lead to compaction of the chromatin 
structure (Figure 2.23.). These data suggest that the recruitment of M18bp1 to heterochromatin is 
dependent on the trimethylation of H3K9 or the enzymes inducing this mark (Suv39h1 and Suv39h2) 
and that overexpression of M18bp1 leads to a compacted chromatin structure. 
 
Figure 2.23. Heterochromatic localization of M18bp1 in mouse embryonic fibroblast cells. Confocal 
analysis of EGFP-tagged M18bp1 in wild type and Suv39h DKO mouse fibroblasts. Cells were transiently 
transfected and DAPI stained. Scale bar is 5µm. 
Several truncation constructs have been created to map the heterochromatin- targeting domain in 
M18bp1. EGFP-tagged M18bp1 fragments divided the protein into an N-terminal part containing the 
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SANTA domain (M1) and a C-terminal part in which the SANT domain is present (M2). While the C-
terminus was localizing to DAPI dense nuclear regions comparable to the full-length protein the N-
terminus showed diffuse cytoplasmic and nuclear EGFP signal.  
 
Figure 2.24. Localization analysis of M18bp1 truncations. Various truncations of M18bp1 (full length, M1-
M5) were expressed as EGFP fusion proteins in wild type MEFs. Fixed cells were stained with DAPI and the 
nuclear distribution of the fusion proteins was monitored by confocal microscopy. DAPI-dense regions represent 
heterochromtic regions in the nucleus. Scale bar is 5µm. 
A central region containing SANTA and SANT domain (M3) was found to localize to heterochromatic 
regions. Removing the SANTA domain from this region in fragment M4 did not alter the localization. 
Furthermore a very small sub-fragment comprising only the SANT domain was expressed and showed 
a broad nuclear distribution (Figure 2.24.).  
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Figure 2.25. Mapping of the minimal heterochromatin targeting domain. Sub-fragments of M18bp1 (full 
length, M6-M12) were expressed as EGFP fusion proteins in wild type MEFs. Fixed cells were stained with 
DAPI and the nuclear distribution of the fusion proteins was monitored in confocal microscopy. DAPI-dense 
regions represent heterochromtic regions in the nucleus. Scale bar is 5µm. 
Additional EGFP-tagged M18bp1 fragments were generated in order to map the minimal region 
necessary for the targeting of M18bp1 to heterochromatin. Unfortunately all tested fragments did not 
localize to heterochromatin (Figure 2.25.). Therefore the minimal region sufficient for the recruitment 
of M18bp1 to heterochromatin is M4, a 359aa long fragment from the C-terminus containing the 
SANT domain but not the SANTA domain. From these data it can be concluded that the C-terminus of 
M18bp1 is responsible for the targeting to heterochromatin. However it is unclear what targets 
M18bp1 to heterochromatin regions in the nucleus. As M18bp1 was associated with the H3K9me3 
peptide direct interaction with these peptides was tested. Direct interaction assays were performed 
using in vitro translated myc- tagged M18bp1 and the differentially methylated H3K9 peptides. 
M18bp1 showed only weak binding affinity to the unmodified H3K9 peptide. Compared to the 
unmodified peptide, binding affinity towards methylated H3K9 peptides was higher. However 
M18bp1 was bound to all three methylation states mono-, di- and trimethylation, suggesting that 
M18bp1 has no specific affinity for the trimethylated peptide (Figure 2.26.A).  
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Figure 2.26. Interaction of M18bp1 with heterochromatin protein 1. A) Binding assay with H3 peptides and 
in vitro translated myc-tagged M18bp1 protein. B) Pulldown experiment with GST-tagged truncations of 
M18bp1 and GST as a control using nuclear extract from wild type ES cells.  
Accordingly, if M18bp1 has basic affinity to H3K9 peptides other proteins might be necessary to 
modulate the specificity toward the trimethylation state. The most abundant proteins present at 
H3K9me3 are HP1 isoforms. They are also known to interact with many proteins, which have 
functions at heterochromatin. A GST pulldown assay was performed using recombinant GST-tagged 
M18bp1 truncations (M1-M4). ES cell extract from wild type cells was incubated with proteins 
coupled to Glutathione sepharose beads. HP1 alpha was detected in western blot to bind to the C-
terminus (M2), the middle fragment (M3) and the heterochromatin-targeting domain (M4) of M18bp1 
but not to the GST control or the N-terminus of the protein (M1). Furthermore nucleosomes carrying 
the H3K9me3 mark were also enriched with the C-terminal truncations (Figure 2.26.B). 
 
Figure 2.27. Interaction of M18bp1 with heterochromatin protein 1. A) Pulldown experiment with GST-tagged 
truncations of M18bp1 and GST as a control using nuclear extract from wild type ES cells. B) Mass-spec analysis of a GST 
pulldown experiment with a central M18bp1 fragment and wild type ES cell nuclear extract. C) Binding assay of 
recombinant GST-tagged M18bp1 truncations and recombinant HP1a protein. 
These data were confirmed in mass-spec analyses using the M3 fragment and GST as a control. The 
recombinant M3 fragment precipitated the HP1 isoforms HP1b and HP1a. (Figure 2.27.B). As both 
experiments were performed with nuclear extract, other proteins present in the extract could mediate 
the interaction of M18bp1 with HP1. Therefore a direct interaction assay was performed, using 
recombinant tag-free HP1 alpha protein in a binding assay with three different C-terminal truncations 
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of M18bp1. Interaction was analyzed in western blot with a HP1 specific antibody. HP1 did not bind 
to the GST-tag suggesting that the assay condition was stringent. The N-terminus of M18bp1 did not 
bind to HP1, while HP1 was bound by the C-terminal part and the central region, which both contain 
the conserved SANT domain. (Figure 2.27.C). 
The SANT domain is a conserved protein domain present in various proteins. The function of this 
motif is still unclear as no enzymatic activity or direct affinity has been shown until now. It has been 
suggested that the SANT domain might facilitate substrate recognition of different proteins.  
 
Figure 2.28. Alignments of mouse SANT domain proteins. Alignment of different SANT domain proteins, 
conserved in M. musculus. Highly conserved regions were selected for the PCR-mediated site-directed 
mutagenesis. 
An alignment of the various SANT domain proteins conserved in M. musculus is depicted in Figure 
2.28. Residues showing highest conservation were chosen for the introduction of an amino acid 
exchange to disrupt conserved structures in the SANT domain, which might be involved in its 
function. EGFP-tagged mutant constructs were transfected in wild type fibroblasts to monitor the 
localization of these mutant proteins (Figure 2.29.A). 
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Figure 2.29. Localization of M18bp1 SANT mutant constructs. A) EGFP constructs of M18bp1 SANT 
domain mutants were analyzed for their localization in wild type mouse fibroblasts. B) Crystal structure model 
of the M18bp1 SANT domain before and after mutagenesis. Scale bar is 5µm. 
In a first step a single mutation (M18bp1W746A) resulting in an exchange of Tryptophan (W), 
containing an uncharged aromatic amino acid against Alanine (A), was generated by mutagenesis 
PCR. Testing the protein construct for its localization in wild type fibroblasts revealed that the single 
amino acid exchange in the SANT domain of M18bp1 did not alter the heterochromatic localization of 
M18bp1. As the neighboring amino acid Serine (S) was found to be also well conserved, a double 
mutant was generated (M18bp1WS746AA). Interestingly the double mutant protein failed to localize to 
heterochromatin suggesting that this motif somehow influences the targeting to this regions. In 
summary a conserved residue in the SANT domain is crucial for the heterochromatic localization of 
M18bp1 in mouse fibroblasts (Figure 2.29 A). Modeling the crystal structure of M18bp1 revealed the 
formation of a cage like structure, which might be crucial for protein-protein interactions (Figure 
2.29.B). 
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2.3. Characterization of H4K20 methyltransferases 
Heterochromatin displays a compact structure with a distinct histone and DNA modification pattern, 
which is important to repress the transcription of repetitive elements. Heterochromatic regions possess 
hypermethylated DNA and are largely devoid of acetylation marks. The characteristic methylation 
pattern at heterochromatin is established in a sequential pathway. Suv39h enzymes introduce the 
methylation at H3K9, which is in turn bound by HP1 proteins. Suv4-20h1 and Suv4-20h2 have been 
characterized as the histone methyltransferases possessing specific activity towards H4K20 upon 
recruitment to heterochromatin via direct binding to HP1 proteins. Suv4-20h enzymes differ in their 
activities to induce H4K20 methylation states as H4K20me2 is reduced in Suv4-20h1 knockout cells, 
whereas MEFs deficient for Suv4-20h2 almost loose H4K20me3. Characteristic for all HMTases is 
their enzymatic domain, called SET domain. As different HMTases have been identified to methylate 
H3K9, Suv4-20h enzymes are the predominant methyltransferases, for introducing H4K20me2 and 
H4K20me3. The H4K20 monomethylation is specifically induced by another SET domain protein 
called PrSet7 (Setd8). During replication ‘old’ histones are distributed equally onto both daughter 
strands and newly synthesized histones are incorporated. PrSet7 induces monomethylation of newly-
synthesized H4 in S phase in close connection to the replication fork protein PCNA. It has been 
proposed that in later stages of the cell cycle this mono-methyl mark is converted to either H4K20me2 
or H4K20me3 dependent on the chromatin context. In order to test this hypothesis HMTase assays 
were performed.  
The HMTases were purified form E.coli as recombinant GST-tagged proteins. PrSet7 was expressed 
as soluble protein, whereas the full length proteins of Suv4-20h1 and Suv4-20h2 were forming 
inclusion bodies in bacteria. Hence the N-termini containing the SET domains of either Suv4-20h1 
and Suv4-20h2 were used for these assays (Figure 2.30.A.).  
 
Figure 2.30. Substrate specificity of the different H4K20 methyltransferases. A) Scheme of the different 
H4K20 specific histone methyltransferases (PrSet7, Suv4-20h1 and Suv4-20h2). Depicted are the conserved 
motifs and the SET domain crucial for the enzymatic activity. B) Coomassie gel of purified recombinant GST 
tagged enzymes. C) Autoradiography of an HMTase assay with recombinant HMTases on different substrates 
(histone H4, octamers, nucleosomes) with 3H labeled SAM (S-adenosyl methionine). 
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The purity of the proteins was monitored on a Coomassie stained SDS page (Figure 2.30.B). 
Subsequently the activity was tested in an HMTase assay using different substrates: histone H4, 
octamers or nucleosomes assembled on a 12x array of the 601 nucleosome positioning sequence 
(Routh et al. 2008). All three enzymes preferentially show methyltransferase activity towards H4, but 
only in the context of the nucleosomal substrates, not on histone H4 or octamers. Suv4-20h2 showed 
the weakest activity on unmodified recombinant nucleosomes (Figure 2.30.C). In conclusion the 
H4K20-specific methyltransferases possess activity on unmodified histone H4 exclusively in the 
nucleosomal context. 
2.3.1 Suv4-20h enzymes prefer the monomethylated substrate to induce H4K20me3 
The monomethylation of H4K20 requires PrSet7 whereas di- and trimethylation are introduced by the 
Suv4-20h enzymes. The higher methylation state might be achieved by converting the 
monomethylation state (Figure 2.31.A). Therefore it was tested whether nucleosomes carrying the 
monomethylation at H4K20 are preferred substrate for Suv4-20h1 and Suv4-20h2.  
 
Figure 2.31. Suv4-20h enzymes prefer monomethylated substrates. A) PrSet7 monomethylates histone H4 in 
the nucleosomal context and provides a preferred template for the methylation by Suv4-20h1 and Suv4-20h2. B) 
HMTase assay using nucleosomal substrates and recombinant PrSet7, Suv4-20h1 and Suv4-20h2. Western blot 
of an HMTase assay using H4K20me3 specific antibody.  
HMTase assays were performed on nucleosomal arrays comparing unmodified vs. premethylated 
substrates (Figure 2.31.B). Nucleosomal arrays were premethylated with PrSet7. PrSet7 did not induce 
significant amounts of H4K20 trimethylation. Suv4-20h1 and Suv4-20h2 induced trimethylation of 
H4K20 on unmodified nucleosomes. However both Suv4-20h1 and Suv4-20h2 showed increased 
methylation activity on the premethylated substrates, suggesting that Suv4-20h1 and Suv4-20h2 
indeed prefer the H4K20me1 substrates to induce the trimethylation on histone H4.  
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2.3.2 PrSet7 interacts with the C-terminus of Suv4-20h2 
PrSet7 has several important functions during the cell cycle; it is required for chromosome 
condensation, mitotic progression and proper DNA replication. The expression of PrSet7 is tightly 
regulated during the cell cycle, with highest expression during G2/M and early G1 phase while it is not 
expressed during S phase (Oda et al. 2009). Furthermore cell cycle regulation is achieved by several 
posttranslational modifications like phosphorylation, sumoylation and ubiquitination (Abbas et al. 
2010; Centore et al. 2010; Oda et al. 2010; Tardat et al. 2010; Spektor et al. 2011). Additionally it 
harbors two PIP domains, a specialized type of PCNA interaction motif (PIP [PCNA-interacting 
peptide] domain) termed ‘PIP degron’, which allows the protein to be degraded through PCNA-
coupled CRL4Cdt2-mediated ubiquitination prior to S phase (Havens and Walter 2009; Oda et al. 
2010). Interestingly the lack of PrSet7 in mice results in a severe phenotype. Embryos die very early in 
development in the eight cell stage (Oda et al. 2009). Compared to the phenotype of Suv4-20h DKO 
mice, which die perinatally, the PrSet7 phenotype is much stronger, leading to the hypothesis that the 
monomethylation mark of H4K20 is a crucial modification requiring strict regulation to ensure 
survival of cells.  
GST pulldown experiments were performed to identify novel binding partners of PrSet7. Surprisingly 
two proteins were highly enriched with PrSet7. One was PCNA and the other one was Suv4-20h2 
(Figure 2.32. and Appendix table IV.) 
 
Figure 2.32. GST pulldown with PrSet7. A) Silver 
staining of GST pulldown experiments with recombinant 
GST-tagged PrSet7 and wild type ES cell nuclear extract. 
GST was used as a control to monitor proteins, associated 
with the tag. B) LC MS/MS analysis of GST pulldown 
experiments. Numbers depicted in the table are the unique 
spectra achieved from Mascot analysis. 
 
The direct interaction of PrSet7 and Suv4-20h2 was 
tested in binding assays. As full length Suv4-20h2 is not soluble upon expression in E.coli several 
truncation constructs were tested. The N-terminus (M1) containing the SET domain was not binding to 
PrSet7. The C-terminus (M2) showed clear interaction. Smaller fragments dividing the C-terminus 
(M4, M6) were also tested and could both bind to PrSet7 (Figure 2.33.).  
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Figure 2.33. The C-terminus of Suv4-20h2 interacts with PrSet7. A) Map of PrSet7 and Suv4-20h2 
truncation constructs used for in vitro translation. B) In vitro translated myc-tagged Suv4-20h2 truncations were 
tested for binding to GST-tagged PrSet7. Left panel shows myc- probed input of in vitro translation reactions. 
Right panel shows the bound proteins. 
The binding assay revealed that PrSet7 and Suv4-20h2 directly interact in vitro. This interaction is 
mediated by the C-terminus of Suv4-20h2. From this assay it is not possible to further map interaction 
site(s) as both non overlapping C-terminal sub-fragments of Suv4-20h2 were binding to PrSet7.  
 
2.3.3. The interaction network of Suv4-20h2 
As Suv4-20h2 is an important player present at pericentric heterochromatin it was interesting to 
identify associated proteins, which might point towards additional functions of Suv4-20h2 and to 
improve the understanding of heterochromatin formation. Two different approaches were chosen to 
identify candidate proteins interacting with Suv4-20h2: a Yeast two-hybrid (Y2H) screen and a GST 
pulldown assay. 
For the Y2H screen human SUV4-20H2 was cloned into a yeast expression vector. Yeast cells express 
the DNA binding domain (DB) of the Gal4 transcription factor fused to the bait protein. Human 
SUV4-20H2 as bait protein was fused to the DNA binding domain, which binds the upstream 
activating sequence (UAS). A human library of prey proteins was expressed as fusions to the Gal4-
activating domain (AD). Bait-prey interaction induces expression of a downstream reporter gene 
(Koegl and Uetz 2007; Mohr and Koegl 2012). From three independent screens three proteins were 
reproducibly identified to interact with SUV4-20H2. HP1a, but not HP1b or HP1g was found to 
interact with Suv4-20h2. This interaction was already characterized, as HP1 proteins are required to 
recruit Suv4-20 proteins to heterochromatin, suggesting that the assay is feasible to identify proteins 
interacting with Suv4-20h2. However it was not clear why only one isoform of HP1 was identified, as 
all three isoforms were present in the prey library, suggesting that the screening approach was not 
driven to full saturation. The undescribed protein RHOXRI and the bol like protein Boll (Boule) were 
also identified in the Y2H screen to interact with SUV4-20H2 (Figure 2.34.). As a member of the 
DAZ (Deleted in AZoospermia) family of genes Boll is highly conserved among different species 
(Shah et al. 2010). Knockout mice of Boll show male infertility due to an arrest in spermatogenesis at 
the round spermatid stage (VanGompel and Xu 2010). 
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Figure 2.34. Yeast to hybrid screen to identify 
interactors of SUV4-20H2. Y2H screen was performed 
at the Yeast Two-Hybrid Protein Interaction Screening 
Service at the DKFZ (Prof. Kögl) in Heidelberg. Suv4-
20h2 was used as bait for screening  a human genomic 
cDNA library. 
 
 
As the yeast two-hybrid screen identified only few candidates another approach was used. GST 
pulldown assays were performed using recombinant Suv4-20h2 C-terminal truncations and nuclear 
extract from mouse ES cells. GST served as control for background binding. Two Suv-20h2 
truncations were tested: M7, a fragment from the very C-terminus, which is not recruited to 
heterochromatin and a central fragment, M5, which is targeted to heterochromatin via HP1 interaction 
motifs (Figure 2.35.).  
 
Figure 2.35. Identification of proteins interacting with the C-terminus of Suv4-20h2. A) Silver staining of 
GST pulldown experiments with recombinant GST-tagged Suv4-20h2 truncations and wild type ES cell nuclear 
extract. GST was used as a control B) LC MS/MS analysis of GST pulldown experiments with recombinant 
GST-tagged Suv4-20h2 truncations and wild type ES cell nuclear extract. Numbers depicted in the table are the 
unique spectra achieved from Mascot analysis. 
Upon mass-spec analysis all three HP1 isoforms were specifically enriched with the M5 fragment. 
Interestingly PrSet7 was also found associated with the C-terminus of Suv4-20h2. These data confirm 
the GST-pulldown results obtained by the reverse assay using PrSet7 as a GST pulldown bait. 
Additionally, several other proteins were found by mass-spec analysis like LaminB1, or subunits of 
the Orc complex involved in replication (Figure 2.35. and Appendix table III.). Two other proteins, 
which precipitated with the M5 fragment of Suv4-20h2 were particularly interesting: Smc1 and Smc3. 
Both proteins are subunits of the Cohesin complex, a multi-subunit complex consisting of Smc1, 
Smc3, Scc1 and Scc3. Cohesin is well known to be crucial for proper sister chromatid cohesion and 
chromatin structure organization. 
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The GST pulldown experiments were performed with nuclear extract, which still contained DNA and 
RNA. It is known that DNA and RNA can mediate protein-protein interactions. In order to test if the 
interaction between Suv4-20h2 and Smc is dependent on nucleic acids, pulldown experiments were 
repeated with either Benzonase treated nuclear extracts or in presence of EtBr, which, in both cases 
abolish interactions that are mediated through DNA or RNA. Benzonase is a very strong nuclease, 
which degrades RNA and DNA very efficiently, while EtBr is thought to block DNA interaction. 
 
Figure 2.36. The interaction of Suv4-20h2 with cohesin and HP1 is DNA-independent. A) Endpoint PCR on 
genomic DNA. DNA isolated from sonicated nuclear extracts and Benzonase treated nuclear extract with 
primers specific for major satellite repeats. B) GST pulldown experiments with recombinant GST-tagged Suv4-
20h2 truncations. In the left panel the nuclear extract from wt ES cells was treated with Benzonase to remove 
contaminating DNA and RNA. In the right panel the incubation of GST tagged Suv4-20h2 truncations and 
nuclear extract occurred in the presence of EtBr. Western blots for GST pulldown experiments using 
recombinant GST, Suv4-20h2-M5 and Suv4-20h2-M7 were probed for GST, HP1a and Smc1. The Input lane 
contains the nuclear extract. Degradation products of the GST tagged proteins are indicated by asterisks. 
 
In both cases we could detect binding of Smc1 proteins to the Suv4-20h2-M5 fragment, demonstrating 
that the interaction is DNA- and RNA-independent (Figure 2.36.). 
2.3.4. Suv4-20h2 interacts with subunits of the cohesin complex 
Subunits of the Cohesin complex appeared as interactors of Suv4-20h2 truncations in the GST 
pulldown assay. Cohesin has been implicated in several important cellular functions. One of the most 
prominent is its role in ensuring sister chromatid cohesion during cell division. In order to confirm the 
interaction a Suv4-20h2HA-Flag knock-in ES cell line was generated for Co-Immunoprecipitation 
experiments. These cells express a HA-3xFLAG tagged fusion protein from the endogenous Suv4-
20h2 promoter. Precipitation of Flag-tagged Suv4-20h2 from these cells co-precipitated the Cohesin 
subunits Smc1 and Smc3, suggesting that a minor fraction of Cohesin, associated with 
heterochromatin binds Suv4-20h2 in vivo (Figure 2.37.).  
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Figure 2.37. Suv4-20h2 and Cohesin interact in vivo. Fractionated nuclear extracts were prepared from wild 
type (wt) and Suv4-20h2HA-FLAG knock-in ES cells (KI). Suv4-20h2 and Smc1 were precipitated from fraction II 
extracts using FLAG and Smc1 antibodies, respectively. Bound proteins were visualized by western blotting 
using FLAG, Smc1, Smc3 and Suz12 antibodies 
In the reverse experiment Cohesin subunit Smc1 was purified with a specific polyclonal antibody and 
could co-precipitate Suv4-20h2. To confirm the specificity of this assay a cohesin- independent 
chromatin protein (Suz12), which is known to associate with compacted chromatin was tested for its 
interaction with Suv4-20h2 and did not show any binding. In conclusion Suv4-20h2 associates with 
subunits of the Cohesin complex.  
2.3.5. Suv4-20h2 mediates the compact heterochromatin structure 
In addition to their enzymatic activity additional functions for the Suv4-20h proteins are not known. In 
(Souza et al. 2009) it has been shown that Suv4-20h2 is a rather immobile protein tightly associated 
with chromatin in HeLa cells. Furthermore earlier studies revealed (Schotta et al. 2004) that Suv4-
20h2 is recruited to pericentric heterochromatin, as its C-terminus directly interacts with HP1 proteins. 
HP1 is present at heterochromatic regions and correlates with transcriptional silencing. It has been 
hypothesized that based on its ability to dimerize and to interact with several other chromatin proteins, 
HP1 proteins facilitate the formation of a higher order structure that is largely inaccessible for the 
transcription machinery. Surprisingly several independent studies could show that HP1 proteins are 
highly mobile proteins in FRAP analysis arguing against a structural function at heterochromatin 
(Schmiedeberg et al. 2004). So the question arises how can a mobile protein, which is not stably 
interacting with heterochromatin can induce such a compacted structure? There might be an additional 
factor involved in the structural role of HP1 proteins. As Suv4-20h2 inetracts with HP1 proteins and 
tightly associated with chromatin it might be a candidate. In order to address this hypothesis the HP1 
interaction was further characterized in vitro. To map a minimal HP1 interaction domain several GST-
tagged fragments of the Suv4-20h2 C-terminus were cloned and purified from bacteria. The already 
known targeting domain of the C-terminus M5 (aa349-441) and a fragment of the very C-terminus of 
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the protein M7 (aa 409-468) were purified with Glutathine sepharose. Additionally several GST-
tagged sub-fragments were generated to subdivide the C-terminus into a 62aa long M12 fragment. 
Unfortunately the M12 fragment was not soluble from E.coli lysates therefore two subfragments were 
generated (M13, M14) (Figure 2.38.A). GST-tagged truncations and GST alone as a control were 
incubated with the three different isoforms of HP1 and bound to GST-beads. After several washes, 
bound proteins were analysed in western blot using specific antibodies against HP1 proteins. None of 
the HP1 isoforms was binding to the GST tag or fragment M7. The C-terminal M5 fragment 
precipitated all three HP1 isoforms. 
 
Figure 2.38. Suv4-20h2 contains several independent HP1 interaction motifs. A) Schematic of the Suv4-
20h2 protein structure. The SET domain is located in the N terminus. The C-terminus harbors the 
heterochromatin targeting module M5, which can directly bind to HP1. Sub-fragments of this domain were 
generated as depicted here. B) GST-tagged protein truncations of Suv4-20h2 (M5, M7, M13 and M14) and 
recombinant GST were bound to glutathione sepharose and incubated with recombinant HP1a, HP1b, and HP1g. 
After extensive wash steps, bound proteins were separated on SDS-PAGE, and Western blots were probed with 
HP1 specific antibodies. 
To test whether the targeting is mediated by interaction with HP1 proteins the short truncations were 
tested in in vitro binding assays. Direct binding of HP1a and HP1g to M13 and M14 was observed, 
whereas HP1b interacted exclusively with M14. Hence Suv4-20h2 displays several independent HP1 
interaction sites within a small 62aa fragment of the C-terminus (Figure 2.38.B).  
As Suv4-20h2 is tightly associated with heterochromatin it might indeed influence the structure of 
pericentric heterochromatin. To analyze this chromatin accessibility was examined using micrococcal 
nuclease (MNase) in wild type and Suv4-20h2 knockout cells. Initially, accessibility of chromatin 
from wild type, Suv4-20h2 KO and Suv4-20h DKO ES cell lines was monitored. Compared to wild 
type cells, Suv4-20h2-depleted cells show a chromatin structure, which is clearly more accessible to 
nucleases. DNA in the chromatin of cells lacking both Suv4-20h1 and Suv4-20h2 is even more 
exposed to MNase and shows therefore fast digestion. The genomic DNA originating from pericentric 
heterochromatin was visualized in Southern blot using a major satellite-specific probe (Figure 2.39).  
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Figure 2.39. ES cells lacking Suv4-20h enzymes show higher MNase accessibility. A) Chromatin structure of 
wt, Suv4-20h2 KO and Suv4-20h DKO cells were analyzed in MNase accessibility assays. Chromatin was 
partially digested with different amounts of nuclease. Ladders of genomic DNA were separated on an agarose 
gel and EtBr stained (upper panel). Major satellite repeat DNA was monitored with specific probes in Southern 
blot (lower panel). B) DNA samples were analyzed on a Bioanalyzer, correlating concentration, size and repeat 
length in comparison with an internal standard. 
 
Similar effects could be observed in mouse embryonic fibroblasts. Upon expression of Suv4-20h2 or 
M12 in Suv4-20h DKO MNase accessibility was comparable to wild type cells, proving that this re-
expression clearly rescues the chromatin compaction phenotype (Figure 2.40). Additionally DNA 
digestion patterns show an increase in the nucleosomal repeat length in Suv4-20 DKO cells compared 
to wild type cells. Upon re-expression of Suv4-20h2 or M12 fragment nucleosomal repeat length is 
again comparable to patterns achieved upon MNase digestion of chromatin from wild type fibroblast 
cells. These data suggest that Suv4-20h2 plays a role in regulating chromatin structure, as it ensures 
chromatin compaction.  
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Figure 2.40. MEF cells lacking Suv4-20h enzymes show higher MNase accessibility. A) Chromatin structure 
of wt, Suv4-20h DKO cells and Suv4-20h DKO cells re-expressing either M12 or the full length Suv4-20h2 
protein were analyzed in MNase accessibility assay. Chromatin was partially digested with different amounts of 
the nuclease. Genomic DNA was separated on an agarose gel and EtBr stained (upper panel). Major satellite 
repeat DNA was monitored with specific probes in Southern blot (lower panel). B) DNA samples were analyzed 
on a Bioanalyzer. 
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3. DISCUSSION 
3.1. The proteome of the histone H3 lysine 9 trimethylation mark in embryonic stem cells 
Pericentric heterochromatin has been associated with several important functions in the cell. It is 
involved in the regulation of gene repression and mediates chromosome segregation. But what 
specializes heterochromatin for its various functions? Pericentric heterochromatin is characterized by a 
unique histone modification pattern comprising the methylation marks H3K9me3 and H4K20me3. 
This chromatin modification state might generate affinities to recruit effector proteins, which provide 
specific activities and functions. One example is the well-characterized interaction of H3K9me3 and 
HP1 proteins (Bannister et al. 2001; Lachner et al. 2001). Recruitment of HP1 proteins mediates gene 
repression and chromatin compaction, but also additional functions might be mediated by this 
interaction (Singh 2010; Zeng et al. 2010). The identification of proteins with affinity towards the 
trimethylation of H3K9 helps to further understand the regulation of heterochromatin and to identify 
novel functions of repressive chromatin. As a screening system for novel proteins involved in the 
regulation of heterochromatin, a peptide- pulldown approach was chosen. This screen provided a list 
of candidate proteins with putative roles in heterochromatin. Well-characterized interactors for 
H3K9me3 HP1a, HP1b and HP1g were specifically precipitated with the trimethylated H3K9 peptide. 
Also several zink finger proteins like PogZ, Zfp828, Zfp462, Zfp280c were enriched with the 
trimethylated histone H3K9 peptide. All identified zink finger proteins belong to the C2H2 class of 
zink finger proteins. Cys2-His2 (C2H2) zinc finger domains were originally identified as DNA 
binding domains, but it has been shown that they can also bind RNA and mediate protein-protein 
interactions (Brayer and Segal 2008).  
Interestingly the H3K9me3 interactome contains many proteins, which are known to interact with HP1 
isoforms, like, for example, the transcriptional regulator Kap1 or the C2H2 zink finger proteins PogZ 
and Zfp828. The KRAB-associated protein 1 (Kap1, Trim28, Tif1b) was the most abundant hit in the 
H3K9me3 pulldown screen. Kap1 has been proposed as a scaffolding protein for transcriptional 
repression (Iyengar and Farnham 2011). The protein harbours several conserved domains: The N-
terminal RBCC domain is necessary and sufficient for interaction with KRAB zink finger proteins, 
which can target Kap1 to genomic regions and mediates its oligomerization. In the central region the 
‘HP1box’, containing the classical HP1 interaction motif PXVXL directly interacts with the 
chromoshadow domain of HP1 isoforms. This interaction seems to be crucial for the targeting of Kap1 
to pericentric heterochromatin. Additionally a PHD finger and a bromodomain are located in the C-
terminus of Kap1 and are required for the interaction of other effector proteins like the H3K9-specific 
methyltransferase Setdb1 (Schultz et al. 2002) or the NuRD complex. Kap1 is target for several 
posttranslational modifications, which regulate its various functions. Especially the phosphorylation of 
Kap1 at Serin 824 has been characterized in the context of a phospho-sumoylation switch (Li et al. 
2007).  
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The PHD domain functions as an intramolecular E3 ligase for sumoylation of the adjacent 
bromodomain (Ivanov et al. 2007). ATM-stimulated Kap1 Ser824 phosphorylation leads to repression 
of Kap1 sumoylation, resulting in derepression of specific genes involved in cell cycle control and 
apoptosis. Kap1 is ubiquitously expressed throughout development (Cammas et al. 2000). Mice 
lacking Kap1 die as embryos (E5.5) suggesting that Kap1 is essential for early mouse development. 
Together, these data suggest that Kap1 is a multifunctional transcriptional regulator of target genes 
and comprises important functions at heterochromatin (Iyengar and Farnham 2011). Although Kap1 is 
well characterized in many functional aspects it is currently unclear whether the interaction of Kap1 
with chromatin is a direct interaction or mediated by HP1 proteins. 
The pogo transposable element-derived protein with zinc finger domain (PogZ) was one of the first 
proteins, which have been described to bind to HP1a not through the classical HP1 interaction motif 
(PXVXL), but through a zinc-finger-like motif (Nozawa et al. 2010). The interaction region of PogZ 
required for binding to the CSD in HP1a and was mapped to amino acid 791- 850 and called HPZ 
(HP1-binding zinc-finger-like). The HPZ motif is rich in cysteine (Cys) and histidine (His) residues. 
Interaction with HP1 proteins requires the HPZ motif, as mutation of all Cys and His residues in the 
HPZ region completely abolish the interaction with all the HP1 isoforms. Featuring this motif PogZ 
competes with proteins containing the PXVXL motif for the binding to HP1 and exhibits a regulatory 
mechanism to displace HP1 specifically. The binding of PogZ to HP1 forces dissociation of HP1 form 
mitotic chromosome arms, a process, which is required for normal mitotic progression. Additionally 
PogZ is required for the regulation of AuroraB function in M phase and thus serves as a major 
regulator of mitosis (Nozawa et al. 2010).  
Zfp828 (CAMP; chromosomealignment-maintaining phosphoprotein) is a zink finger protein 
containing characteristic repeat motifs. The repeat motifs were named according to the consensus 
sequence identified: the SPE motif (consensus: PxxSPExxK), the WK motif (SPxxWKxxP), and the 
FPE motif (FPExxK). For the WK motif an interaction with MAD2L2 was shown in far-western 
analysis. MAD2L2 is involved in mitotic control mechanism as an inhibitor of the anaphase-
promoting complex/cyclosome (APC/C) (Chen and Fang 2001; Pfleger et al. 2001). Zfp828 localizes 
to chromatin and the mitotic spindle in a cell cycle dependent manner and is target for CDK-mediated 
phosphorylation at multiple sites during mitosis. Upon knockdown of Zfp828, HeLa cells displayed 
severe mitotic defects (Itoh et al. 2011). These knockdown cells did not show any alterations in HP1 
localization, however Zfp828 has been identified in interaction studies to associate with HP1 proteins 
(Vermeulen et al. 2010). These data provide evidence for a function of zink finger proteins as DNA 
binding factors, which might be responsible for recruitment of HP1 to specific genomic loci. A 
function of Zfp828 at heterochromatin has not been investigated yet. 
Another protein enriched with the H3K9me3 peptide was Dnttip2 (deoxynucleotidyltransferase 
terminal-interacting protein 2, TdIF2). Dnttip2 was first identified in a yeast two-hybid screen as 
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interactor of the terminal deoxynucleotidyltransferase (TdT) (Fujita et al. 2003). TdT is a DNA 
polymerase required for the synthesis of extra nucleotides during V(D)J recombination (Komori et al. 
1996). Dnttip2 binds core histones and binds to TdT through a C-terminal region. The formation of 
this complex inhibits TdT activity in vitro. Dnttip2 has been proposed to function as a chromatin 
remodelling protein, as it comprises binding affinity for DNA and releases histone H2A/H2B dimers 
from chromatin in a PCNA-dependent manner (Fujita et al. 2003). Dnttip2 shows nuclear and 
nucelolar localization. ChIP experiments for Dnttip2 in HEK cells expressing FLAG-tagged Dnttip2 
revealed that it is associated with the promoter of human ribosomal RNA genes (Koiwai et al. 2011). 
Koiwai and colleagues furthermore identified another interaction partner, the acetyltransferase Tat 
interactive protein 60 (Tip60), using Dnttip2 as bait in Y2H screen. The direct interaction of Dnttip2 
with Tip60 was suggested to be important for regulating HAT activity at ribosomal promoters. IF 
experiments revealed that it localizes to heterochromatin in a H3K9me3 dependent manner, however it 
is unclear what mediates the recruitment to pericentric heterochromatin and what might be the 
function. 
Surprisingly M18bp1 (Knl2, C79407), a centromere-associated protein was precipitated specifically 
with the H3K9me3 peptide. M18bp1 is present at centromeres and is involved in priming of 
centromeric chromatin for CenpA integration (Hayashi et al. 2004; Fujita et al. 2007). M18bp1 
localizes to centromeric and heterochromtic regions in the nucleus. As no function for 
heterochromatin-specific histone modifications like H3K9me3 at centromeric chromatin has been 
described in higher organisms, it was rather surprising to find M18bp1 in the H3K9me3 screen.  
In summary interaction partners of the repressive histone methylation mark H3K9me3 were identified. 
Upon those are already known effector proteins at heterochromatin, indicating that the method is a 
powerful tool to identify proteins with important functions at repressive chromatin. Further evidence 
for the identification of H3K9me3-associated proteins was given by the analysis of the nuclear 
localization of some candidate proteins. Database search revealed also proteins, which are unnamed or 
not described yet. Furthermore many proteins have been identified which are not functionally 
characterized, or not known to play a role at heterochromatin. Future projects will deal with the 
characterization of those candidate proteins. As a basis for further studies various tools were 
developed to characterize the functions of these proteins. Immunofluorescence in different cell types 
can be used for initial localization studies. The generation of knock-in ES cells is feasible to follow the 
EGFP- tagged proteins at endogenous levels in mouse embryonic stem cells and provides the 
opportunity to perform co-immunoprecipitation experiments with affinity tags to examine the 
interaction network of candidate proteins. From the extensive data set, the characterization of M18bp1 
in mouse was the central focus of this study.  
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3.2. The recruitment of M18bp1 to centromeres is mediated by CenpC 
M18bp1 has been shown to be important in several aspects of centromere formation and has been 
originally characterized as a centromere priming factor (Fujita et al. 2007). Analysing the nuclear 
distribution of this protein in mouse embryonic stem cells clearly showed that M18bp1 is present at 
both centromeric and pericentric heterochromatin. Expression of M18bp1 in wild type fibroblast cells 
showed clear co-localization with the centromere-specifc histone variant CenpA. As we have shown in 
(Dambacher et al. 2012) the localization of M18bp1 to centromeres is highly cell-cycle-regulated. 
Confocal microscopy data in mouse embryonic stem cells clearly showed that M18bp1 is present at 
centromeres in a distinct window of the cell cycle. Co-localization with CenpA can be monitored from 
anaphase through to late G1phase the time frame when the loading of newly synthesized CenpA takes 
place (Dunleavy et al. 2009). The cell-cycle-dependent localization of M18bp1 is consistent with 
previous studies in human cells (Lagana et al. 2010) underlining the evolutionary conservation of the 
protein. Although M18bp1 is present at centromeres, it was still unclear how it is recruited to 
centromere regions. The current study proposes a mechanism that is responsible for the recruitment of 
M18bp1 to centromeric regions. A central region of M18bp1, which contains a conserved SANT 
domain directly binds to the C-terminus of CenpC in vivo and in vitro. Similar results have been 
obtained in X. laevis (Moree et al. 2011), suggesting that the direct interaction of M18bp1 with CenpC 
is conserved in higher organisms. The region identified to be responsible for the CenpC interaction is a 
rather big fragment M4 (359aa), containing the SANT domain. Testing a very short fragment (M5; 
65aa) comprising solely the SANT domain did not show any affinity to CenpC, suggesting that either 
the interaction is mediated via a distinct structural feature, which cannot form upon truncating the 
protein. Another explanation would be that other protein regions are necessary to mediate the stable 
interaction with CenpC. Although the SANT domain is a conserved motif in several proteins (Boyer et 
al. 2004), for example chromatin remodeling factors, very little is known about concrete functions of 
these domain. Further experiments are required to examine whether the SANT domain is involved in 
the regulation of the M18bp1-CenpC interaction and to identify a specific function for the SANT 
domain. The introduction of point mutations in conserved motifs in the SANT domain of M18bp1 
would allow the mapping of the minimal interaction domain, which still comprises all features crucial 
for the binding of M18bp1 to CenpC. Upon mapping of the interacting regions co-crystallization 
would give further information about the nature of the interaction. Additional mechanisms might exist 
that either regulate M18bp1 or CenpC recruitment to centromeric regions or that regulate the 
interaction of M18bp1 with CenpC. As CenpC belongs to the CCAN (Constitutive Centromere 
Associated Network) it localizes to centromeres throughout the cell cycle (Foltz et al. 2006; 
Perpelescu and Fukagawa 2011), while M18bp1 is only present from anaphase until G1 phase of the 
cell cycle. The regulation of CenpC might be ensured via posttranslational modifications. It has been 
shown that M18bp1, CenpA (Silva et al. 2012) and CenpC are indeed substrates for posttranslational 
modifications, e.g. phosphorylation and sumoylation (Chung et al. 2004; Nousiainen et al. 2006; Olsen 
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et al. 2006). (Silva et al. 2012) propose a Cdk-mediated phosphoswitch model: M18bp1 is 
phosphorylated by Cdk1/Cdk2 in G2, M and S phase of the cell cycle. This phosphorylation prohibits 
recruitment to centromeres and CenpA integration. When APC/C mediates the loss of Cdk activity in 
anaphase this leads to de-phosphorylation and subsequent localization of M18bp1 to minor satellite 
repeat regions. Also CenpA is dephosphorylated and loaded upon preparation of the chromatin 
mediated by M18bp1. Interestingly, upon transient expression of CenpC (Dambacher et al. 2012), 
some cells show clear centromere localization of CenpC, which does not co-localize with M18bp1. 
This observation suggests the hypothesis that there might be additional regulatory mechanisms, which 
control CenpC or the M18bp1-CenpC interaction. M18bp1 is recruited to centromeres in a CenpC-
dependent manner, suggesting a pathway for centomere assembly beginning with CenpA as hallmark 
for active centromeres recruiting CenpC. CenpC then recruits the CenpA loading factor M18bp1 to 
centromeric regions to ensure constant CenpA levels at centromeres. Further evidence for such a 
pathway is provided by knockdown studies of CenpC in mES cells (Dambacher et al. 2012). Upon 
knockdown of CenpC in these cells, reduced CenpA levels at centromeres were observed, 
accompanied by an impaired M18bp1 recruitment to centromeric regions.  
3.3. M18bp1 is essential for early mouse development and spermatogenesis 
In order to further elucidate the functions of M18bp1, knockout mice were analyzed. The straight 
knockout in (M18bp1bGal/bGal) was prenatally lethal as no embryos were observed after E7.5. 
Furthermore the generation of ES cell lines from blastocyst stage E3.5 out of M18bp1 bGal/+ 
intercrosses failed. Microscopy of fixed blastocysts showed that already in very early stages, mutant 
blastocysts show developmental retardation. Blastocyst cells showed mitotic defetcs and reduced 
CenpA levels. Furthermore, blastocysts possessed apoptotic bodies, a DNA structure pointing towards 
cells entering apoptosis.	   
Recently (Kim et al. 2012) described the Mis18alpha knockout mouse. Mis18alpha mutant embryos 
survive until E5.5, although knockout blastocysts showed reduced CenpA levels and apoptotic cells. 
Surprisingly, CenpA mutant mice survive until E6.5 (Howman et al. 2000), suggesting that embryos 
might tolerate reduced levels of CenpA up to a certain developmental stage. M18bp1 knockout mice 
show a much earlier and more severe phenotype compared to the defects described for CenpA and 
Mis18alpha knockout embryos. CenpA is diluted during replication as the existing CenpA amount is 
distributed between the two daughter strands. Newly synthesized CenpA is integrated in G1 phase to 
re-establish the full CenpA level. Therefore a phenotype caused only by defective CenpA deposition 
would appear later, as CenpA level have to be diluted to a critical level, like in CenpA mutant mice. 
The much earlier phenotype in M18bp1 ko mice might therefore have different reasons. Further s are 
necessary to distinguish between cause and consequence leading to the severe blastocyst phenotype 
observed in M18bp1 mutant mice. Intercrosses of M18bp1 ko mice and p53-deficient mice could be 
phenotypically analyzed to investigate whether apoptosis is dependent on the p53 pathway. If p53-
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dependent pathways are responsible for apoptosis the blastocyst phenotype should be partially be 
rescued in mice lacking p53.  
For the analysis of the cellular phenotype, inducible M18bp1fl/fl; Cre ERT2 primary mouse embryonic 
fibroblasts (pMEFs) were established. Upon 4-OHT-induced depletion of M18bp1, M18bp1 ko 
fibroblasts showed strongly impaired proliferation and loss of proliferation was observed after 4-5 
days. Two phenotypes can be observed upon induction of the knockout in primary mouse fibroblasts: 
a) very early mitotic defects leading to apoptosis and b) cells which survive show 3-5 days upon Cre- 
induction severe micro- and polynucleation, altered nuclear chromatin organization and the loss of 
CenpA. The earliest defects are visible 12h after depletion. Cells showed mitotic abnormalities, like 
anaphase bridges, lagging chromosomes and not properly aligned metaphase plates, which point 
towards segregation defects. These phenotypes probably lead to apoptosis and cell death. The 
chromosomes seem to be fussy and improperly condensed. But there are also cells, which are not 
affected so severely. The reason for this is not known. Some cells might have lower Cre recombinase 
activity, resulting in a partial or delayed deletion of M18bp1. The residual M18bp1 might be sufficient 
for the survival of the cells. It could also be possible, as M18bp1 is highly cell cycle regulated, that 
cells might be able to tolerate the loss of M18bp1 in specifc cell cycle stages. Surviving cells show 
micro and polynucleation, suggesting that cell division and cytokinesis are affected. Furthermore the 
chromatin structure in the nucleus is severely altered, as chromocenters are not stochastically 
distributed throughout the nucleus and do not have a defined shape, suggesting that the loss of 
M18bp1 affects chromosome compaction and organization. A potential function of M18bp1 in 
chromatin organization has to be addressed in further experiments. The data clearly demonstrate that 
M18bp1 is absolutely essential to ensure proliferation of fibroblast cells as only a minor fraction of 
mutant M18bp1 cells, could pass through mitosis with minor defects. However cells show a loss of 
CenpA as a later phenotype after 3-5 days of deletion. As M18bp1 is involved in the deposition of 
newly synthesized CenpA onto chromatin this mechanism is blocked upon lack of M18bp1, therefore 
the existing CenpA amount is diluted with every cell cycle. It has been shown that also the reduction 
in CenpA levels can cause severe mitotic defects (Howman et al. 2000; Regnier et al. 2005). Probably 
in the first mitosis, without M18bp1, segregation defects occur that lead to apoptosis. But what are the 
reasons for such a dramatic phenotype and what are precise molecular functions of M18BP1 in the 
above-mentioned processes? Due to the lethality of the M18bp1 deletion, it is hard to distinguish 
between cause and consequence of the described defects. Rescue experiment might help to distinguish 
the phenotypes. Furthermore it might be interesting to analyze whether known centromere proteins 
still localize to centromeric regions in the absence of M18bp1.  
Interestingly it has been described that mitotic defects appearing in HeLa cells upon knockdown of 
M18bp1 could be rescued by either TSA treatment of the cells or overexpression of p300 (Fujita et al. 
2007). It would be interesting to test this in the context of the inducible M18bp1 knockdown to 
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elaborate which phenotype is caused upon changes in acetylation patterns at centromeric chromatin. 
Furthermore it would be interesting to analyze if histone modification marks like H3K4me2, 
H3K9me3, H4K20m3 and H3S10ph are altered in M18bp1 ko fibroblasts.	  Life cell imaging could be 
used to distinguish the different phenotypes. Large-scale quantification of the different phenotypes in 
correlation with mitotic progression in wild type compared to M18bp1 mutant cells could be used to 
detect potential mitotic delay induced by the activation of specific mitotic checkpoint proteins. 
Additionally rescue cell lines re-expressing M18bp1 under the endogenous promoter, can be used to 
determine the different M18bp1-specific phenotypes. To be able to distinguish the defects caused by 
the loss of CenpA from CenpA- independent defects, M18bp1 depletion could be induced in cells 
arrested in G0 phase of the cell cycle. In non-dividing cells CenpA levels should be stable. Upon 
release from G0 arrest, Cenp-A independent mitotic functions of M18bp1 could be identified. 
Additionally, CenpA deposition defects in M18bp1 ko cells could be examined by expression of 
SNAP-tagged CenpA according to (Jansen et al. 2007; Lagana et al. 2010). The SNAP-tag is a 
covalent ﬂuorescent labeling approach. Firstly the SNAP-tag allows pulse chase labelling to visualize 
all existing SNAP-tagged CenpA at the time of labelling and get information about CenpA 
maintenance. Secondly the signal of the SNAP-tagged CenpA can be quenched to allow monitoring of 
de novo synthesed SNAP-tagged CenpA, giving information about CenpA loading. Comparing wild 
type and M18bp1 knockout cells expressing SNAP-tagged CenpA can be used to detect M18bp1-
dependent changes in CenpA levels during the cell cycle.	  
As M18bp1 knockout mice die very early in development, a conditional knockout system in which 
recombination occurs in adult tissues and independent of development was analysed. M18bp1fl/fl; 
TNAP Cre mice were generated, deleting M18bp1 under a promoter specific for germ cells. The IHC 
analysis of M18bp1 mutant testis revealed two types of tubles: Some tubles looked normal and 
contained all different cell types important for proper spermatogenesis, but most tubles contained only 
Sertoli cells and showed complete abolishment of spermatogenesis, suggesting a role of M18bp1 in 
spermatogenesis. Sertoli cells are not germ cells and therefore no deletion should occur in these cells.  
M18bp1 is an essential gene for mouse development. Expression data from mouse tissues reveal that 
the protein is highly abundant in embryonic stem cells, neuronal stem cells and also hematopoietic 
stem cells, as well as testis, suggesting important functions of M18bp1 in cell types with a high 
proliferation rate. 
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Figure 3.1. Expression levels of human M18BP1 in cancer. Affymetrix expression profiling of M18BP1 in 
normal bone marrow (nBM) and different hematopoietic malignancies (data kindly provided from S Bohlander). 
M18bp1 plays essential roles for cell division and proliferation. According to this it is interesting that 
M18bp1 is overexpressed in various hematopoietic tumors (Figure 3.1.). These data suggest that tumor 
cells that need to ensure proliferation require high levels of M18bp1. Cancer cells have often up-
regulated other mitotic genes, e.g. MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, 
and TTK (Yuan et al. 2006). Mad1 mRNA is up-regulated in breast carcinomas (Yuan et al. 2006), 
small-cell lung cancer cell lines (Coe et al. 2006) and mantle-cell lymphoma cell lines (de Leeuw et al. 
2004) and its up-regulation is a marker of poor prognosis. Mad1 is a component of the mitotic 
checkpoint that remains tightly bound to Mad2 throughout the cell cycle (Ryan et al. 2012). Another 
example is Hek1 (highly expressed in cancer 1). Hek1 is a subunit of the Ndc80 complex involved in 
microtubule binding by the kinetochore. Overexpression of Hec1 in an inducible mouse model results 
in mitotic checkpoint hyperactivation, aneuploidy and tumor formation in vivo (Diaz-Rodriguez et al. 
2008). Chromosome instability and deregulated proliferation of cells have been discussed in the 
context of cancer, as no oncogene has been shown to cause cancer on its own (Coschi and Dick 2012). 
A transgenic cell or mouse model could be generated to analyse the dose dependent tumorigenic 
potential of M18bp1. M18bp1 expression could be controlled in a TET-on or TET-off system 
according to (Gossen and Bujard 1992). The appearance of aneuploidy and tumorigenesis could be 
analysed in cells and in the in vivo mouse system.	  
3.4. Centromeric and pericentric interaction partners of M18bp1 
Proteins, which interact with M18bp1 are likely to contribute to organizing centromeric as well as 
pericentric heterochromatin and might explain the severe phenotypes observed in M18bp1 knockout 
cells. A M18bp1FLAG knock-in cell line was generated and used for FLAG immunoprecipitation 
experiments. Systematic analyses of candidate proteins from mass-spec data revealed two groups of 
proteins, which are particularly interesting in the context of M18bp1. On the one hand proteins 
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associated with heterochromatin have been identified and on the other hand, centromere proteins and 
mitotic regulators associated with M18bp1 have been detected. Importantly, proteins which were 
already known to associate with M18bp1 were also present in the mass-spec datasets. (Fujita et al. 
2007) primarily described M18bp1 in a complex with Mis18alpha and Mis18beta. Based on 
knockdown experiments in HeLa cells, they concluded that the core members of the Mis18 complex 
are interdependent of each other. Upon absence of one component the remaining subunits are not able 
to localize to centromeres. Furthermore, they identified RbAp46/48 (Rbbp4, Rbbp7) to interact with 
hMis18 in a dynamic (nonstable) fashion. Mass-spec data derived from independent M18bp1 FLAG-
IP experiments showed Mis18alpha, Mis18beta and CenpC consistently enriched with M18bp1. Also 
Rbbp4 was present in the list of proteins, which precipitate with M18bp1. Rbbp4 and its homologs can 
act as autonomous chaperones. Rbbp4 was found in the multi-chaperone complex CAF-1 as well as in 
chromatin-remodeling complexes, HAT or HDAC complexes (De Koning et al. 2007). Rbbp4 and 
Rbbp7 enhance the activities of these complexes. Histone H3/H4 dimers/tetramers can interact with 
Rbbp4 and Rbbp7 (Murzina et al. 2008). Conceivably, the partial unfolding of histone H4 when bound 
to Rbbp4 and Rbbp7 chaperones might facilitate the action of ATP-dependent chromatin-remodeling 
complexes. M18bp1 has been reported to ‘prime’ chromatin for CenpA deposition, which implicates 
the recruitment of different chromatin modulating activities to centromeric regions, like HDAC, HAT, 
chromatin remodelers. In this context Rbbp4 and 7 might be interesting candidates mediating 
chromatin reorganization functions. The reorganization of the chromatin structure at centromeres is 
probably required to allow HJURP- mediated deposition of CenpA. Furthermore another protein was 
found in the immunoprecipitation experiment, which has been previously reported to associate with 
M18bp1, the small GTPase activating protein MgcRacGap (Lagana et al. 2010). 
The severe mitotic phenotypes upon depletion of M18bp1 suggest a function in mitotic regulation. 
Mitosis is crucial for the survival of organisms, as reproduction and cell division require proper 
replication and segregation of the genome (Lara-Gonzalez et al. 2012). Mitotic defects can alter 
genomic inheritance and lead to cells with altered karyotypes. Therefore cells developed several layers 
of control mechanisms ensuring that every daughter cell inherits one complement of the genetic 
information after cell division. Different mitotic checkpoints like the spindle assembly checkpoint 
(SAC), the chromosomal passenger complex (CPC) and the anaphase promoting complex (APC/C) 
monitor crucial steps of cell division. Interestingly we found components of these machineries 
associated with M18bp1: the inner centromere protein Incenp, the kinase AuroraB and Borealin (also 
known as Dasra) are components of the chromosomal passenger complex (CPC). Survivin is also 
present in the CPC (Carmena et al. 2012). The complex is highly regulated by different 
phosphorylation events, which also define its localization during cell cycle. Various functions have 
been reported for the CPC ranging from correcting chromosome-microtubule attachment errors and 
consecutive activation of the spindle assembly checkpoint (SAC), to regulation of chromosome 
condensation and cytokinesis. Interestingly depletion of CPC components in mice causes severe 
mitotic defects, which are comparable to the phenotypes in M18bp1 ko cells. Incenp mouse knockout 
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embryos die at a very early stage in development around E3.5. The analysis of E3.5 embryos shows 
compared to control embryos few cells, which were large and contained macronuclei with large 
chromosome complements. Addionally, cells show micronuclei formation, internuclear bridges and 
abnormal spindles (Cutts et al. 1999; Uren et al. 2000). AuroraB knockout cells show severe mitotic 
defects as prometaphases displayed several misaligned chromosomes and abnormal spindles 
(Fernandez-Miranda et al. 2010). The siRNA- mediated knockdown of Borealin in HeLa cells shows 
defective spindle attachment with multiple spindle poles leading to lagging chromosomes in anaphase 
and failures in cytokinesis (Gassmann et al. 2004). As members of the CPC were identified in the 
M18bp1 IP approach and additionally, phenotypes described from CPC mutant cells are comparable to 
M18bp1 ko cells, it would be interesting to test for a direct interaction of M18bp1 and CPC subunits. 
Misregulation of the CPC in M18bp1 mutant cells might explain the early phenotype.  
Furthermore the lack of M18bp1 causes defects in chromosome condensation as knockout MEFs show 
de-condensed chromosomes during anaphase. Interestingly, Condensin-depleted cells show a similar 
phenotype (Vagnarelli et al. 2006). Upon conditional knockout of SMC2 in DT40 cells, chromosomes 
lose their compact structure and show severe segregation defects and chromosome bridges in 
anaphase. In this study, the chromosome architecture in anaphase could be rescued either by 
exogenous expression of EGFP-tagged cyclin B3 or a PP1 binding mutant of Repo-ManRAXA. Repo-
Man recruits a pool of PP1γ to chromatid arms at anaphase onset. Repo-ManRAXA comprises a 
dominant negative mutant that localises to anaphase chromosomes and can block recruitment of PP1. 
They termed this activity critical for mitotic chromosome structure that is inactivated by Repo-Man–
PP1 during anaphase ‘regulator of chromosome architecture’ (RCA). The similar phenotype of 
condensing-depleted cells and M18bp1 knockout cells suggest the hypothesis that misregulation in 
condensin causes chromosome decondensation in M18bp1 mutant cells. Additional evidence is 
provided by the mass-spec dataset derived from M18bp1 FLAG-IP as condensin subunits were found 
to be associated with M18bp1. Further experiments are necessary to characterize this association and 
to determine whether M18bp1 directly interacts with the condensin complex. 
Active centromeres display a characteristic pattern of post-translatonal histone modification marks 
(Sullivan and Karpen 2004; Lam et al. 2006; Ribeiro et al. 2010; Bergmann et al. 2011). Several 
independent studies indicate that the local chromatin state is crucial for the maintenance of a 
functional kinetochore structure (Nakano et al. 2003; Nakashima et al. 2005; Nakano et al. 2008; 
Cardinale et al. 2009; Bergmann et al. 2011). The epigenetic control of centromeric regions has been 
investigated in an artificial system, human artiﬁcial chromosomes (HACs). These data suggest that 
different histone modification activities are recruited to centromeric regions. Not much is known about 
histone-modifying enzymes, which act at centromeric regions. However, ChIP experiments on minor 
satellite repeat regions showed clear enrichment for H3K9me3 at centromeric heterochromatin 
(Martens et al. 2005). Interestingly, several proteins, known from the sequential pathway involved in 
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the establishment of pericentric heterochromatin are enriched with the M18bp1 protein. Suv39h1 and 
Suv39h2, HP1a, b, g as well as Dnmts have been identified, suggesting that effector proteins at 
heterochromatin might display functions at centromeric chromatin. Another interesting candidate 
protein in this context might be CenpV. CenpV was especially interesting as overexpression of CenpV 
causes hypercondensation of pericentromeric heterochromatin. The phenotypes described by Tadeu et. 
al. upon knockdown of CenpV in HeLa cells are similar to the M18bp1 knockout phenotype: 
misalignment of metaphase chromosomes, lagging chromosomes in anaphase, cytokinesis defects and 
rapid cell death. Interestingly they describe the ‘mislocalization and destabilization of the 
chromosomal passenger complex (CPC) and alterations in the distribution of H3K9me3 in interphase 
nucleoplasm’ (Tadeu et al. 2008; Honda et al. 2009) providing further evidence for connected 
regulatory pathways in centromeric and pericentric heterochromatin. 
3.5. M18bp1 is recruited to pericentric heterochromatin via direct interaction with HP1 
Originally we got interested in M18bp1 from data of a peptide pulldown from ES cells, as M18bp1 
was enriched with the repressive histone modification H3K9me3. Localization studies in mouse 
fibroblast cells revealed that M18bp1 localizes to heterochromatic foci. This localization was clearly 
Suv39h- or H3K9me3-dependent. The central region of M18bp1 (M4) was mapped to be sufficient for 
targeting the protein to pericentric heterochromatin through direct interaction with HP1 isoforms. 
Interestingly the overexpression of M18bp1 in fibroblasts seems to be toxic for the cells, as cells 
expressing high levels of M18bp1 show highly condensed chromatin and apoptosis. Cells with lower 
expression levels of M18bp1 show a compacted chromatin structure with less chromocenters. The 
cells expressing M18bp1 show less chromocenters, which are more compacted compared to non-
transfected cells. 
In order to understand the potential function of M18bp1 at major satellite repeats we screened the data 
from immunoprecipitation experiments performed with the FLAG-tagged M18bp1 from knock-in ES 
cells. These data contain several proteins with characterized functions at pericentric heterochromatin 
(Suv39h1, Suv39h and the three HP1 isoforms). Remarkably all three HP1 isoforms precipitate with 
M18bp1. The interaction of M18bp1 with HP1 proteins was characterized in direct binding assays. 
The region of M18bp1 interacting with HP1 was mapped to a central fragment, which we originally 
found to mediate the interaction with CenpC. The shortest M18bp1 fragment interacting with HP1 was 
M4 with more than 300aa. HP1 proteins are highly conserved heterochromatin-associated proteins. 
Each of the three isoforms possesses conserved domains: The chromodomain (CD) mediates 
interaction with heterochromatin, while the chromoshadow domain (CSD) mediates dimerization of 
HP1 and recruitment of a variety of other nuclear chromatin-modifying proteins. Many of these HP1 
binding partners contain a consensus PXVXL motif (Smothers and Henikoff 2000; Thiru et al. 2004). 
M18bp1 sequence was analysed to identify a HP1 interaction motif. There was no classical consensus 
sequence- but one motif, which might mediate the binding to HP1 (Figure 3.2.). Mutagenesis of this 
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potential interaction motif might help to further characterize the M18bp1 interaction with HP1 
proteins. The chromo shadow domain of HP1 proteins has been reported to mediate protein-protein 
interactions. Therefore this domain should be tested in direct binding assays with recombinant 
M18bp1 truncations. 
 
Figure 3.2. Summary of biochemical analyses of M18bp1 truncations. M18bp1 binds to histone H3 peptide 
trimethylated at lysine 9. A central region (M4) has been identified in binding assays to directly bind to HP1 
isoforms and is also sufficient to target M18bp1 to heterochromatin in mouse fibroblasts. A putative HP1 
interaction motif has been identified (aa585-589). 
Alignment of the known mouse SANT domain proteins identified conserved amino acids within the 
SANT domain, which was used to introduce point mutations. The single point mutant M18bp1W746A 
was able to localize to heterochromatin, the double mutant M18bp1WS746A showed a diffuse nuclear 
localization pattern. The SANT domain has been crystalized from other proteins like the chromatin 
remodeler Chd1 (Ryan et al. 2011). Modeling the structure of the M18bp1 SANT domain based on 
these data revealed that the domain forms a cage-like structure with the conserved residues pointing 
towards the center of this cage. The structure itself might be important for mediating the binding of 
M18bp1 with other proteins. Further analyses are necessary to explain the functions of the SANT 
domain. This might also help to characterize the interaction of M18bp1 with HP1 proteins and its 
potential function at heterochromatic regions. 
The binding of M18bp1 to HP1 proteins is sufficient to recruit M18bp1 to heterochromatin. But 
further analyses are necessary to investigate the function of M18bp1 at pericentric heterochromatin. 
There is some evidence from S.cerevisiae (Pidoux and Allshire 2005) and D. melanogaster (Olszak et 
al. 2011) that heterochromatin is crucial for proper centromere formation. If heterochromatin 
somehow affects centromeres in mammalian cells is currently unclear, although there is evidence that 
such a regulatory mechanism might exist. (Kim et al. 2012) observed epigenetic changes when 
Mis18alpha is missing. Mis18 alpha knockout fibroblasts show reduced CenpA levels and a decrease 
in H3K4me2. Furthermore, the loss of M18bp1 causes reduction in classical heterochromatin marks 
like decreased H3K9me3, increase in acetylation and a decrease in DNA methylation at minor satellite 
repeats. Also well-characterized proteins associated with pericentric heterochromatin like HP1a, HP1b 
and Suv39h1 are reduced at minor satellite repeat regions. These data suggest that the Mis18 complex 
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might be important for pericentric heterochromatin in mammalian cells. ChIP experiments are 
necessary to analyse changes in histone modification patterns and HP1 levels at minor and major 
satellite repeat regions in the absence of M18bp1.  
 
Figure 3.3. The various functions of M18bp1. M18bp1 possess various functions at centromeric and 
pericentric heterochromatin. A) M18bp1 is involved in several steps wihich are important for CenpA deposition. 
It is recruited to centromeric chromatin in early G1 phase in a complex with Mis18alpha and beta. M18bp1 
somehow prepares the chromatin to allow CenpA deposition by the CenpA specific chaperone HJURP in mid 
G1 phase. In late G1 phase M18bp1 together with MgcRacGap is involved in the maintenance of newly 
integrated CenpA B) M18bp1 localizes to pericentric heterochromatin and binds to HP1 isoforms. It might be 
involved in defining the border of centromeric heterochromatin. C) Cells lacking M18bp1 show severe mitotic 
defects leading to cell death. M18bp1 is important for proper chromatin condensation during mitosis and might 
associate with the machinery of the mitotic checkpoint control like the chromosomal passenger complex (CPC) 
complex. Mitotic pictures adapted from http://alevelnotes.com/Eukaryotic-Cellular-Division-Process/147. 
In summary M18bp1 might possess several functions on chromatin as depicted in (Figure 3.3.). A 
well-described function of M18bp1 is its contribution to centromere establishment through regulation 
of CenpA deposition and maintenance (Figure 3.3 A). Based on data achieved in this thesis M18bp1 
might have additional functions at heterochromatin. The HP1-mediated recruitment to pericentric 
heterochromatin might define the border between pericentric and centromeric chromatin (Figure 3.3 
A). Based on the analysis of the cellular phenotype in M18bp1 knockout fibroblasts, M18bp1 might 
interact with subunits of the chromosomal passenger complex, required for proper progression through 
mitosis (Figure 3.3.C). 
3.6. Novel functions of Suv4-20h2 
Three proteins have been identified to mediate the methylation of H4K20. PrSet7 has been 
characterized as the only HMTase responsible for the monomethylation of H4K20 (Nishioka et al. 
2002). Suv4-20h1 and Suv4-20h2 are recruited to chromatin in an HP1-dependent manner to introduce 
the di-and trimethylation of histone H4 on lysine 20 (Schotta et al. 2008). While PrSet7 is highly cell- 
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cycle regulated and target for various posttranslational modifications, the regulation of Suv4-20h 
enzymes is rather unknown. The direct interaction of PrSet7 and Suv4-20h2 might indicate a 
synergistic regulation of both HMTases. In order to identify the functional context this interaction 
further experiments have to be done.  
Heterochromatin is an important structure in the cell and involved in various functions. Defects in 
heterochromatin formation result in improper transcriptional regulation and cause chromosome 
instability. Heterochromatin is defined as rather transcriptionally inert and forms a very compacted 
structure. This compacted chromatin structure is hypothesized to be achieved by a network of multi-
merized HP1 proteins. This hypothesis has been questioned as HP1 proteins appear to be highly 
mobile in FRAP analysis (Schmiedeberg et al. 2004). Additional proteins might therefore be required 
to mediate a compact chromatin structure. A known interactor of HP1 present at heterochromatin is 
Suv4-20h2 (Schotta et al. 2008). Interestingly Suv4-20h2 has been shown to be a stable component of 
heterochromatin in FRAP experiments (Souza et al. 2009).  
The region in Suv4-20h2, harbouring the HP1 interaction motifs, was mapped to a 62aa fragment  
(M12) in the C-terminus. Each sub-fragment of M12 (M13 and M14) independently binds HP1 
isoforms in vitro, suggesting that Suv4-20h2 comprises several independent HP1 interaction domains 
in the C-terminus of the protein. FRAP analyses in mouse embryonic fibroblasts expressing EGFP- 
tagged Suv4-20h2 and the M12, M13 and M14 truncations of Suv4-20h2 revealed that M12 is as 
stably bound to heterochromatin as the full length protein. M13 and M14 show higher mobility 
(unpublished data M.Hahn). The direct binding assays and the FRAP data provide evidence, that each 
of these single interactions might synergistically contribute to the stabilization of Suv4-20h2 through 
multiple HP1 proteins.  
Additional evidence for a structural role of Suv4-20h2 at heterochromatin is provided by MNase 
accessibility assays. Chromatin from cells lacking both Suv4-20h1 and Suv4-20h2, or only Suv4-20h2 
comprises a more open chromatin structure. Importantly, the re-expression of full-length Suv4-20h2, 
or the M12 fragment, is able to re-establish a compacted chromatin structure, comparable to chromatin 
from wild type cell. MNase digestion patterns show a shift in the nucleosomal repeat length upon loss 
of Suv4-20h enzymes. Changes in nucleosome repeat length might implicate changes in nucleosome 
linker length caused by reduced linker histone H1 levels. If this effect is mediated by Suv4-20h2 and 
specific for pericentric heterochromatin has to be further investigated. ChIP experiments quantifying 
H1 levels at major satellite repeat and control regions in wild type and Suv4-20h2 KO cells might 
provide further information. Long linker length correlates with a more open chromatin structure, 
whereas short linker sequences are present in compacted chromatin (Grigoryev 2012). The loss of H1 
leads to global shortening of the spacing between nucleosomes in thymus nuclei from wild type and 
H1-triple-null mice (Fan et al. 2003). Upon MNase digest, chromatin from the H1-deﬁcient mutant 
nuclei migrates faster than that from wild-type nuclei, which is comparable to the effect observed in 
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Suv4-20h mutant cells. Together, these data imply that Suv4-20h2 is a central component of 
heterochromatin regulating chromatin accessibility. As a scaffolding protein it binds multiple HP1 
proteins, bridging H3K9me3- rich heterochromatin domains, which then might lead to the stable 
inaccessible structure of heterochromatin. Additionally, Suv4-20h2 might regulate additional proteins 
like linker histone H1, which facilitate the structural function of Suv4-20h2 at heterochromatin.  
Cohesin is present at pericentric heterochromatin but it is not known how the recruitment to 
heterochromatin is mediated. In fission yeast it has been shown that Cohesin is recruited to 
heterochromatic regions by Swi6/HP1 proteins (Nonaka et al. 2002). In mammalian cells, Cohesin 
does not interact with HP1 proteins (Koch et al. 2008). Therefore it is currently not known which 
proteins are involved in recruitment and maintenance of Cohesin at pericentric heterochromatin. In 
GST pull- down experiments using a C-terminal GST-tagged Suv4-20h2 fragment, cohesin subunits 
(Smc1, Smc3) were precipitated. Co-immunoprecipitation experiments using either FLAG- tagged 
Suv4-20h2 or using Smc1 antibody provided additional evidence that Suv4-20h2 is associated with the 
Cohesin complex. Further indication that Suv4-20h2 might be involved in the recruitment of Cohesin 
to pericentric heterochromatin was provided by ChIP experiments. Comparing levels of cohesin 
subunits (Smc1 and Rad21) in wild type and Suv4-20h2 KO mouse embryonic fibroblasts, cohesin 
was selectively reduced at major satellite repeat regions in Suv4-20h2-deficient cells (unpublished 
data S. Dulev). 
 
 
Figure 3.4. The functions of Suv4-20h2. A) Suv4-20h2 is part of the core protein network required for 
establishment of pericentric heterochromatin. Suv4-20h2 directly interacts with PrSet7 and converts the 
monomethylation of H4K20 into trimethylation. B) Suv4-20h2 is an important constituent of pericentric 
heterochromatin. It provides several HP1 binding sites to tether these proteins to heterochromatin and therefore 
to ensure a compact chromatin structure. C) Suv4-20h2 is required for the recruitment of cohesin to pericentric 
heterochromatin. 
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In summary several novel functions of Suv4-20h2 can be proposed based on the work of this thesis. 
Suv4-20h2 directly interacts with PrSet7, the enzyme responsible for the monomethylation at H4K20. 
It preferentially converts nucleosomes monomethylated at H4K20 into trimethylated nucleosomes, 
suggesting that PrSet7 and Suv4-20h2 are acting in a synergistic manner to introduce H4K20me3 at 
pericentric heterochromatin (Figure 3.4.A). Suv4-20h2 is a stable constituent of pericentric 
heterochromatin and is required to tether HP1 proteins to heterochromatin ensuring the highly 
compacted chromatin structure at pericentric heterochromatin (Figure 3.4.B). Data provided in this 
thesis furthermore propose Suv4-20h2 as crucial for the recruitment of cohesin to pericentric 
heterochromatin (Figure 3.4.C). 
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4. MATERIAL AND METHODS 
4.1 Cell biology methods 
Cultivation of mammalian cell 
HEK cells were cultivated in High Glucose DMEM with L-Glutamine complemented with sodium 
pyruvate, penicillin/streptomycin (PAA) and fetal calf serum (Sigma). MEF and ES cells were 
cultivated in High Glucose DMEM with L-Glutamine complemented with sodium pyruvate, fetal calf 
serum (Sigma), beta-mercaptoethanol, non-essential amino acids (PAA) and penicillin/streptomycin 
(PAA) in a 37°C incubator at 5% CO2. For ES cell culture medium was supplemented with leukemia 
inhibitory factor (LIF) and gelatinized tissue culture dishes were used. 
Transfection  
Cells were transfected on slides using Lipofectamine 2000 (Invitrogen) or TransIT-LT1 (Mirus) 
according to the manufacturers instructions. ES cells were seeded on matrigel (BD Biosciences) 
coated slides 24h before transfection. 
Immunofluorescence and microscopy 
Immunofluorescence analyses were performed as described (Lehnertz et al. 2003) using the antibodies 
depicted in Table 4.5. 
A Leica TCS SP5 confocal laser scanning microscope with a HCX PL APO CS 63x/1.3 NA glycerol 
immersion objective and a Zeiss LSM510 confocal microscope were used to obtain the images. 
Sequential excitation at 405nm, 488 nm, 543 nm and 633nm was provided by diode, argon and 
helium-neon gas lasers, respectively. Emission detection ranges of the PMTs were adjusted to 
minimize crosstalk between the channels. Images were further analysed using ImageJ software. 
For live cell imaging, cells were cultivated in optical chambers (Ibidi) using pMEF medium buffered 
with 20mM HEPES under low oxygen conditions at 37°C for 24 hours. Then 3nM Tamoxifen was 
added and cells were monitored for 12h.  
Knockin- ES cell lines 
The Suv4-20h2-EGFP targeting constructs were obtained using the recombineering cloning technique 
described previously (Liu et al. 2003). To generate Suv4-20h2HA-FLAG knock-in cells, the NotI-
linearized targeting vector was electroporated into feeder-independent wild type ES cells. Cells were 
selected in 180 µg/ml G418 (PAA) and 2 µM Ganciclovir (Invivogen). Single colonies were picked 
and screened by nested PCR to obtain the final ES cell clone.  
MATERIALS AND METHODS 	   75	  
The M18bp1-FLAG targeting constructs were obtained using the recombineering cloning technique 
described previously (Liu et al. 2003). To generate retrieval and mini-targeting vectors, PCR 
fragments were amplified from the BAC clone RP23-396P24 (Children's Hospital Oakland Research 
Institute). For the retrieval plasmid, PCR fragments were cloned into the pL253 plasmid using NotI, 
HindIII and SpeI. A genomic region of 7 kb, spanning the last exons of M18bp1, was retrieved from 
the BAC clone using recombineering in EL350 bacteria. The mini-targeting plasmid was constructed 
by generating PCR fragments flanking the M18bp1 stop codon. These PCR fragments were cloned 
together with the floxed Neo cassette from pL452 (EcoRI-BamHI fragment) into pBluescript IISK+ 
using NotI, EcoRI, BamHI and SalI. In a subsequent cloning step, the EGFP tag was inserted with 
EcoRI. For the final targeting vector, the 7 kb region was mini-targeted by recombineering with the 
NotI-SalI fragment containing the EGFP and floxed Neo from the minitargeting plasmid. To generate 
M18bp1 knock-in cells, the NotI-linearized targeting vector was electroporated into feeder-
independent wild type mouse ES cells. Cells were selected in 180 µg/ml G418 (PAA) and 2 µM 
Ganciclovir (Invivogen). Single colonies were picked and screened by nested PCR to obtain the final 
ES cell clone (K2A7).  
4.2 Molecular biology methods 
 Cloning of candidate proteins 
cDNAs were obtained by PCR on genomic DNA template purified from either mouse fibroblasts or 
embryonic stem cells. Primers were designed with gateway att- side overhangs. Cloning was 
performed using gateway cloning system (Invitrogen) following the manufacturers instructions. 
Primers used for cloning are listed in Table 4.3. 
 Site directed mutagenesis PCR to create point mutations 
Primers containing the DNA sequence leading to point mutation in the amino acid sequence of the 
protein were designed. Mutagenesis primer are listed in Table 4.3. The mutagenesis PCR was done 
following the manufacturers instructions for Quick change site directed mutagenesis kit using Pfu 
Polymerase (Stratagene). The template was digested with the restriction enzyme DraI (NEB). 
Chemically competent E.coli (Stellar) were transformed with 5ul of the reaction using heat shock 
procedure and selected on agar plates containing the adequate antibiotics. DNA was purified and 
mutagenesis was verified by sequencing. 
RT-qPCR for monitoring M18bp1 expression levels 
RNA of cells was harvested using RNeasy (Qiagen). 1.25 µg RNA was used for cDNA synthesis 
using Superscript III Kit (Invitrogen) and random hexameric primers (NEB). QPCR reactions were 
carried out in technical triplicates using a Roche Light Cycler 480 with FAST SYBR® Master Mix 
(Applied Biosystems), and gene-specific primers. Ct-values were normalized to the geometric mean of 
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Actin and Gapdh for each individual cDNA and fold changes where calculated by the 2-ΔΔCt-method 
(Vandesompele et al. 2002). qPCR primer are listed in Table 4.4. 
4.3 Biochemical Methods 
Determination of protein concentration 
The concentration of proteins was determined using Bradford assay (Bradford 1976; Compton and 
Jones 1985).  
 SDS page 
Separation of proteins by SDS-PAGE was performed in the PerfectBlue Dual gel Twin system 
(Peqlab) using precast gel cassettes (Invitrogen). Resolving and stacking gels were poured according 
to the manufacture’s instructions using 30% (v/v) polyacrylamide solution (Rotiphorese, 37.5:1 
acrylamide/bisacrylamide) and resolving gel buffer (375 mM Tris/HCl pH 8.8) or stocking gel buffer 
(125 mM Tris/HCl pH 6.8) respectively. Prior to loading samples were mixed with Roti Load1 (Roth) 
and heat-denatured for 7 min at 95°C. Various molecular weight protein standards were purchased 
from Bio-Rad/Peqlab. Electrophoresis was performed at 40 - 80 mA at RT for varying time. SDS gels 
were either used for Coomassie staining, silver staining or western blotting. 
 Coomassie staining of protein gels 
Proteins were visualized in SDS page by incubating in staining solution [0.1% Coomassie R250, 10% 
acetic acid, 25% methanol] for 15 min at room temperature. Destain [8% acidic acid, 25% methanol in 
water] was used to remove excessive staining solution. 
Silver staining of protein gels 
SDS page was fixed in fixation solution [10% acetic acid, 30% isopropanol] for at least 2h or over 
night at room temperature. The gel was washed 3x 20min in 30% ethanol followed by sensitizing 
using 0.01% Na2S2O3 for 1min at room temperature and washed 3x 30sec with water. Staining 
solution [0.1% AgNO3 in H2O] was applied for 1h at room temperature shaking. The gel was again 
washed 3x 30sec with water and incubated with the developer solution [3% NaCO3, 0.05% 
formaldehyde, 0.02% Na2S2O3 in H2O]. Reaction was stopped by adding 5% glycine solution. Rinsed 
in water and stored in water at 4°C. 
 Western blot 
Proteins separated by SDS-PAGE were transferred to to a PVDF membrane (Roth). Transfer was 
achieved with a wet blot system (Criterion Blotter, Bio-Rad). Before the transfer, the polyacrylamide 
gel and the PVDF membrane was activated in MeOH and rinsed in blotting buffer [25 mM Tris, 192 
mM glycine, 10% methanol]. The transfer was performed at 400mA for 1h at 4°C. The membranes 
were incubated in Blocking Buffer [1 x PBS, 3% BSA] for 1 h at RT in order to saturate free binding 
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sites on the membrane and hence minimize the non-specific background. After blocking the 
membranes were incubated either for 2.5h at RT or o/n at 4°C with an appropriate dilution of the 
primary antibody. The membranes were extensively washed for 3 x 20min in [PBS-T Buffer 1 x PBS, 
0.05% (v/v Tween 20)]. The HRP-coupled secondary antibody was incubated for 1-1.5h at room 
temperature in the appropriate dilution in 3% skimmed milk in 1x PBS. The membranes were again 
washed 3x 20min in PBS-T and exposed to X ray films upon using ECL developer solution mix 
(Amersham biosciences). 
 Generation and purification of M18bp1 antibodies 
M18bp1 antibody was raised with (Gramsch Laboratories) in rabbit immunized with two peptides 
derived from the mouse protein.  
 
Figure 4.1. Peptides used for antibody generation.  
Antibody serum was purified using Protein A/Protein G Agarose beads, eluted with glycine pH 2.5 
and immediately neutralized by 1M Tris pH 12 and tested on extracts from mouse embryonic stem 
cells. 
Generation of nucleosomal substrates 
Recombinant human histones were expressed in Bl21 E. coli and purified according to (Morales et al. 
2004). To obtain linear 601 arrays, the insert was cut out with EcoRI and HindIII. Plasmid DNA was 
digested by DraI to 19, 692, 811 and 1113-bp fragments serving as competitor DNA. Nucleosomal 
arrays were assembled by continuous salt dialysis as described in (Huynh et al. 2005). Arrays were 
purified by precipitation with 5 mM MgCl2 (Schwarz et al. 1996). 
 
 Expression and purification of GST tagged proteins from E. coli 
GST fusion proteins were expressed from pGEX6P1 vector in E. coli Bl21 (Stratagene). Bacteria were 
induced at OD 0.6 by adding 1mM IPTG at 37°C for 3h or over night with at 25°C. Harvested cells 
were resuspended in Lysis buffer [20 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, 1mM DTT, 
complete (Roche)] and disrupted using a Branson sonicator. Suspension was adjusted to 1%Triton and 
incubated for 30min at 4°C. Cell debris was removed by centrifugation 60min 12000 rpm 4°C. GST 
tagged proteins were bound to Glutathione-S-Sepharose beads (Amersham Biosciences) for 1h 4°C 
rotating. After washing with 10x bed volume of wash buffer I [20mM Tris pH 7.5, 500 mM NaCl, 2 
mM EDTA, 1% Triton-X-100 und 1mM DTT], wash buffer II (20 mM Tris pH 7.5, 150 mM NaCl, 2 
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mM EDTA, 0.1% TritonX-100 und 1mM DTT] und wash buffer III [20 mM Tris pH 7.5, 150 mM 
NaCl, 2 mM EDTA und 1mM DTT] bound proteins were eluted with elution buffer [10mM Tris [pH 
8.0], 10 mM Glutathion], dialyzed against 1xPBS,20% glycerol snap frozen and stored at -80°C. 
 Peptide pulldown assay 
50µg of biotinylated peptides were bound to 50µl streptavidine beads (Dynabeads C1 Invitrogen) for 
1h at room temperature on a rotation wheel in binding buffer [50 mM Tris pH 7.5, 500 mM NaCl, 1 
mM EDTA, 0.1% NP40]. Nuclear extract was prepared from ES cells using Ficoll gradient to remove 
cytoplasm followed by salt extraction with 500mM NaCl in binding buffer and sonication. Binding 
was allowed over night at 4°C in a rotating wheel. Unspecifically bound proteins were removed in 3 
washing steps with wash buffer [50 mM Tris pH 7.5, 500 mM NaCl, 1 mM EDTA, 0.1% NP40]. 
Beads were resuspended in SDS sample buffer and protein separation was performed on SDS page. 
Proteins were visualized by silver staining.  
GST pulldown assay 
GST fusions of PrSet7, M18bp1 truncations and Suv4-20h2 truncations were expressed from 
pGEX6P1 vector in E. coli and purified using Glutathione-S-Sepharose beads (Amersham 
Biosciences). Nuclei of wild type ES cells were isolated by spinning through a Ficoll gradient. For the 
Benzonase treatment cells were resuspended in low salt IP buffer [50 mM Tris pH 7.5, 150 mM KCl, 
1 mM EDTA, 20% glycerol, 0.1% NP40] and digested with Benzonase (Merck Chemicals) for 15 min 
at 30°C, then adjusted to 500 mM KCl, incubated on ice for 30 minutes followed by 3x 10 sec 
sonication at an amplitude of 30 in a Branson sonifier. For the salt extract, proteins were extracted 
with high salt IP buffer [50 mM Tris pH 7.5, 500 mM KCl, 1 mM EDTA, 20% glycerol, 0.1% NP40, 
proteinase inhibitor cocktail (Roche)] incubated on ice for 30 minutes, followed by 3x 10 sec 
sonication at an amplitude of 30 in a Branson sonifier. Both nuclear extracts were diluted to a final 
concentration of 250 mM KCl with no salt IP buffer; precipitated or non-soluble proteins were then 
removed by centrifugation. 5µg of either GST or the different GST-Suv4-20h2 fusion proteins were 
incubated with the Benzonase treated nuclear extract or salt extract supplemented with 50µg/ml EtBr 
over night at 4°C on a rotation wheel. Precipitates were again removed by centrifugation before 60µl 
Glutathione-S-Sepharose beads were added and incubated for another hour at 4°C. Beads were washed 
with IP buffer containing 300 mM KCl; subsequently, the bound proteins were eluted with 50µl SDS 
sample buffer. Proteins were separated on a SDS-polyacrylamid gel, visualized by silver staining and 
identified by mass-spectrometry analysis. 
 In vitro binding assay  
GST fusion proteins of M18bp1 (aa1-440), M18bp1 (aa441-998), M18bp1 (aa325-800), M18bp1 
(aa441-800) M18bp1 (aa735-800) were expressed in Escherichia coli and purified on Glutathione-S- 
Sepharose (Amersham Biosciences). In vitro translation of CenpC proteins (CenpC (aa1-367), Cenpc 
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(aa368-656), CenpC (657-906)) was performed using TnT® Quick Coupled Transcription/Translation 
System (Promega). 10µl of the in vitro translated myc- tagged CenpC and 5µg GST protein coupled to 
Glutathione-S- Sepharose were incubated in IP buffer [50mM Tris pH7.5, 150mM NaCl, 1mM EDTA, 
0.1%NP40, 20% glycerol and proteinase inhibitor cocktail (Roche)] o/n at 4°C on a rotating wheel. 
The beads were washed four times with IP buffer containing 1M NaCl and resuspended in 50 µl 
loading buffer. Bound proteins were separated on SDS-polyacrylamidgels and detected by 
immunoblotting using α-myc antibody (9E10). 
 HP1 interaction test 
GST fusion proteins of M18bp1 and Suv4-20h2, HP1a, HP1b and HP1g were expressed in E. coli and 
purified using Glutathione-S-Sepharose beads (Amersham Biosciences). GST-tags of HP1a, HP1b and 
HP1g were removed by PreScission (GE Healthcare) cleavage. Interaction tests were performed by 
incubating 5µg GST-Suv4-20h2 fusion protein with 5µg of either HP1a, HP1b and HP1g in IP buffer 
[50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% NP40, 20% glycerol and proteinase inhibitor 
cocktail (Roche)] for 1h at room temperature on a rotating wheel. Then 60µl Glutathione-S- Sepharose 
beads were added and incubated for 1h at 4°C on a rotating wheel. The beads were washed three times 
with IP buffer containing 300 mM NaCl and eluted with 50 µl SDS sample buffer. Proteins were 
separated on SDS-polyacrylamidgels and detected by immunoblotting using isoform-specific HP1 
antibodies (Euromedex). 
Co-immunoprecipitation 
Nuclei from wild type and Suv4-20h2-HA-FLAG ES cells were isolated by spinning through a Ficoll 
gradient. The nuclear pellet was resuspended in low salt IP Buffer [50mM Tris pH 7.5, 150mM KCl, 
1mM EDTA, 20% glycerol, 0.1% NP40, proteinase inhibitor cocktail (Roche)]. Fraction I extract was 
isolated after digestion for 15 minutes at 37°C with Benzonase (Merck) in low salt IP buffer, followed 
by mild sonication 1x 10 sec at amplitude 20 in a Branson sonifier. Insoluble proteins were separated 
by spinning for 10 minutes at 13000 rpm at 4°C. The protein pellet was further extracted with high salt 
IP Buffer [50mM Tris pH 7.5, 500mM KCl, 1mM EDTA, 20% glycerol, 0.1% NP40, proteinase 
inhibitor cocktail (Roche)] on ice for 30 minutes followed by 3x 10 sec sonication at an amplitude of 
30 in a Branson sonifier. Fraction II extract was then diluted to a final concentration of 250mM NaCl 
with no salt IP Buffer and precipitated or insoluble proteins were removed by centrifugation (30min, 
13000rpm, 4°C). The different extracts were incubated with either 5µg Flag M2 antibody (Sigma) or 
Smc1 antibody (Bethyl Labs) coupled to ProteinA/G magnetic beads (Dynabeads Invitrogen) o/n at 
4°C on a rotating wheel. The beads were washed in IP buffer containing 300mM KCl for five times 
and eluted with SDS sample buffer. Proteins were separated on SDS-polyacrylamidgels and analysed 
by western blotting using antibodies for Flag M2 (Sigma), Smc1 (Bethyl labs), Smc3 (Abcam) and 
Suz12 (Cell Signalling). 
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 Immunoprecipitation of proteins co-expressed in HEK293FT cells 
HEK293FT cells (Invitrogen) were co- transfected one day before with EGFP-C1-Cenpc and pCMV 
myc-M18bp1. After harvesting the cells by trypsinization, nuclei were isolated via spinning through a 
Ficoll gradient. The nuclear pellet was resuspended in high salt IP Buffer [50mM Tris pH 7.5, 500mM 
NaCl, 1mM EDTA, 20% glycerol, 0.1% NP40] with 4 strokes through 19.5G syringe needle. After 
incubation on ice for 30 minutes the solution was sonicated 3x 10” at an amplitude of 30 in a Branson 
sonicator. The nuclear extract was diluted to a final concentration of 150mM NaCl with no salt IP 
Buffer and precipitates were removed by centrifugation. The extract was incubated o/n at 4°C on a 
rotating wheel with either GFP binder beads [ChromoTek], covalently coupled myc 9E10 antibody on 
agarose Protein A/ProteinG beads or agarose beads only. The beads were washed in IP buffer 
containing 300mM NaCl for five times and afterwards denatured in SDS sample buffer. Proteins were 
separated on SDS-polyacrylamidgels and analyed by western blotting using α-myc and α-GFP. 
 Chromatin accessibility assay 
Cytoplasm of wild type, Suv4-20h2 KO and Suv4-20h2 DKO ES cells and wild type, Suv4-20h DKO, 
DKO+FL and DKO+M12 fibroblast cell lines was removed by spinning through a Ficoll gradient. 
Isolated nuclei were resuspended in Ex100 buffer [10 mM HEPES pH 7.6, 100 mM KCl, 1.5 mM 
MgCl2 0.5 mM EGTA, 10% Glycerol, proteinase inhibitor cocktail (Roche)] and digested with 
different amounts of MNase (Sigma) in the presence of 3mM CaCl2. Digest was stopped after 9 min 
by addition of 1/10 volume MNase stop buffer [0.5 M EDTA, 10% SDS]. Genomic DNA was purified 
and then separated on a 1% agarose gel, followed by blotting onto a Nylon membrane [Roti-Nylon 
plus, Roth] via capillary transfer. Hybridization with a 32P-labeled major satellite probe was performed 
using standard conditions. MNase digestion patterns were further analyzed using the Agilent 2100 
bioanalyzer (Agilent Technologies). 100ng of each sample were loaded onto a DNA LabChip using 
the Agilent DNA 12000 kit and analysis was performed using the 2100 expert software (Agilent 
Technologies). 
 Southern blot 
Sample DNA from MNase digests was purified using Phenol-Chloroform extraction followed by 
Isopropanol precipitation. Equal amounts were separated on an agarose gel in 1x TAE buffer and 
DNA was blotted onto Nylon membrane (Roth) by capillary transfer over night in 20x SSC buffer [3M 
NaCl, 0.3M sodium citrate]. After blotting overnight, membranes were baked at 80°C for 2 hours and 
prewashed at 68°C for 30minutes in 2xSSC and subsequently for 2 hours in 2x SCC 1xDenhardt's (0.5 
% SDS, 1 mM EDTA, 0.02 % BSA, 0.02 % PVP-40, 0.02 % Ficoll). Before hybridization membranes 
were incubated for 1 hour at 68°C in pre-incubation solution (2XSSC, 1xDenhardt's an denatured 
salmon sperm carrier DNA). Membranes were subsequently incubated overnight at 68°C in a rotating 
cylinder with 5 ml pre-incubation solution containing a radioactively labelled probe major satellite 
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repeat probe. Membranes were washed three times with 3xSSC 1xDenhardt's for 30 minutes at 68°C 
and then analyzed by exposure to Fuji FLA3000 phosphoimager screens. 
 HMTase activity assay 
Recombinant GST-tagged SET domain proteins (100ng-500ng) were incubated in 50mM Tris-HCl, 
pH 8.5, 20mM NaCl and BSA, with 1ul of 3H-labelled SAM (Hartmann adenosyl-Lmethionine, S-
(methyl-3H)) or non radioactive SAM (NEB) and 1 ug of either recombinant human H4 or histone 
octamers (H2A, H2B, H3 and H4) or assembled nucleosomes for 1 h at 30°C. For scintillation counter 
analysis samples were spotted onto negatively charged Whatman filter analyzed in the Scintillation 
counter. Or samples were loaded on high percentage SDS page and probed with specific antibodies. 
4.4 Mouse methods 
 Generation of conditional mouse knockout strains 
Heterozygous mice with successful germ line transmission of the targeted allele were purchased from 
the EUCOMM project. C57BL/6J mice expressing Flp recombinase to remove the neomycin 
resistance cassette resulting in “flox”-alleles. To disrupt M18bp1 protein, heterozygous M18bp1fl/+ and 
mice were crossed with different Cre lines.  
Genotyping 
Genomic DNA was isolated from tail biopsy. Proteinase K (Invitrogen) in tail buffer [50mM Tris pH 
7.4, 100 mM EDTA, 100mM NaCl, 1% SDS] at 55°C over night was used to rmove proteins. DNA 
was precipitated by high salt in isopropanol and resuspended in 1x TE buffer. Genotyping was 
performed as standard endpoint PCR reaction in 25ul volume.  
Isolation of blastocysts and primary mouse fibroblasts (pMEFs) 
Blastocyst were isolated E3.5, pMEFs at E12.5 according to  
Hogan, B., Beddington, R., Constantini, F., and Lacy, E. 1994. Manipulating the Mouse Embryo: A 
Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NewYork. 
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Table 4.1. Cloning vectors 
vector company description 
pDonor Zeo Invitrogen Bacterial expression vector, containing att sides for gateway cloning 
pEGFP N1 Invitrogen Mammalian expression vector, C-terminal EGFP tag, CMV promoter, 
polyadenylation signal from SV40 
pCMV myc Invitrogen Mammalian expression vector, N-terminal c-myc, HA tag, CMV 
promoter, polyadenylation signal from SV40 
pGex6P1 Invitrogen Bacterial expression vector, N-terminal GST tag, tac promoter, 
PreScission cleavage site 
pET21 Novagen Bacterial expression vector 
 
Table 4.2. Bacteria strains 
strain company genotype 
DB3.1 Invitrogen F- gyrA462 endA1 glnV44 Δ(sr1-recA) mcrB mrr hsdS20(rB-, mB-) 
ara14 galK2 lacY1 proA2 rpsL20(Smr) xyl5 Δleu mtl1 
DH5 alpha Promega F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
Stellar clontech F–, ara,Δ(lac-proAB) [Φ80d lacZΔM15], rpsL(str), thi,  
Δ(mrr-hsdRMS-mcrBC), ΔmcrA, dam, dcm 
Bl21 (DE3) NEB F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3  
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
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Table 4.3. Primer sequences. 
cloning primer   
M12,M13+M14 pGex6P1 direct cloning   
Suv4-20h2 pGex6P1: 350f BamHI f GGGATCCgtcctccgcactgcctgtgt 
Suv4-20h2 pGex6P1: 385f BamHI f GGGATCCcgctggaccccacaacag 
Suv4-20h2 pGex6P1: 412r EcoRI r GGAATTCctaggctaggcgggtaagttc 
Suv4-20h2 pGex6P1: 385r EcoRI r GGAATTCctagcgagtctgggggcgcag 
M7 f ggggacaagtttgtacaaaaaagcaggcttaaccatgacccgcctagccccagcc 
 r ggggaccactttgtacaagaaagctgggtctggctcaccactattgat 
M12 f ggggacaagtttgtacaaaaaagcaggcttaaccatggtcctccgcactgcctgt 
 r ggggaccactttgtacaagaaagctgggtcggctaggcgggtaagttc 
M13 f ggggacaagtttgtacaaaaaagcaggcttaaccatggtcctccgcactgcctgt 
 r ggggaccactttgtacaagaaagctgggtcgcgagtctgggggcgcag 
M14 f ggggacaagtttgtacaaaaaagcaggcttaaccatgcgctggaccccacaacag 
 r ggggaccactttgtacaagaaagctgggtcggctaggcgggtaagttc 
HP1b f ggggacaagtttgtacaaaaaagcaggcttaactatggggaaaaagcaaaac 
 r ggggaccactttgtacaagaaagctgggtcattcttgtcgtcttttttgtc 
HP1g f ggggacaagtttgtacaaaaaagcaggcttaaaaatggcctccaataaaactac 
 r ggggaccactttgtacaagaaagctgggtcttgtgcttcatcttcaggac 
HP1a f ggggacaagtttgtacaaaaaagcaggcttaagacatgggaaagaagacc 
 r ggggaccactttgtacaagaaagctgggtcgctcttcgcgctttctttttc 
M18bp1 f ggggacaagtttgtacaaaaaagcaggcttaactatgattgtaacacctttga 
 r ggggaccactttgtacaagaaagctgggtcgtcagaattggaaaagtaa 
 M1 f ggggacaagtttgtacaaaaaagcaggcttaactatgattgtaacacctttga 
 r ggggaccactttgtacaagaaagctgggtctcttgctgtttcctgtctg 
 M2 f ggggacaagtttgtacaaaaaagcaggcttaactatgcaggaaacagcaagag 
  r ggggaccactttgtacaagaaagctgggtcgtcagaattggaaaagtaa 
 M3 f ggggacaagtttgtacaaaaaagcaggcttaactatgactgttgtaaaagaag 
 r ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
M4 f ggggacaagtttgtacaaaaaagcaggcttaactatgcaggaaacagcaagag 
 r ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
M5 f ggggacaagtttgtacaaaaaagcaggcttaactatggaccatctacctggtt 
 r ggggaccactttgtacaagaaagctgggtcatgttttcgggatccttgg 
Dnttip2 f ggggacaagtttgtacaaaaaagcaggcttaactatggtggtcaccaggtcc 
 r ggggaccactttgtacaagaaagctgggtcattgcgaaatttcttctttttc 
PogZ f ggggacaagtttgtacaaaaaagcaggcttaactatggcggacaccgacctgtt 
 r ggggaccactttgtacaagaaagctgggtcgatctccatcagatcaagg 
Zfp828 f ggggacaagtttgtacaaaaaagcaggcttaactatggaagtgtgtcaggaatt 
 r ggggaccactttgtacaagaaagctgggtcaatctgctgctcctccaatg 
Mutagenesis primer   
M18bp1W746A 
 
f GTTTAACTGATGATGAAGAAGCCAGTGAGCAAGAGTTACAGAAG 
 r CTTCTGTAACTCTTGCTCACTGGCTTCTTCATCATCAGTTAAAC 
M18bp1W746A 
 
f GTTTAACTGATGATGAAGAAGCCGCCGAGCAAGAGTTACAGAAGC 
 r GCTTCTGTAACTCTTGCTCGGCGGCTTCTTCATCATCAGTTAAAC 
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primer for Suv4-20h2 knock-in cells   
MGC_tag_1f f CACTCCCACTGTCCTTTCCTAA 
MGC_tag_1r r CAAACTCACAGAGAGCCACCTA 
MGC_tag_2f f TCGCATTGTCTGAGTAGGTGTC 
   
primer for genotyping of M18bp1 ko mice   
M18bp1 wt / M18bp1 flox f CCATGCCTGTTTATACCAGTTAGCA 
M18bp1 wt / M18bp1 flox r GCCCATTTAAAGCACCAATTGTTAA 
M18bp1 bGal f CCATGCCTGTTTATACCAGTTAGCA 
M18bp1 bGal r CATCTCCCCTTCAGTCTTCCTGT 
M18bp1 delta f CCATGCCTGTTTATACCAGTTAGCA 
 M18bp1 delta r GCGAGCTCAGACCATAACTTCGTAT 
Flpe f GTGGATCGATCCTACCCCTTGCG 
 Flpe r GTCCAACTGCAGCCCAAGCTTCC 
TNAP Cre f CCA CGA CCA AGT GAC AGC AAT G 
TNAP Cre r CAG AGA CGG AAA TCC ATC GCT C 
Cre ERT2 f TCG CGA TTA TCT TCT ATA TCT TCA G 
Cre ERT2 r GCT CGA CCA GTT TAG TTA CCC 
   
primer for M18bp1 knock-in cells   
cloning fragment AB f ATAGCGGCCGCCTAACTCAAATGCAAAACC 
cloning fragment AB r CGCAAGCTTTGATTAATAGTTTTTCACTAT 
cloning fragment YZ f TCCAAGCTTCCATGACTTGCTCACCTTG 
cloning fragment YZ r TGCACTAGTTATGAAAGAACTCTCATAATG 
cloning fragment CD f ATAGCGGCCGCTCTCCACCACCAACACGGA 
cloning fragment CD r TCGGAATTCGTCAGAATTGGAAAAGTAAT 
cloning fragment EF f CGAGGATCCTGATAGACGACTTGCAGGAAT 
cloning fragment EF r TCTGTCGACAGTCCACAATCTTAACTCTG 
nested PCR outer f ACCGCTTCCTCGTGCTTTAC 
nested PCR outer r AAAGCCAAGCTCACTGTTTC 
nested PCR inner f GATTGGGAAGACAATAGCAGGCATG 
nested PCR inner r GCGCAAGTAAATCATCAAAAGGCTG 
 
 
Table 4.4. Primers used for quantitative PCR 
gene mRNA direction sequence in 5’ to 3’ direction 
beta actin NM_007393.3 fw ggtcatcactattggcaacg 
rw tccatacccaagaaggaagg 
M18bp1 NM_172578.2 fw ctccaaaaggccagcatcacg 
rw ttgccggaggtaggctgttcc 
Gapdh NM_008084.2 fw tcaagaaggtggtgaagcag 
rw gttgaagtcgcaggagacaa 
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Table 4.5. Antibodies used for immunoflourescence and western blot  
antibody company 
CenpA Cell Signalling 
CenpC Abcam 
M18bp1 Gramsch Heidelberg, peptide antibody from rabbit 
HP1a Euromedex 
HP1b Euromedex 
HP1g Euromedex 
Tubulin Sigma 
H4K20me3 Schotta et al 2004 
Smc1 Abcam 
Smc3 Bethyl 
Suz12 Cell Signalling 
myc 9E10  
GFP Roche 
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ABBREVIATIONS 
CCAN: Constitutive Centromere Associated Network 
Cko: conditional knockout 
CPC: chromosomal passenger complex 
DAPI: 4,6-Diamino-2-phenylindol 
DNA: Desoxyribonucleinsäure 
EGFP:  enhanced Green Fluorescent Protein 
GST:  Glutathion-S-Transferase 
H4K20me3 : trimethylation of histone H4 at lysine 20 
H3K9me3: trimethylation of histone H3 at lysine 9 
HP1: heterochromatin protein 1 
HMTase: histone lysine methyaltransferase 
kb: Kilobasen  
kDa: Kilodalton 
ko: knockout 
SAM: S-adenosyl-[methyl-3H]-l-methionin 
SANT: switching-defective protein 3 (Swi3), adaptor 2 (Ada2), nuclear receptor co-repressor (N-CoR) 
and transcription factor (TFIIIB) 
SANTA: SANT associated  
SET: suppressor of variegation, enhancer of zeste and trithorax 
Suv39h1: suppressor of variegation 3-9 homolog 1 
Suv39h2: suppressor of variegation 3-9 homolog 2 
Suv4-20h1: suppressor of variegation 4-20 homolog 1 
Suv4-20h2: suppressor of variegation 4-20 homolog 2 
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Table I Mass-spec list of the H3K9 peptide pulldown assays. The number of unique spectra that were 
identified for each protein in the mass-spec analysis is indicated (Scaffold analysis). 
name 
H3K9u
n 
H3K9me
3 
tripartite motif protein 28 [Mus musculus] 5 78 
histone cluster 1, H2bd [Homo sapiens] 38 34 
histone H2A type 1-F [Mus musculus] 26 28 
Hist2h4 protein [Mus musculus] 40 29 
histone H1.4 [Mus musculus] 31 30 
Treacher Collins Franceschetti syndrome 1, homolog, isoform CRA_b [Mus musculus] 28 50 
heterochromatin protein 1-beta [Homo sapiens] 4 35 
PREDICTED: similar to ribosomal protein L23a [Mus musculus] 35 32 
beta actin [Homo sapiens] 39 34 
myb-binding protein 1a [Mus musculus] 43 31 
histone H1.5 [Mus musculus] 23 22 
RIKEN cDNA 9430010O03, isoform CRA_c [Mus musculus] 26 21 
PREDICTED: similar to Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Numatrin) (Nucleolar protein 
NO38) [Mus musculus] 24 18 
histone cluster 1, H3a [Homo sapiens] 22 17 
unnamed protein product [Mus musculus] 0 31 
PREDICTED: similar to Fibrillarin isoform 2 [Mus musculus] 22 19 
LINE-1 type transposase domain-containing protein 1 [Mus musculus] 18 25 
PREDICTED: similar to Chromobox homolog 3 (HP1 gamma homolog, Drosophila) isoform 2 [Pan troglodytes] 0 18 
unnamed protein product [Mus musculus] 25 17 
lamin-B1 [Mus musculus] 24 20 
nucleolar protein 58 [Mus musculus] 21 17 
RecName: Full=Histone H1.3; AltName: Full=H1 VAR.4; AltName: Full=H1d 11 10 
ribosomal L1 domain containing 1, isoform CRA_b [Mus musculus] 22 14 
ribosomal protein L26 [Homo sapiens] 14 12 
histone cluster 2, H2ac [Homo sapiens] 11 6 
nucleolar protein 56 [Mus musculus] 17 9 
mCG114749, isoform CRA_a [Mus musculus] 13 10 
H2A histone family, member Z [Homo sapiens] 7 7 
chromodomain-helicase-DNA-binding protein 4 [Mus musculus] 1 23 
mCG1028606 [Mus musculus] 10 10 
protease, serine, 1 [Mus musculus] 6 6 
60S ribosomal protein L35 [Mus musculus] 10 9 
lamina-associated polypeptide 2 isoform epsilon [Mus musculus] 9 10 
putative rRNA methyltransferase 3 [Mus musculus] 16 10 
histone H1.1 [Mus musculus] 10 7 
RecName: Full=Nucleolar RNA helicase 2; AltName: Full=Nucleolar RNA helicase II; AltName: 
Full=Nucleolar RNA helicase Gu; AltName: Full=RH II/Gu; AltName: Full=Gu-alpha; AltName: Full=DEAD 
box protein 21 14 6 
transcription intermediary factor 1-alpha [Mus musculus] 0 18 
putative ribosomal RNA methyltransferase NOP2 [Mus musculus] 15 7 
heterogeneous nuclear ribonucleoprotein A3 [Mus musculus] 12 9 
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit, isoform 1, isoform CRA_e [Mus 
musculus] 7 11 
unnamed protein product [Mus musculus] 8 5 
EBNA1 binding protein 2 [Mus musculus] 11 4 
BAP28 protein [Mus musculus] 8 6 
unnamed protein product [Mus musculus] 6 6 
mCG13479, isoform CRA_a [Mus musculus] 8 4 
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Pogz protein [Mus musculus] 0 16 
PREDICTED: similar to ribosomal protein [Mus musculus] 4 3 
unnamed protein product [Mus musculus] 5 6 
60S ribosomal protein L12 [Mus musculus] 7 8 
PREDICTED: similar to ribosomal protein L3 isoform 1 [Mus musculus] 10 5 
PREDICTED: hypothetical protein [Mus musculus] 7 7 
PREDICTED: hypothetical protein [Mus musculus] 11 5 
60 kDa heat shock protein, mitochondrial [Mus musculus] 9 6 
PREDICTED: hypothetical protein [Mus musculus] 7 5 
mCG22088 [Mus musculus] 6 7 
unnamed protein product [Mus musculus] 9 5 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 [Mus musculus] 7 6 
unnamed protein product [Mus musculus] 6 5 
heat shock protein 8 [Rattus norvegicus] 5 9 
ribosomal protein L8 [Homo sapiens] 9 2 
reduced expression 2 [Mus musculus] 0 7 
mKIAA4193 protein [Mus musculus] 7 7 
mCG20089, isoform CRA_a [Mus musculus] 3 10 
nucleolar and coiled-body phosphoprotein 1, isoform CRA_a [Mus musculus] 9 4 
mCG145163 [Mus musculus] 3 3 
zinc finger protein 57 [Mus musculus] 0 6 
unnamed protein product [Mus musculus] 5 4 
Sf3b1 protein [Mus musculus] 5 3 
RecName: Full=H/ACA ribonucleoprotein complex subunit 4; AltName: Full=Dyskerin; AltName: 
Full=Nucleolar protein family A member 4; AltName: Full=snoRNP protein DKC1; AltName: Full=Nopp140-
associated protein of 57 kDa; AltName: Full=Nucleolar protei 5 6 
histone H2A.x [Mus musculus] 3 3 
RRS1 ribosome biogenesis regulator homolog [Mus musculus] 6 3 
ribosome production factor 2 homolog isoform 1 [Mus musculus] 6 3 
expressed sequence AA408556, isoform CRA_a [Mus musculus] 3 2 
PREDICTED: similar to ribosomal protein L19 isoform 1 [Macaca mulatta] 4 3 
unnamed protein product [Mus musculus] 0 6 
Ribosomal protein, large, P0 [Mus musculus] 5 3 
complement component 1 Q subcomponent-binding protein, mitochondrial [Mus musculus] 4 3 
N-acetyltransferase 10, isoform CRA_a [Mus musculus] 4 3 
unnamed protein product [Mus musculus] 4 4 
U3 small nucleolar ribonucleoprotein protein IMP3 [Mus musculus] 4 3 
ribosome biogenesis protein BRX1 homolog [Mus musculus] 7 2 
pescadillo homolog [Mus musculus] 6 2 
alpha thalassemia/mental retardation syndrome X-linked homolog (human) [Mus musculus] 1 6 
DNA segment, Chr 13, Wayne State University 177, expressed [Mus musculus] 5 3 
type II keratin 5 [Mus musculus] 7 1 
putative ATP-dependent RNA helicase Pl10 [Mus musculus] 3 3 
mCG133010, isoform CRA_c [Mus musculus] 3 3 
keratin, type I cytoskeletal 10 [Mus musculus] 3 3 
mCG127344, isoform CRA_b [Mus musculus] 4 3 
mCG8513 [Mus musculus] 4 3 
mCG120690 [Mus musculus] 3 3 
PREDICTED: similar to ribosomal protein S24 [Macaca mulatta] 3 3 
H/ACA ribonucleoprotein complex subunit 1 [Mus musculus] 2 3 
mCG7617, isoform CRA_a [Mus musculus] 6 1 
unnamed protein product [Mus musculus] 3 2 
PREDICTED: similar to acidic ribosomal phosphoprotein P1 isoform 1 [Mus musculus] 2 2 
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peter pan homolog (Drosophila), isoform CRA_a [Mus musculus] 3 2 
alpha-tubulin isotype M-alpha-2 4 2 
keratin, type II cytoskeletal 73 [Mus musculus] 3 2 
unnamed protein product [Mus musculus] 1 5 
bromodomain adjacent to zinc finger domain protein 2A [Mus musculus] 3 3 
PREDICTED: hypothetical protein [Mus musculus] 4 2 
mCG1128, isoform CRA_a [Mus musculus] 4 2 
ADP/ATP translocase 2 [Mus musculus] 4 1 
RNA-binding protein 39 [Mus musculus] 2 3 
40S ribosomal protein S19 [Mus musculus] 2 2 
Atp5b protein [Mus musculus] 1 3 
protein transport protein Sec61 subunit beta [Mus musculus] 3 2 
Gtpbp4-pending protein [Mus musculus] 6 0 
expressed sequence C79407 (M18bp1)[Mus musculus] 0 4 
unnamed protein product [Mus musculus] 5 0 
histone H2B type 1-H [Mus musculus] 2 1 
ribosomal protein S14 [Mus musculus] 3 2 
nucleoporin 93, isoform CRA_a [Mus musculus] 3 2 
Chain A, N-Terminal Fragment Of Importin-Beta 2 3 
unnamed protein product [Mus musculus] 3 2 
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4, isoform 
CRA_a [Mus musculus] 1 4 
heterogeneous nuclear ribonucleoproteins A2/B1 isoform 1 [Mus musculus] 2 3 
splicing factor, arginine/serine-rich 7, 35kDa, isoform CRA_a [Homo sapiens] 2 3 
ribosomal RNA processing protein 1 homolog A [Mus musculus] 2 3 
mCG23455, isoform CRA_a [Mus musculus] 4 1 
RecName: Full=Serine/arginine repetitive matrix protein 2 3 2 
unnamed protein product [Mus musculus] 2 2 
nucleolar complex protein 3 homolog [Mus musculus] 4 1 
mCG122723 [Mus musculus] 3 1 
mCG21756, isoform CRA_b [Mus musculus] 2 3 
guanine nucleotide binding protein-like 3 (nucleolar), isoform CRA_a [Mus musculus] 3 2 
block of proliferation 1 [Mus musculus] 4 1 
lamin B receptor [Mus musculus] 2 3 
unnamed protein product [Mus musculus] 1 3 
heterogeneous nuclear ribonucleoprotein L, isoform CRA_b [Mus musculus] 3 0 
unnamed protein product [Mus musculus] 2 2 
nuclear pore complex protein Nup160 [Mus musculus] 2 2 
histone H2B type 1-B [Mus musculus] 2 1 
mCG16669, isoform CRA_e [Mus musculus] 2 2 
mKIAA0187 protein [Mus musculus] 3 1 
60S ribosomal protein L36 3 0 
mCG12239 [Mus musculus] 0 4 
zinc finger protein 828 [Mus musculus] 0 4 
epithelial protein lost in neoplasm-a [Mus musculus] 1 2 
gamma-aminobutyric acid receptor beta-2 subunit [Mus musculus] 2 1 
nucleolar transcription factor 1 isoform 2 [Mus musculus] 1 2 
Hist1h3e protein [Mus musculus] 2 1 
unnamed protein product [Mus musculus] 1 2 
Utp3 protein [Mus musculus] 1 2 
60S ribosomal protein L38 [Mus musculus] 1 2 
RNA-binding protein 25 [Mus musculus] 3 0 
DNA segment, Chr 19, Brigham & Women's Genetics 1357 expressed, isoform CRA_b [Mus musculus] 3 0 
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PREDICTED: similar to Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [Mus musculus] 1 2 
Eukaryotic translation elongation factor 1 alpha 1 [Mus musculus] 2 1 
pinin [Mus musculus] 1 1 
apoptosis antagonizing transcription factor, isoform CRA_b [Mus musculus] 2 0 
DNA topoisomerase 2-alpha [Mus musculus] 2 1 
RanBP2 protein [Mus musculus] 0 3 
dynein, axonemal, heavy chain 11 [Mus musculus] 1 2 
zinc finger protein 280c [Mus musculus] 0 3 
RecName: Full=Ribosomal RNA processing protein 1 homolog B; AltName: Full=RRP1-like protein B 1 2 
phospholipase C gamma 1 [Mus musculus] 2 1 
Rangap1 protein [Mus musculus] 1 2 
leukocyte receptor cluster (LRC) member 8, isoform CRA_a [Mus musculus] 2 1 
ankyrin repeat and SOCS box-containing 15 [Mus musculus] 2 0 
Acin1 protein [Mus musculus] 3 0 
histone H1.2 [Mus musculus] 1 1 
caspase recruitment domain-containing protein 9 [Mus musculus] 1 1 
ribosomal protein L10a [Rattus norvegicus] 2 0 
PREDICTED: hypothetical protein [Mus musculus] 1 2 
PREDICTED: similar to putative integral membrane protein TMIE [Mus musculus] 0 2 
Bclaf1 protein [Mus musculus] 1 1 
mCG17415 [Mus musculus] 1 1 
mCG121979, isoform CRA_b [Mus musculus] 0 2 
putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 isoform 2 [Mus musculus] 2 0 
WD repeat domain 36, isoform CRA_b [Mus musculus] 2 0 
RecName: Full=60S ribosome subunit biogenesis protein NIP7 homolog; AltName: Full=PEachy; AltName: 
Full=kDa93 2 0 
retinoblastoma-binding protein mRbAp48 0 2 
lymphocyte-specific helicase [Mus musculus] 1 1 
heterogeneous nuclear ribonucleoprotein H [Mus musculus] 0 2 
nucleolar protein 10 [Mus musculus] 1 1 
U3 small nucleolar RNA-associated protein 15 homolog [Mus musculus] 1 1 
growth arrest and DNA-damage-inducible, gamma interacting protein 1 [Mus musculus] 0 2 
mCG10343, isoform CRA_b [Mus musculus] 1 1 
PREDICTED: similar to FUS interacting protein (serine-arginine rich) 1 [Macaca mulatta] 1 1 
mCG23000, isoform CRA_a [Mus musculus] 2 0 
Sec61 alpha 1 subunit [Homo sapiens] 2 0 
MARCKS-like 1 [Mus musculus] 1 1 
serine/arginine repetitive matrix 1 [Mus musculus] 2 0 
hypothetical protein LOC66276 [Mus musculus] 1 1 
poly(rC)-binding protein 1 [Mus musculus] 1 1 
PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae), isoform CRA_a [Mus musculus] 2 0 
hnRNP-associated with lethal yellow [Mus musculus] 2 0 
unnamed protein product [Mus musculus] 1 1 
SET domain containing 3 [Mus musculus] 2 0 
immunoglobulin heavy chain [Mus musculus] 1 1 
mCG5393 [Mus musculus] 1 1 
nucleolar complex protein 2 homolog [Mus musculus] 2 0 
Suv39h2 protein [Mus musculus] 0 2 
splicing factor, arginine/serine-rich 1 (ASF/SF2), isoform CRA_c [Mus musculus] 1 1 
unnamed protein product [Mus musculus] 2 0 
mCG5312, isoform CRA_a [Mus musculus] 0 2 
sal-like 2 (Drosophila), isoform CRA_a [Mus musculus] 1 1 
CKLF-like MARVEL transmembrane domain containing 6 [Mus musculus] 0 2 
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protein lin-28 homolog A [Mus musculus] 1 0 
RIKEN cDNA 4932418E24 [Mus musculus] 2 0 
A-kinase anchor protein 9 [Mus musculus] 1 1 
PREDICTED: similar to ribosomal protein L28 [Mus musculus] 2 0 
lymphoid-restricted membrane protein [Mus musculus] 0 2 
RecName: Full=Septin-1; AltName: Full=Differentiation protein 6; Short=Protein Diff6; AltName: Full=Peanut-
like protein 3 1 1 
mCG120696 [Mus musculus] 0 1 
nucleolar protein 7 [Mus musculus] 0 1 
methyl-CpG binding domain protein 3, isoform CRA_a [Mus musculus] 0 1 
MutS homolog 2 (E. coli) [Mus musculus] 0 1 
mCG13856, isoform CRA_a [Mus musculus] 0 1 
deoxynucleotidyltransferase terminal-interacting protein 2 [Mus musculus] 0 1 
eukaryotic translation initiation factor 4A2, isoform CRA_c [Mus musculus] 0 1 
promyelocytic leukemia, isoform CRA_a [Mus musculus] 0 1 
mCG3370 [Mus musculus] 0 1 
EMG1 nucleolar protein homolog (S. cerevisiae), isoform CRA_b [Mus musculus] 0 1 
SWI/SNF complex subunit SMARCC1 [Mus musculus] 0 1 
Ngdn protein [Mus musculus] 0 1 
RecName: Full=Proline-, glutamic acid- and leucine-rich protein 1; AltName: Full=Modulator of non-genomic 
activity of estrogen receptor 1 0 
isocitrate dehydrogenase 3 (NAD+) alpha, isoform CRA_b [Mus musculus] 1 0 
mCG144546 [Mus musculus] 1 0 
splicing factor 3B, 14 kDa subunit [Homo sapiens] 1 0 
DEAD (Asp-Glu-Ala-Asp) box polypeptide 51 [Mus musculus] 1 0 
Eftud2 protein [Mus musculus] 1 0 
mCG120440 [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
RecName: Full=Heat shock protein HSP 90-beta; AltName: Full=HSP 84; AltName: Full=Tumor-specific 
transplantation 84 kDa antigen; Short=TSTA 1 0 
nucleolar protein 14 [Mus musculus] 1 0 
eukaryotic translation initiation factor 6 [Mus musculus] 1 0 
Nucleolar complex associated 4 homolog (S. cerevisiae) [Mus musculus] 1 0 
probable ATP-dependent RNA helicase DDX27 [Mus musculus] 1 0 
60S ribosomal protein L32' 1 0 
U3 small nucleolar RNA-interacting protein 2 [Mus musculus] 1 0 
pleckstrin homology-like domain, family A, member 1 [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
Mphosph10 protein [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 0 1 
mCG117568, isoform CRA_a [Mus musculus] 0 1 
heterogeneous nuclear ribonucleoprotein A1 isoform b [Mus musculus] 0 1 
ras-related protein Rab-5C [Mus musculus] 1 0 
karyopherin (importin) alpha 2 [Mus musculus] 0 1 
RecName: Full=B-Raf proto-oncogene serine/threonine-protein kinase 0 1 
mCG140775 [Mus musculus] 0 1 
zinc finger protein 518B [Mus musculus] 0 1 
mCG132526 [Mus musculus] 1 0 
mCG115615, isoform CRA_a [Mus musculus] 1 0 
MEK kinase 2 1 0 
RecName: Full=Sentrin-specific protease 3; AltName: Full=Sentrin/SUMO-specific protease SENP3; AltName: 
Full=SUMO-1-specific protease 3; AltName: Full=Smt3-specific isopeptidase 1; Short=Smt3ip1 1 0 
MYST histone acetyltransferase 2, isoform CRA_a [Mus musculus] 0 1 
M-phase phosphoprotein, mpp8 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 1 0 
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unnamed protein product [Mus musculus] 0 1 
tumor necrosis factor, alpha-induced protein 3 [Mus musculus] 1 0 
ras-related protein Rab-32 [Mus musculus] 0 1 
pentatricopeptide repeat domain 1 [Mus musculus] 1 0 
anti-DNA immunoglobulin heavy chain IgG [Mus musculus] 0 1 
DEAH (Asp-Glu-Ala-His) box polypeptide 9, isoform CRA_a [Mus musculus] 0 1 
RecName: Full=Protein capicua homolog 0 1 
hypothetical protein LOC227545 [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
mCG145590 [Mus musculus] 0 1 
hypothetical protein LOC75964 isoform 2 [Mus musculus] 1 0 
poly A binding protein, cytoplasmic 4 [Mus musculus] 0 1 
olfactory receptor 1089 [Mus musculus] 1 0 
hypothetical protein LOC240185 [Mus musculus] 0 1 
mCG10523, isoform CRA_b [Mus musculus] 1 0 
Tpr [Mus musculus] 0 1 
Voltage-dependent anion channel 2 [Mus musculus] 1 0 
myosin-7B [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
RecName: Full=Probable ATP-dependent RNA helicase DDX20; AltName: Full=DEAD box protein 20; 
AltName: Full=DEAD box protein DP 103; AltName: Full=Component of gems 3; AltName: Full=Gemin-3; 
AltName: Full=Regulator of steroidogenic factor 1; Short=ROS 1 0 
unnamed protein product [Mus musculus] 1 0 
CTTNBP2 N-terminal-like protein [Mus musculus] 0 1 
collagen alpha-4(IV) chain precursor [Mus musculus] 0 1 
PREDICTED: similar to electrogenic sodium bicarbonate cotransporter NBC4c isoform 3 [Mus musculus] 1 0 
RIKEN cDNA 4930523C11 gene [Mus musculus] 0 1 
dynein cytoplasmic 2 heavy chain 1 [Mus musculus] 0 1 
SMEK homolog 3, putative [Mus musculus] 0 1 
1700007B14Rik protein [Mus musculus] 0 1 
heterogeneous nuclear ribonucleoprotein U, isoform CRA_b [Mus musculus] 1 0 
mCG120998, isoform CRA_b [Mus musculus] 1 0 
PREDICTED: similar to insulinoma protein (rig) isoform 1 [Mus musculus] 0 1 
nuclear factor related to kappa B binding protein, isoform CRA_a [Mus musculus] 0 1 
RIKEN cDNA 4930431B11, isoform CRA_a [Mus musculus] 1 0 
Nuclear VCP-like [Mus musculus] 1 0 
argininosuccinate lyase [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 1 0 
chordin [Mus musculus] 0 1 
RNA-binding protein PNO1 [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
Myb protein P42POP, isoform CRA_a [Mus musculus] 0 1 
multiple ankyrin repeats, single KH-domain homolog [Mus musculus] 0 1 
Cytoplasmic FMR1 interacting protein 1 [Mus musculus] 1 0 
Plexin B2 [Mus musculus] 1 0 
mCG130959 [Mus musculus] 0 1 
suppression of tumorigenicity 5 protein isoform 1 [Mus musculus] 1 0 
ATPase, class II, type 9A [Mus musculus] 0 1 
zinc finger proten 607 [Mus musculus] 1 0 
neuropilin 1, isoform CRA_a [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
PREDICTED: hypothetical protein [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
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vimentin, isoform CRA_a [Mus musculus] 0 1 
CDK105 protein [Rattus norvegicus] 1 0 
heparan-alpha-glucosaminide N-acetyltransferase [Mus musculus] 0 1 
mKIAA2013 protein [Mus musculus] 1 0 
PREDICTED: hypothetical protein LOC68531 [Mus musculus] 1 0 
PREDICTED: hypothetical protein LOC67170 [Mus musculus] 0 1 
phosphoinositide 3-kinase regulatory subunit 6 isoform 1 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
Nucleolin [Mus musculus] 1 0 
succinate dehydrogenase complex, subunit C, integral membrane protein [Mus musculus] 0 1 
proton-coupled amino acid transporter 1 [Mus musculus] 0 1 
PREDICTED: similar to hCG1645909 [Mus musculus] 1 0 
Msn protein [Mus musculus] 1 0 
splicing factor 3B subunit 4 [Mus musculus] 0 1 
mCG20427 [Mus musculus] 1 0 
RNA polymerase II elongation factor ELL2 [Mus musculus] 1 0 
non-receptor tyrosine kinase [Mus musculus] 1 0 
uncharacterized serine/threonine-protein kinase SgK494 [Mus musculus] 0 1 
arylacetamide deacetylase-like 3 [Mus musculus] 0 1 
non-POU-domain-containing, octamer binding protein [Mus musculus] 1 0 
mCG145123 [Mus musculus] 0 1 
rotatin [Mus musculus] 1 0 
ubiquitin carboxyl-terminal hydrolase isozyme L3 [Mus musculus] 1 0 
PREDICTED: hypothetical protein [Mus musculus] 1 0 
hypothetical protein B930041G04 [Mus musculus] 1 0 
mCG1027331 [Mus musculus] 1 0 
mCG12136, isoform CRA_d [Mus musculus] 0 1 
5033413D22Rik protein [Mus musculus] 0 1 
PREDICTED: hypothetical protein [Mus musculus] 1 0 
mCG5258, isoform CRA_b [Mus musculus] 0 1 
anti-DNA immunoglobulin heavy chain IgG [Mus musculus] 1 0 
unnamed protein product [Mus musculus] 1 0 
lethal(3)malignant brain tumor-like protein [Mus musculus] 1 0 
mCG130077 [Mus musculus] 0 1 
FYN binding protein, isoform CRA_b [Mus musculus] 1 0 
Ankrd43 protein [Mus musculus] 1 0 
mCG9260 [Mus musculus] 1 0 
novel protein [Mus musculus] 1 0 
serine/threonine-protein kinase N1 [Mus musculus] 1 0 
 
Table II Mass-spec list of the M18bp1 FLAG IP. The number of unique spectra that were identified 
for each protein in the mass-spec analysis is indicated (Scaffold analysis). 
gene gene name wt K2A7 Diff 
M18bp1 mis18-binding protein 1 0 184 184 
Chd4 chromodomain-helicase-DNA-binding protein 4 0 69 69 
Snrnp200 U5 small nuclear ribonucleoprotein 200 kDa helicase 0 61 61 
Numa1 nuclear mitotic apparatus protein 1 0 54 54 
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Hnrnpm heterogeneous nuclear ribonucleoprotein M 1 48 47 
Baz1b tyrosine-protein kinase BAZ1B 0 43 43 
Spnb3 spectrin beta chain, brain 2 0 43 43 
H2afy core histone macro-H2A.1 0 37 37 
CBX1 chromobox protein homolog 1 0 35 35 
Nup160 nuclear pore complex protein Nup160 0 34 34 
Rpl5 60S ribosomal protein L5 0 32 32 
Tpr nuclear pore complex-associated protein Tpr 0 32 32 
Cbx5 chromobox protein homolog 5 0 30 30 
Hist1h1d histone H1.3 0 30 30 
Ddx10 probable ATP-dependent RNA helicase DDX10 0 29 29 
Flna filamin-A 0 29 29 
Oip5 protein Mis18-beta 0 29 29 
Tjp1 tight junction protein ZO-1 0 29 29 
Uhrf1 E3 ubiquitin-protein ligase UHRF1 0 29 29 
Supt16h FACT complex subunit SPT16 0 28 28 
Trip12 thyroid hormone receptor interactor 12 0 28 28 
Baz2a bromodomain adjacent to zinc finger domain protein 2A 0 27 27 
Utp18 U3 small nucleolar RNA-associated protein 18 homolog 0 27 27 
Pogz pogo transposable element with ZNF domain 0 26 26 
Prpf40a pre-mRNA-processing factor 40 homolog A 0 26 26 
Smc3 structural maintenance of chromosomes protein 3 0 26 26 
Utp15 U3 small nucleolar RNA-associated protein 15 homolog 0 26 26 
Elavl1 ELAV-like protein 1 0 25 25 
Pes1 pescadillo homolog 0 25 25 
2610039C10Rik protein Mis18-alpha 0 24 24 
Atad2 ATPase family AAA domain-containing protein 2 0 24 24 
Utf1 undifferentiated embryonic cell transcription factor 1 0 24 24 
Igf2bp1 insulin-like growth factor 2 mRNA-binding protein 1 0 22 22 
Orc1 origin recognition complex subunit 1 0 22 22 
Rpl13a 60S ribosomal protein L13a 0 22 22 
Tjp2 tight junction protein ZO-2 0 22 22 
Gnb2l1 guanine nucleotide-binding protein subunit beta-2-like 1 0 21 21 
Plk1 serine/threonine-protein kinase PLK1 0 21 21 
Smarcc1 SWI/SNF complex subunit SMARCC1 0 21 21 
Bms1 ribosome biogenesis protein BMS1 homolog 0 20 20 
Cenpc1 centromere protein C 1 0 20 20 
Fn1 fibronectin 0 20 20 
Lin28a protein lin-28 homolog A 0 19 19 
Nol11 nucleolar protein 11 0 19 19 
Zc3h18 zinc finger CCCH domain-containing protein 18 0 19 19 
Aurkb aurora kinase B 0 18 18 
Ddx39 ATP-dependent RNA helicase DDX39A 0 18 18 
Dhx37 probable ATP-dependent RNA helicase DHX37 0 18 18 
Flii protein flightless-1 homolog 0 18 18 
Ruvbl2 ruvB-like 2 0 18 18 
Cdca8 borealin 0 17 17 
Cenpv centromere protein V 0 17 17 
Pcbp1 poly(rC)-binding protein 1 0 17 17 
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Rbm34 RNA-binding protein 34 0 17 17 
Rrs1 ribosome biogenesis regulatory protein homolog 0 17 17 
Smc1a structural maintenance of chromosomes protein 1A 0 17 17 
Syncrip heterogeneous nuclear ribonucleoprotein Q 0 17 17 
Utp3 something about silencing protein 10 0 17 17 
Wdr12 ribosome biogenesis protein WDR12 0 17 17 
Glyr1 putative oxidoreductase GLYR1 0 16 16 
Hells lymphocyte-specific helicase 0 16 16 
Lamc1 laminin subunit gamma-1 0 16 16 
Pabpc1 polyadenylate-binding protein 1 0 16 16 
Rpl18 60S ribosomal protein L18 0 16 16 
Sfpq splicing factor, proline- and glutamine-rich 0 16 16 
Slc25a5 ADP/ATP translocase 2 1 17 16 
Actn1 alpha-actinin-1 0 15 15 
Gnai2 guanine nucleotide-binding protein G(i) subunit alpha-2 0 15 15 
Nol10 nucleolar protein 10 0 15 15 
Nup155 nuclear pore complex protein Nup155 0 15 15 
Terf1 telomeric repeat-binding factor 1 0 15 15 
2610101N10Rik U2 snRNP-associated SURP motif-containing protein 0 14 14 
Lyar cell growth-regulating nucleolar protein 0 14 14 
Rpl7l1 60S ribosomal protein L7-like 1 0 14 14 
Rps14 40S ribosomal protein S14 0 14 14 
Rps16 40S ribosomal protein S16 1 15 14 
SRSF10 serine/arginine-rich splicing factor 10 0 14 14 
Vdac1 voltage-dependent anion-selective channel protein 1 0 14 14 
Atrx transcriptional regulator ATRX 0 13 13 
Ddx56 probable ATP-dependent RNA helicase DDX56 0 13 13 
Eif6 eukaryotic translation initiation factor 6 0 13 13 
Emg1 ribosomal RNA small subunit methyltransferase NEP1 0 13 13 
Hist1h1a histone H1.1 0 13 13 
Noc4l nucleolar complex protein 4 homolog 0 13 13 
Ptbp1 polypyrimidine tract-binding protein 1 0 13 13 
Ruvbl1 ruvB-like 1 0 13 13 
Vdac2 voltage-dependent anion-selective channel protein 2 0 13 13 
Ahctf1 protein ELYS 0 12 12 
Anxa6 annexin A6 0 12 12 
D2Wsu81e uncharacterized protein C9orf114 homolog 0 12 12 
Ddx52 probable ATP-dependent RNA helicase DDX52 0 12 12 
Eif3a eukaryotic translation initiation factor 3 subunit A 1 13 12 
Fxr1 fragile X mental retardation syndrome-related protein 1 0 12 12 
Gnb2 guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 0 12 12 
Impdh2 inosine-5'-monophosphate dehydrogenase 2 0 12 12 
Polr2b DNA-directed RNA polymerase II subunit RPB2 0 12 12 
Rbbp4 histone-binding protein RBBP4 0 12 12 
Rpf1 ribosome production factor 1 0 12 12 
Skiv2l2 superkiller viralicidic activity 2-like 2 0 12 12 
Trim27 zinc finger protein RFP 0 12 12 
Lamb1 laminin subunit beta-1 0 11 11 
Ngdn neuroguidin 0 11 11 
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Psip1 PC4 and SFRS1-interacting protein 0 11 11 
Rpl10 60S ribosomal protein L10 0 11 11 
Rpl22 60S ribosomal protein L22 0 11 11 
Set protein SET 0 11 11 
Snrnp70 U1 small nuclear ribonucleoprotein 70 kDa 0 11 11 
Arglu1 arginine and glutamate-rich protein 1 0 10 10 
Bysl bystin 0 10 10 
Cdh1 cadherin-1 0 10 10 
Ezh2 histone-lysine N-methyltransferase EZH2 0 10 10 
Hnrnpa0 heterogeneous nuclear ribonucleoprotein A0 0 10 10 
Hsp90b1 endoplasmin 0 10 10 
Imp4 U3 small nucleolar ribonucleoprotein protein IMP4 0 10 10 
Larp7 la-related protein 7 0 10 10 
Ppp1r9a neurabin-1 0 10 10 
Pycr2 pyrroline-5-carboxylate reductase 2 0 10 10 
Rfc5 replication factor C subunit 5 0 10 10 
Rpl24 60S ribosomal protein L24 0 10 10 
Rrp1 ribosomal RNA processing protein 1 homolog A 0 10 10 
Rsf1 remodeling and spacing factor 1 0 10 10 
Srsf5 serine/arginine-rich splicing factor 5 0 10 10 
Ssrp1 FACT complex subunit SSRP1 0 10 10 
Stoml2 stomatin-like protein 2 0 10 10 
Tkt transketolase 0 10 10 
Tmpo lamina-associated polypeptide 2 0 10 10 
Ywhag 14-3-3 protein gamma 0 10 10 
1600021P15Rik protein MB21D2 0 9 9 
2310008H09Rik protein C16orf88 homolog 0 9 9 
Brix1 ribosome biogenesis protein BRX1 homolog 0 9 9 
Incenp inner centromere protein 0 9 9 
Lrwd1 leucine-rich repeat and WD repeat-containing protein 1 0 9 9 
Msh2 DNA mismatch repair protein Msh2 0 9 9 
Myef2 myelin expression factor 2 0 9 9 
Nup98 nucleoporin 98 0 9 9 
Prpf19 pre-mRNA-processing factor 19 0 9 9 
Rbm25 RNA-binding protein 25 0 9 9 
Cacybp calcyclin-binding protein 0 8 8 
Cenpo centromere protein O 0 8 8 
Dcaf13 DDB1- and CUL4-associated factor 13 0 8 8 
Ddx46 probable ATP-dependent RNA helicase DDX46 0 8 8 
Dnmt3l DNA (cytosine-5)-methyltransferase 3-like 0 8 8 
Eif4a3 eukaryotic initiation factor 4A-III 0 8 8 
Gar1 H/ACA ribonucleoprotein complex subunit 1 0 8 8 
Gm6472 0 0 8 8 
H2afy2 core histone macro-H2A.2 0 8 8 
Hk2 hexokinase-2 0 8 8 
Ilf2 interleukin enhancer-binding factor 2 0 8 8 
Mad1l1 mitotic spindle assembly checkpoint protein MAD1 0 8 8 
Mta2 metastasis-associated protein MTA2 0 8 8 
Nop16 nucleolar protein 16 0 8 8 
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Phf17 protein Jade-1 0 8 8 
Phip PH-interacting protein 0 8 8 
Polr2a DNA-directed RNA polymerase II subunit RPB1 0 8 8 
Ppp2r1a 
serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha 
isoform 0 8 8 
Rps13 40S ribosomal protein S13 0 8 8 
Snrpa1 0 0 8 8 
Snrpb2 U2 small nuclear ribonucleoprotein B'' 0 8 8 
Supt6h transcription elongation factor SPT6 0 8 8 
Tdh L-threonine 3-dehydrogenase, mitochondrial 0 8 8 
Urb2 unhealthy ribosome biogenesis protein 2 homolog 0 8 8 
Wdr18 WD repeat-containing protein 18 0 8 8 
WDR5 WD repeat-containing protein 5 0 8 8 
Zfp462 zinc finger protein 462 0 8 8 
1110037F02Rik protein virilizer homolog 0 7 7 
2210011C24Rik uncharacterized protein LOC70134 0 7 7 
2810004N23Rik uncharacterized protein C1orf131 homolog 0 7 7 
Arpc1b actin-related protein 2/3 complex subunit 1B 0 7 7 
Cct6a T-complex protein 1 subunit zeta 0 7 7 
Coro1c coronin-1C 0 7 7 
Crnkl1 crooked neck-like protein 1 0 7 7 
Ddb1 DNA damage-binding protein 1 0 7 7 
Ddx3y ATP-dependent RNA helicase DDX3Y 0 7 7 
Dis3 exosome complex exonuclease RRP44 0 7 7 
Exosc4 exosome complex component RRP41 0 7 7 
Gsn gelsolin 0 7 7 
Hdac1 histone deacetylase 1 0 7 7 
Hmga1 high mobility group protein HMG-I/HMG-Y 0 7 7 
Hspg2 basement membrane-specific heparan sulfate proteoglycan core protein 0 7 7 
Kif2a kinesin-like protein KIF2A 0 7 7 
Lbr lamin-B receptor 0 7 7 
Nup37 nucleoporin Nup37 0 7 7 
Pcna proliferating cell nuclear antigen 0 7 7 
Ppih peptidyl-prolyl cis-trans isomerase H 0 7 7 
Rfc4 replication factor C subunit 4 0 7 7 
Rps10 40S ribosomal protein S10 0 7 7 
Rps23 40S ribosomal protein S23 0 7 7 
Rrp15 RRP15-like protein 0 7 7 
Senp3 sentrin-specific protease 3 0 7 7 
Stk38 serine/threonine-protein kinase 38 0 7 7 
Surf6 surfeit locus protein 6 0 7 7 
Tcp1 T-complex protein 1 subunit alpha 0 7 7 
Utp11l probable U3 small nucleolar RNA-associated protein 11 0 7 7 
Wdr43 WD repeat-containing protein 43 1 8 7 
2310058A11Rik 0 0 6 6 
Brd2 bromodomain-containing protein 2 0 6 6 
Cdk1 cyclin-dependent kinase 1 0 6 6 
Cdk105 ribosome biogenesis protein NSA2 homolog 0 6 6 
D14Ertd668e PHD finger protein 11 0 6 6 
Diexf digestive organ expansion factor homolog 0 6 6 
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Eif2s1 eukaryotic translation initiation factor 2 subunit 1 0 6 6 
Eprs bifunctional glutamate/proline--tRNA ligase 0 6 6 
Hjurp Holliday junction recognition protein 0 6 6 
Ikbkap elongator complex protein 1 0 6 6 
Immt mitochondrial inner membrane protein 0 6 6 
Kpna2 importin subunit alpha-2 0 6 6 
Krt71 keratin, type II cytoskeletal 71 0 6 6 
Nacc1 nucleus accumbens-associated protein 1 0 6 6 
Pak1ip1 p21-activated protein kinase-interacting protein 1 0 6 6 
Rlf zinc finger protein Rlf 0 6 6 
RPS9 40S ribosomal protein S9 0 6 6 
Sgol2 shugoshin-like 2 0 6 6 
Slc25a4 ADP/ATP translocase 1 1 7 6 
Stmn2 stathmin-2 0 6 6 
Sugt1 suppressor of G2 allele of SKP1 homolog 0 6 6 
Trim35 tripartite motif-containing protein 35 0 6 6 
Usp9x probable ubiquitin carboxyl-terminal hydrolase FAF-X 0 6 6 
Wdr74 WD repeat-containing protein 74 0 6 6 
Ywhah 14-3-3 protein eta 0 6 6 
Zfp512 zinc finger protein 512 0 6 6 
Zmym3 zinc finger MYM-type protein 3 0 6 6 
Aars alanine--tRNA ligase, cytoplasmic 0 5 5 
Actr2 actin-related protein 2 0 5 5 
Alyref THO complex subunit 4 0 5 5 
Cct3 T-complex protein 1 subunit gamma 0 5 5 
Cct8 T-complex protein 1 subunit theta 0 5 5 
Clk3 dual specificity protein kinase CLK3 0 5 5 
Ctcf transcriptional repressor CTCF 0 5 5 
Ddx23 probable ATP-dependent RNA helicase DDX23 0 5 5 
Ddx39b spliceosome RNA helicase Ddx39b 0 5 5 
Dppa4 developmental pluripotency-associated protein 4 0 5 5 
Eed polycomb protein EED 0 5 5 
Eef1d elongation factor 1-delta 0 5 5 
Eef1g elongation factor 1-gamma 0 5 5 
Eif3d eukaryotic translation initiation factor 3 subunit D 0 5 5 
G3bp1 ras GTPase-activating protein-binding protein 1 0 5 5 
Grwd1 glutamate-rich WD repeat-containing protein 1 0 5 5 
Hat1 histone acetyltransferase type B catalytic subunit 0 5 5 
Khdrbs1 KH domain-containing, RNA-binding, signal transduction-associated protein 1 0 5 5 
Krr1 KRR1 small subunit processome component homolog 0 5 5 
Mov10 putative helicase MOV-10 0 5 5 
Ncapg2 condensin-2 complex subunit G2 0 5 5 
Nono non-POU domain-containing octamer-binding protein 0 5 5 
Nup85 nuclear pore complex protein Nup85 0 5 5 
Orc3 origin recognition complex subunit 3 0 5 5 
Pbrm1 protein polybromo-1 0 5 5 
Polr2e DNA-directed RNA polymerases I, II, and III subunit RPABC1 0 5 5 
Ppp1cb serine/threonine-protein phosphatase PP1-beta catalytic subunit 0 5 5 
Puf60 poly(U)-binding-splicing factor PUF60 0 5 5 
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Pwp1 periodic tryptophan protein 1 homolog 0 5 5 
Rae1 mRNA export factor 0 5 5 
Rfc2 replication factor C subunit 2 0 5 5 
RPL27 60S ribosomal protein L27 0 5 5 
RPL30 60S ribosomal protein L30 0 5 5 
Rps2 40S ribosomal protein S2 0 5 5 
Serbp1 plasminogen activator inhibitor 1 RNA-binding protein 0 5 5 
Smu1 WD40 repeat-containing protein SMU1 0 5 5 
Suz12 polycomb protein Suz12 0 5 5 
Tubb4b tubulin beta-4B chain 1 6 5 
Ywhab 14-3-3 protein beta/alpha 1 6 5 
1110003H02Rik 0 0 4 4 
2610528E23Rik uncharacterized protein C3orf26 homolog 0 4 4 
4922501C03Rik protein QN1 homolog 0 4 4 
Aqr intron-binding protein aquarius 0 4 4 
Arpc3 actin-related protein 2/3 complex subunit 3 0 4 4 
Asns asparagine synthetase [glutamine-hydrolyzing] 0 4 4 
C1qbp complement component 1 Q subcomponent-binding protein, mitochondrial 0 4 4 
Cenpi centromere protein I 0 4 4 
Ctnnb1 catenin beta-1 0 4 4 
Cul4b cullin-4B 0 4 4 
Dimt1 probable dimethyladenosine transferase 0 4 4 
Dnaja2 dnaJ homolog subfamily A member 2 0 4 4 
Dnajc9 dnaJ homolog subfamily C member 9 0 4 4 
Dnmt3a DNA (cytosine-5)-methyltransferase 3A 0 4 4 
Eef1b2 elongation factor 1-beta 0 4 4 
Ehmt2 histone-lysine N-methyltransferase EHMT2 0 4 4 
Esco2 N-acetyltransferase ESCO2 0 4 4 
Gm10335 0 0 4 4 
Gm3362 predicted gene, 100041478 0 4 4 
Golgb1 golgi autoantigen, golgin subfamily b, macrogolgin 1 0 4 4 
Gstm1 glutathione S-transferase Mu 1 0 4 4 
Hdgfrp2 hepatoma-derived growth factor-related protein 2 0 4 4 
Kif22 kinesin-like protein KIF22 0 4 4 
Kri1 protein KRI1 homolog 0 4 4 
Krt8 keratin, type II cytoskeletal 8 0 4 4 
Lama1 laminin subunit alpha-1 0 4 4 
Luc7l3 luc7-like protein 3 0 4 4 
Mei4 meiosis-specific protein MEI4-like 0 4 4 
Mlf1ip centromere protein U 0 4 4 
Ncaph2 condensin-2 complex subunit H2 0 4 4 
Ncbp1 nuclear cap-binding protein subunit 1 0 4 4 
Nol7 nucleolar protein 7 0 4 4 
Npm3 nucleoplasmin-3 0 4 4 
Nup214 nuclear pore complex protein Nup214 0 4 4 
Nup88 nuclear pore complex protein Nup88 0 4 4 
Pcm1 pericentriolar material 1 protein 0 4 4 
Pdia3 protein disulfide-isomerase A3 0 4 4 
Pds5b sister chromatid cohesion protein PDS5 homolog B 0 4 4 
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Pdzd11 PDZ domain-containing protein 11 0 4 4 
Polr2c DNA-directed RNA polymerase II subunit RPB3 0 4 4 
Ppp1cc serine/threonine-protein phosphatase PP1-gamma catalytic subunit 0 4 4 
Psmd13 26S proteasome non-ATPase regulatory subunit 13 0 4 4 
Pspc1 paraspeckle component 1 0 4 4 
Ranbp1 ran-specific GTPase-activating protein 0 4 4 
Rfc3 replication factor C subunit 3 0 4 4 
Rpl35 60S ribosomal protein L35 0 4 4 
RPL36 60S ribosomal protein L36 0 4 4 
Rprd1b regulation of nuclear pre-mRNA domain-containing protein 1B 0 4 4 
Rps17 40S ribosomal protein S17 0 4 4 
Rps6 40S ribosomal protein S6 0 4 4 
Rps6ka5 ribosomal protein S6 kinase alpha-5 0 4 4 
Serpinb9 serine (or cysteine) proteinase inhibitor, clade B, member 9 0 4 4 
Sin3a paired amphipathic helix protein Sin3a 0 4 4 
slc2a14 glucose transporter 14 0 4 4 
Snd1 staphylococcal nuclease domain-containing protein 1 0 4 4 
Snrnp40 U5 small nuclear ribonucleoprotein 40 kDa protein 0 4 4 
SNRPN small nuclear ribonucleoprotein-associated protein N 0 4 4 
Snw1 SNW domain-containing protein 1 0 4 4 
Srfbp1 serum response factor-binding protein 1 0 4 4 
Ssfa2 sperm-specific antigen 2 homolog 0 4 4 
Strap serine-threonine kinase receptor-associated protein 0 4 4 
Vps41 vacuolar protein sorting-associated protein 41 homolog 0 4 4 
Xrn2 5'-3' exoribonuclease 2 0 4 4 
Zdbf2 DBF4-type zinc finger-containing protein 2 homolog 0 4 4 
Zfp280c zinc finger protein 280C 0 4 4 
3110082I17Rik uncharacterized protein C7orf50 homolog 0 3 3 
4930417G10Rik UPF0638 protein C2orf84 homolog 0 3 3 
Abt1 activator of basal transcription 1 0 3 3 
Actl6a actin-like protein 6A 0 3 3 
Bcas2 pre-mRNA-splicing factor SPF27 0 3 3 
Ccdc86 coiled-coil domain-containing protein 86 0 3 3 
Cct2 T-complex protein 1 subunit beta 0 3 3 
Cinp cyclin-dependent kinase 2-interacting protein 0 3 3 
Clta clathrin light chain A 0 3 3 
Cntln centlein 0 3 3 
Crat carnitine O-acetyltransferase 0 3 3 
CSNK2B casein kinase II subunit beta 0 3 3 
Ddx1 ATP-dependent RNA helicase DDX1 0 3 3 
Ddx47 probable ATP-dependent RNA helicase DDX47 0 3 3 
Ddx49 probable ATP-dependent RNA helicase DDX49 0 3 3 
Eif2s3x eukaryotic translation initiation factor 2 subunit 3, X-linked 0 3 3 
Eif3b eukaryotic translation initiation factor 3 subunit B 0 3 3 
Exosc9 exosome complex component RRP45 0 3 3 
Fmnl3 formin-like protein 3 0 3 3 
Fmr1 fragile X mental retardation protein 1 homolog 0 3 3 
Fscn1 fascin 0 3 3 
G3bp2 ras GTPase-activating protein-binding protein 2 0 3 3 
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Gm10051 predicted gene, ENSMUSG00000058905 0 3 3 
Gnl3l guanine nucleotide-binding protein-like 3-like protein 0 3 3 
H2afx histone H2A.x 0 3 3 
Hnrpdl heterogeneous nuclear ribonucleoprotein D-like 0 3 3 
Ik protein Red 0 3 3 
Ing5 inhibitor of growth protein 5 0 3 3 
Inhba inhibin beta A chain 0 3 3 
Krt31 keratin, type I cuticular Ha1 0 3 3 
Lonrf1 LON peptidase N-terminal domain and RING finger protein 1 0 3 3 
Luc7l putative RNA-binding protein Luc7-like 1 0 3 3 
Magea10 melanoma-associated antigen 10 0 3 3 
Magohb protein mago nashi homolog 1-related 0 3 3 
Mocs3 adenylyltransferase and sulfurtransferase MOCS3 0 3 3 
Mrps15 28S ribosomal protein S15, mitochondrial 0 3 3 
Mthfd1 C-1-tetrahydrofolate synthase, cytoplasmic 0 3 3 
Myl12a myosin light chain, regulatory B-like 1 4 3 
Myo5a unconventional myosin-Va 0 3 3 
Nid2 nidogen-2 0 3 3 
Palm3 paralemmin-3 0 3 3 
Phb prohibitin 0 3 3 
Pno1 RNA-binding protein PNO1 0 3 3 
Psma7 proteasome subunit alpha type-7 1 4 3 
Rcc2 protein RCC2 0 3 3 
Rmi1 recQ-mediated genome instability protein 1 0 3 3 
Rnf2 E3 ubiquitin-protein ligase RING2 0 3 3 
Rpl23 60S ribosomal protein L23 0 3 3 
Rpl28-ps3 0 0 3 3 
Rrp8 ribosomal RNA-processing protein 8 0 3 3 
Sec13 protein SEC13 homolog 0 3 3 
Slc25a13 calcium-binding mitochondrial carrier protein Aralar2 0 3 3 
Snrpb small nuclear ribonucleoprotein-associated protein B 0 3 3 
Srrt serrate RNA effector molecule homolog 0 3 3 
Trim24 transcription intermediary factor 1-alpha 0 3 3 
Uprt uracil phosphoribosyltransferase homolog 1 4 3 
Usp7 ubiquitin carboxyl-terminal hydrolase 7 0 3 3 
Wdr81 WD repeat-containing protein 81 0 3 3 
Wtap pre-mRNA-splicing regulator WTAP 0 3 3 
Zfp326 zinc finger protein 326 0 3 3 
Zfp703 zinc finger protein 703 0 3 3 
Zfp930 uncharacterized protein LOC234358 0 3 3 
1200003J13Rik 0 0 2 2 
1810008A18Rik protein FAM207A 0 2 2 
2310022A10Rik uncharacterized protein C19orf47 homolog 0 2 2 
2610027L16Rik pumilio domain-containing protein C14orf21 homolog 0 2 2 
2610509C24Rik 0 0 2 2 
2700060E02Rik UPF0568 protein C14orf166 homolog 0 2 2 
4930432E11Rik 0 0 2 2 
4930503B20Rik uncharacterized protein LOC75015 0 2 2 
4932418E24Rik uncharacterized protein LOC329366 0 2 2 
APPENDIX 	   104	  
4933425J19Rik 0 0 2 2 
4933425L11Rik 0 0 2 2 
6030440G07Rik 0 0 2 2 
9230104L09Rik cystatin E2 0 2 2 
Abhd11 abhydrolase domain-containing protein 11 0 2 2 
Adar double-stranded RNA-specific adenosine deaminase 0 2 2 
Adnp activity-dependent neuroprotector homeobox protein 0 2 2 
Adnp2 ADNP homeobox protein 2 0 2 2 
Akap8 A-kinase anchor protein 8 0 2 2 
Akr1b3 aldose reductase 0 2 2 
Alms1 Alstrom syndrome protein 1 homolog 0 2 2 
Apol7a apolipoprotein L 7a 0 2 2 
Arap1 arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 0 2 2 
Arhgap12 rho GTPase-activating protein 12 0 2 2 
Arpc1a actin-related protein 2/3 complex subunit 1A 0 2 2 
Arpc2 actin-related protein 2/3 complex subunit 2 0 2 2 
Arpc5l actin-related protein 2/3 complex subunit 5-like protein 0 2 2 
Arxes1 signal peptidase complex subunit 3 0 2 2 
Atad3a ATPase family AAA domain-containing protein 3 1 3 2 
Atg2a autophagy-related protein 2 homolog A 0 2 2 
Atic bifunctional purine biosynthesis protein PURH 0 2 2 
Atp13a1 probable cation-transporting ATPase 13A1 0 2 2 
Atp5f1 ATP synthase subunit b, mitochondrial 0 2 2 
Atxn10 ataxin-10 0 2 2 
Basp1 brain acid soluble protein 1 0 2 2 
Baz1a 0 0 2 2 
Blzf1 Golgin-45 0 2 2 
Bmp5 bone morphogenetic protein 5 0 2 2 
Brd3 bromodomain-containing protein 3 0 2 2 
Brd7 bromodomain-containing protein 7 0 2 2 
C4a sex-limited protein 0 2 2 
Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase 0 2 2 
Canx calnexin 0 2 2 
Card9 caspase recruitment domain-containing protein 9 0 2 2 
Carf 
amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein 
homolog 0 2 2 
Cars cysteine--tRNA ligase, cytoplasmic 0 2 2 
Cbx2 chromobox protein homolog 2 0 2 2 
Ccdc50 coiled-coil domain-containing protein 50 0 2 2 
Cct5 T-complex protein 1 subunit epsilon 0 2 2 
Cd55 complement decay-accelerating factor, GPI-anchored 0 2 2 
Celsr1 cadherin EGF LAG seven-pass G-type receptor 1 0 2 2 
Cenpm centromere protein M 0 2 2 
Cenpt centromere protein T 0 2 2 
Cep68 centrosomal protein of 68 kDa 0 2 2 
Cgnl1 cingulin-like protein 1 0 2 2 
Chchd3 coiled-coil-helix-coiled-coil-helix domain-containing protein 3, mitochondrial 0 2 2 
Chd1 chromodomain-helicase-DNA-binding protein 1 0 2 2 
Chd2 chromodomain helicase DNA binding protein 2 0 2 2 
Ciapin1 anamorsin 0 2 2 
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Clca3 calcium-activated chloride channel regulator 1 0 2 2 
Cldn15 claudin-15 0 2 2 
Cnn3 calponin-3 0 2 2 
Cnnm2 metal transporter CNNM2 0 2 2 
Cntnap5a contactin-associated protein like 5-1 0 2 2 
Col3a1 collagen alpha-1(III) chain 0 2 2 
Col5a2 collagen alpha-2(V) chain 0 2 2 
Cpne1 copine-1 0 2 2 
Cpne3 copine-3 0 2 2 
Csnk1a1 casein kinase I isoform alpha 0 2 2 
Ctr9 RNA polymerase-associated protein CTR9 homolog 0 2 2 
Cttnbp2 cortactin-binding protein 2 0 2 2 
Cwc27 peptidyl-prolyl cis-trans isomerase CWC27 homolog 0 2 2 
Dapk1 death-associated protein kinase 1 0 2 2 
Dars aspartate--tRNA ligase, cytoplasmic 0 2 2 
Ddx25 ATP-dependent RNA helicase DDX25 0 2 2 
Dhx30 putative ATP-dependent RNA helicase DHX30 0 2 2 
Dmap1 DNA methyltransferase 1-associated protein 1 0 2 2 
Dmwd dystrophia myotonica WD repeat-containing protein 0 2 2 
Dnahc5 dynein heavy chain 5, axonemal 0 2 2 
Dnajc6 putative tyrosine-protein phosphatase auxilin 0 2 2 
Dnalc4 dynein light chain 4, axonemal 0 2 2 
Dock6 0 0 2 2 
Dppa2 developmental pluripotency-associated protein 2 0 2 2 
Dpy19l1 protein dpy-19 homolog 1 0 2 2 
Dsn1 kinetochore-associated protein DSN1 homolog 0 2 2 
E2f2 transcription factor E2F2 0 2 2 
Edc4 enhancer of mRNA-decapping protein 4 0 2 2 
Egfl6 epidermal growth factor-like protein 6 0 2 2 
Ehd4 EH domain-containing protein 4 0 2 2 
Ehmt1 histone-lysine N-methyltransferase EHMT1 0 2 2 
Eif3c eukaryotic translation initiation factor 3 subunit C 0 2 2 
Elac1 zinc phosphodiesterase ELAC protein 1 0 2 2 
Elavl3 ELAV-like protein 3 0 2 2 
Emid1 EMI domain-containing protein 1 0 2 2 
Eml4 echinoderm microtubule-associated protein-like 4 0 2 2 
Enah protein enabled homolog 0 2 2 
Esco1 N-acetyltransferase ESCO1 0 2 2 
Esrrb steroid hormone receptor ERR2 0 2 2 
Exoc6 exocyst complex component 6 0 2 2 
F630043A04Rik spindle and kinetochore-associated protein 3 0 2 2 
Fam161b protein FAM161B 0 2 2 
Fam167a protein FAM167A 0 2 2 
Fam3c protein FAM3C 0 2 2 
Farsb phenylalanine--tRNA ligase beta subunit 0 2 2 
Fcf1 rRNA-processing protein FCF1 homolog 0 2 2 
Fgd6 FYVE, RhoGEF and PH domain-containing protein 6 0 2 2 
Fggy FGGY carbohydrate kinase domain-containing protein 0 2 2 
Flt3 receptor-type tyrosine-protein kinase FLT3 0 2 2 
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Fmn1 formin-1 0 2 2 
Foxred1 FAD-dependent oxidoreductase domain-containing protein 1 0 2 2 
Fyttd1 UAP56-interacting factor 0 2 2 
Gcc2 GRIP and coiled-coil domain-containing protein 2 0 2 2 
Gcnt3 
beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-
acetylglucosaminyltransferase 3 0 2 2 
Gdpd3 glycerophosphodiester phosphodiesterase domain-containing protein 3 0 2 2 
Gfi1 zinc finger protein Gfi-1 0 2 2 
Gjb3 gap junction beta-3 protein 0 2 2 
Glg1 Golgi apparatus protein 1 0 2 2 
Gltscr2 glioma tumor suppressor candidate region gene 2 0 2 2 
Gm10725 0 0 2 2 
Gm11703 0 0 2 2 
Gm12569 0 0 2 2 
Gm13213 0 0 2 2 
Gm4617 0 0 2 2 
Gm9234 predicted gene, EG668548 0 2 2 
Gpatch4 G patch domain-containing protein 4 0 2 2 
Gpr179 probable G-protein coupled receptor 179 0 2 2 
Gramd1b GRAM domain-containing protein 1B 0 2 2 
Gstz1 maleylacetoacetate isomerase 0 2 2 
Gtl3 UPF0468 protein C16orf80 homolog 0 2 2 
Gzf1 GDNF-inducible zinc finger protein 1 0 2 2 
H2AFZ histone H2A.Z 0 2 2 
Habp4 intracellular hyaluronan-binding protein 4 0 2 2 
Hba-a1 hemoglobin subunit alpha 0 2 2 
Hbegf proheparin-binding EGF-like growth factor 0 2 2 
Hist1h1c histone H1.2 0 2 2 
HIST1H2AD histone H2A type 1-D 1 3 2 
Hmgb2 high mobility group protein B2 0 2 2 
Hmgn1 non-histone chromosomal protein HMG-14 0 2 2 
Hsd17b2 estradiol 17-beta-dehydrogenase 2 0 2 2 
Hspa4 heat shock 70 kDa protein 4 0 2 2 
Iars isoleucine--tRNA ligase, cytoplasmic 0 2 2 
Ift122 intraflagellar transport protein 122 homolog 0 2 2 
Igdcc4 immunoglobulin superfamily DCC subclass member 4 0 2 2 
Igf2bp3 insulin-like growth factor 2 mRNA-binding protein 3 0 2 2 
Il12rb2 interleukin-12 receptor subunit beta-2 0 2 2 
Irgm2 interferon inducible GTPase 2 0 2 2 
Itpr2 inositol 1,4,5-trisphosphate receptor type 2 0 2 2 
Jarid2 protein Jumonji 0 2 2 
Kif20b kinesin-like protein KIF20B 0 2 2 
Kif3a kinesin-like protein KIF3A 0 2 2 
Kif9 kinesin-like protein KIF9 0 2 2 
Krt12 keratin, type I cytoskeletal 12 0 2 2 
Krt28 keratin, type I cytoskeletal 28 0 2 2 
Krt72-ps keratin, type II cytoskeletal 72 0 2 2 
Lce1e late cornified envelope protein family member 0 2 2 
Lgals3bp galectin-3-binding protein 0 2 2 
Lgmn legumain 0 2 2 
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Lipi lipase I 0 2 2 
LOC100044627 0 0 2 2 
LOC100045924 0 0 2 2 
LOC100047183 0 0 2 2 
LOC100047252 0 0 2 2 
LOC631302 0 0 2 2 
Lrig3 leucine-rich repeats and immunoglobulin-like domains protein 3 0 2 2 
Lrpprc leucine-rich PPR motif-containing protein, mitochondrial 0 2 2 
Map4k3 mitogen-activated protein kinase kinase kinase kinase 3 0 2 2 
Mapkapk5 MAP kinase-activated protein kinase 5 0 2 2 
Marcksl1 MARCKS-related protein 0 2 2 
Mdn1 midasin 0 2 2 
Meaf6 chromatin modification-related protein MEAF6 0 2 2 
Mettl11a alpha N-terminal protein methyltransferase 1A 0 2 2 
Mical3 protein-methionine sulfoxide oxidase MICAL3 0 2 2 
Mllt4 afadin 0 2 2 
Mphosph8 M-phase phosphoprotein 8 0 2 2 
Mpp2 MAGUK p55 subfamily member 2 0 2 2 
Mrps7 28S ribosomal protein S7, mitochondrial 0 2 2 
Mta1 metastasis-associated protein MTA1 0 2 2 
Mtch1 mitochondrial carrier homolog 1 0 2 2 
Mtch2 mitochondrial carrier homolog 2 0 2 2 
Myo9b unconventional myosin-IXb 0 2 2 
Myt1l myelin transcription factor 1-like protein 0 2 2 
N4bp3 NEDD4-binding protein 3 0 2 2 
Nars2 probable asparagine--tRNA ligase, mitochondrial 0 2 2 
Nes nestin 0 2 2 
Nhsl2 NHS-like protein 2 0 2 2 
Nip7 60S ribosome subunit biogenesis protein NIP7 homolog 0 2 2 
Nisch nischarin 0 2 2 
Nle1 notchless protein homolog 1 0 2 2 
Nlrp3 NACHT, LRR and PYD domains-containing protein 3 0 2 2 
Nol8 nucleolar protein 8 0 2 2 
Nppb natriuretic peptides B 0 2 2 
Nrf1 nuclear respiratory factor 1 0 2 2 
Nub1 NEDD8 ultimate buster 1 0 2 2 
Nucks1 nuclear ubiquitous casein and cyclin-dependent kinases substrate 0 2 2 
Nudt13 nucleoside diphosphate-linked moiety X motif 13 0 2 2 
Nup35 nucleoporin NUP53 0 2 2 
Nup50 nuclear pore complex protein Nup50 0 2 2 
Odf2l outer dense fiber protein 2-like 0 2 2 
Olfr1496 olfactory receptor 1496 0 2 2 
Olfr95 olfactory receptor 95 0 2 2 
Pa2g4 proliferation-associated protein 2G4 0 2 2 
Pabpc4 polyadenylate-binding protein 4 0 2 2 
Parp2 poly [ADP-ribose] polymerase 2 0 2 2 
Pcbp2 poly(rC)-binding protein 2 0 2 2 
Pdcd5 programmed cell death protein 5 0 2 2 
Pdgfc platelet-derived growth factor C 0 2 2 
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Pgk2 phosphoglycerate kinase 2 0 2 2 
Phgdh D-3-phosphoglycerate dehydrogenase 0 2 2 
Pik3cb phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta isoform 0 2 2 
Pin4 peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 0 2 2 
Pinx1 PIN2/TERF1-interacting telomerase inhibitor 1 0 2 2 
Pitpnm3 membrane-associated phosphatidylinositol transfer protein 3 0 2 2 
Plaa phospholipase A-2-activating protein 0 2 2 
Plch1 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase eta-1 0 2 2 
Polk DNA polymerase kappa 0 2 2 
Polr1c DNA-directed RNA polymerases I and III subunit RPAC1 0 2 2 
Polr1d DNA-directed RNA polymerases I and III subunit RPAC2 0 2 2 
Pou5f1 POU domain, class 5, transcription factor 1 0 2 2 
Ppp2cb serine/threonine-protein phosphatase 2A catalytic subunit beta isoform 0 2 2 
Ppp3cc serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform 1 3 2 
Prkdc DNA-dependent protein kinase catalytic subunit 0 2 2 
Prpf38a pre-mRNA-splicing factor 38A 0 2 2 
Psat1 phosphoserine aminotransferase 0 2 2 
Psma2 proteasome subunit alpha type-2 0 2 2 
Psma6 proteasome subunit alpha type-6 0 2 2 
Psmd14 26S proteasome non-ATPase regulatory subunit 14 0 2 2 
Ptges3 prostaglandin E synthase 3 0 2 2 
Ptma prothymosin alpha 0 2 2 
Qk protein quaking 0 2 2 
Rars2 probable arginine--tRNA ligase, mitochondrial 0 2 2 
Rbbp7 histone-binding protein RBBP7 0 2 2 
Rbm44 RNA-binding protein 44 0 2 2 
Rbm8a RNA-binding protein 8A 0 2 2 
Rbpms RNA-binding protein with multiple splicing 0 2 2 
Rbpms2 RNA-binding protein with multiple splicing 2 0 2 2 
Rif1 telomere-associated protein RIF1 0 2 2 
Rpa1 replication protein A 70 kDa DNA-binding subunit 0 2 2 
Rpa2 replication protein A 32 kDa subunit 0 2 2 
Rpgrip1 X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 0 2 2 
Rpl29-ps5 0 0 2 2 
Rpl35a 60S ribosomal protein L35a 0 2 2 
Rpl38 60S ribosomal protein L38 0 2 2 
Rpp30 ribonuclease P protein subunit p30 0 2 2 
RPS20 40S ribosomal protein S20 0 2 2 
Rps25-ps1 0 1 3 2 
RPS27 40S ribosomal protein S27 0 2 2 
Rras2 ras-related protein R-Ras2 0 2 2 
Rwdd2b RWD domain-containing protein 2B 0 2 2 
Sae1 SUMO-activating enzyme subunit 1 0 2 2 
Sall4 sal-like protein 4 0 2 2 
Sap30 histone deacetylase complex subunit SAP30 0 2 2 
Sart1 U4/U6.U5 tri-snRNP-associated protein 1 0 2 2 
Sbno1 protein strawberry notch homolog 1 0 2 2 
Scaf11 splicing factor, arginine/serine-rich 2, interacting protein 0 2 2 
Scpep1 retinoid-inducible serine carboxypeptidase 0 2 2 
APPENDIX 	   109	  
Seh1l nucleoporin SEH1 0 2 2 
Serpinc1 antithrombin-III 0 2 2 
Shf SH2 domain-containing adapter protein F 0 2 2 
Slc26a10 solute carrier family 26 member 10 0 2 2 
Slc38a1 sodium-coupled neutral amino acid transporter 1 0 2 2 
Slc3a2 4F2 cell-surface antigen heavy chain 0 2 2 
Slfn2 schlafen family member 12-like 0 2 2 
Slfn4 schlafen 4 0 2 2 
Sltm SAFB-like transcription modulator 0 2 2 
Smarcd2 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 
subfamily D member 2 0 2 2 
Smarce1 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 
subfamily E member 1 0 2 2 
Snrk SNF-related serine/threonine-protein kinase 0 2 2 
Soat1 sterol O-acyltransferase 1 0 2 2 
Son protein SON 0 2 2 
Spata18 mitochondria-eating protein 0 2 2 
Spata24 spermatogenesis-associated protein 24 0 2 2 
Sphk1 sphingosine kinase 1 0 2 2 
Sri sorcin 0 2 2 
Srsf11 splicing factor, arginine/serine-rich 11 0 2 2 
Stag2 cohesin subunit SA-2 0 2 2 
Supt5h transcription elongation factor SPT5 0 2 2 
Suv39h2 histone-lysine N-methyltransferase SUV39H2 0 2 2 
Syce1l synaptonemal complex central element protein 1-like 0 2 2 
Taldo1 transaldolase 0 2 2 
Tcirg1 T-cell, immune regulator 1 0 2 2 
Terf2 telomeric repeat-binding factor 2 0 2 2 
Tet1 methylcytosine dioxygenase TET1 0 2 2 
Tex11 testis-expressed sequence 11 protein 0 2 2 
Tex15 testis expressed gene 15 0 2 2 
Tex9 testis-expressed sequence 9 protein 0 2 2 
Thoc6 THO complex subunit 6 homolog 0 2 2 
Timm50 mitochondrial import inner membrane translocase subunit TIM50 0 2 2 
Tmco5b transmembrane and coiled-coil domain-containing protein 5B 0 2 2 
Tmem199 transmembrane protein 199 0 2 2 
Tmem209 transmembrane protein 209 0 2 2 
Traf3ip1 TRAF3-interacting protein 1 0 2 2 
Trim58 tripartite motif-containing protein 58 0 2 2 
Trove2 60 kDa SS-A/Ro ribonucleoprotein 0 2 2 
Trp53bp1 tumor suppressor p53-binding protein 1 0 2 2 
Trrap transformation/transcription domain-associated protein 0 2 2 
Tshz1 teashirt homolog 1 0 2 2 
Ttc14 tetratricopeptide repeat protein 14 0 2 2 
Ttc30a1 tetratricopeptide repeat protein 30A1 0 2 2 
Ttf1 transcription termination factor 1 0 2 2 
Tulp4 tubby-related protein 4 0 2 2 
Tusc5 tumor suppressor candidate 5 homolog 0 2 2 
Txlna alpha-taxilin 0 2 2 
Txnl1 thioredoxin-like protein 1 0 2 2 
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Ube2v1 ubiquitin-conjugating enzyme E2 variant 1 0 2 2 
Ubqln3 ubiquilin-3 0 2 2 
Usp-ps 0 0 2 2 
Vps72 vacuolar protein sorting-associated protein 72 homolog 0 2 2 
Wipi2 WD repeat domain phosphoinositide-interacting protein 2 0 2 2 
Xbp1 X-box-binding protein 1 0 2 2 
Xpo1 exportin-1 0 2 2 
Xrcc5 X-ray repair cross-complementing protein 5 0 2 2 
Xrcc6 X-ray repair cross-complementing protein 6 0 2 2 
Yap1 yorkie homolog 0 2 2 
Zdhhc23 probable palmitoyltransferase ZDHHC23 0 2 2 
Zfml zinc finger protein 638 0 2 2 
Zfp157 zinc finger protein 157 0 2 2 
Zfp27 zinc finger protein 27 0 2 2 
Zfp292 zinc finger protein 292 0 2 2 
Zfp335 zinc finger protein 335 0 2 2 
Zhx3 zinc fingers and homeoboxes protein 3 0 2 2 
Zmynd12 zinc finger, MYND domain containing 12 0 2 2 
Zscan10 zinc finger and SCAN domain-containing protein 10 0 2 2 
1810019E15Rik 0 0 1 1 
2610029M16Rik 0 0 1 1 
4932429P05Rik SMEK homolog 3, putative 0 1 1 
9830107B12Rik RIKEN cDNA 9830107B12 0 1 1 
Acss1 acetyl-coenzyme A synthetase 2-like, mitochondrial 0 1 1 
Adat3 tRNA-specific adenosine deaminase-like protein 3 0 1 1 
Adrm1 proteasomal ubiquitin receptor ADRM1 0 1 1 
Ahdc1 AT-hook DNA-binding motif-containing protein 1 0 1 1 
AK020040 0 0 1 1 
Ankrd60 ankyrin repeat domain-containing protein 60 0 1 1 
Anp32a acidic leucine-rich nuclear phosphoprotein 32 family member A 0 1 1 
Arid3b AT-rich interactive domain-containing protein 3B 0 1 1 
Arl10 ADP-ribosylation factor-like protein 10 0 1 1 
Atad2b ATPase family AAA domain-containing protein 2B 0 1 1 
Atp13a2 probable cation-transporting ATPase 13A2 0 1 1 
Atp5o ATP synthase subunit O, mitochondrial 0 1 1 
Bard1 BRCA1-associated RING domain protein 1 0 1 1 
Bmx cytoplasmic tyrosine-protein kinase BMX 0 1 1 
C1ra complement C1r-A subcomponent 0 1 1 
C86695 uncharacterized protein LOC97476 0 1 1 
C87222 0 1 2 1 
Cacng4 voltage-dependent calcium channel gamma-4 subunit 0 1 1 
Cct4 T-complex protein 1 subunit delta 0 1 1 
Cenpb major centromere autoantigen B 0 1 1 
Cenpq centromere protein Q 0 1 1 
Cherp calcium homeostasis endoplasmic reticulum protein 0 1 1 
Cmas N-acylneuraminate cytidylyltransferase 0 1 1 
Cox4nb ER membrane protein complex subunit 8 0 1 1 
D14Abb1e protein FAM208A 0 1 1 
Dcaf7 DDB1- and CUL4-associated factor 7 0 1 1 
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Ddx50 ATP-dependent RNA helicase DDX50 0 1 1 
Dek protein DEK 0 1 1 
Des desmin 0 1 1 
Dnaja3 dnaJ homolog subfamily A member 3, mitochondrial 0 1 1 
Drg1 developmentally-regulated GTP-binding protein 1 0 1 1 
Ehhadh peroxisomal bifunctional enzyme 0 1 1 
Eif3h eukaryotic translation initiation factor 3 subunit H 0 1 1 
Eml5 echinoderm microtubule-associated protein-like 5 0 1 1 
Esrra steroid hormone receptor ERR1 0 1 1 
Etf1 eukaryotic peptide chain release factor subunit 1 0 1 1 
Farsa phenylalanine--tRNA ligase alpha subunit 0 1 1 
Fkbp4 peptidyl-prolyl cis-trans isomerase FKBP4 0 1 1 
Fxr2 fragile X mental retardation syndrome-related protein 2 0 1 1 
Gadd45gip1 growth arrest and DNA damage-inducible proteins-interacting protein 1 1 2 1 
Gal3st2 galactose-3-O-sulfotransferase 2 0 1 1 
Glud1 glutamate dehydrogenase 1, mitochondrial 0 1 1 
Gm10044 0 0 1 1 
Gm101 primary ciliary dyskinesia protein 1 1 2 1 
Gm11810 predicted gene, OTTMUSG00000004420 0 1 1 
Gm12335 0 0 1 1 
Gm13119 uncharacterized protein LOC433779 0 1 1 
Gm4764 0 0 1 1 
Gm4952 glycine N-acyltransferase-like protein 0 1 1 
Gm4963 0 1 2 1 
Gm6091 0 0 1 1 
Gm9774 0 0 1 1 
Gps1 COP9 signalosome complex subunit 1 0 1 1 
Grtp1 growth hormone-regulated TBC protein 1 0 1 1 
Hist1h2aa histone cluster 1, H2aa 0 1 1 
Hist1h2bj histone H2B type 1-F/J/L 0 1 1 
Hmga1-rs1 high mobility group protein HMG-I/HMG-Y 0 1 1 
Hnrnph2 heterogeneous nuclear ribonucleoprotein H2 0 1 1 
Hnrnpr heterogeneous nuclear ribonucleoprotein R 1 2 1 
Hnrpll heterogeneous nuclear ribonucleoprotein L-like 0 1 1 
Hps3 Hermansky-Pudlak syndrome 3 protein homolog 0 1 1 
Igf2bp2 insulin-like growth factor 2 mRNA-binding protein 2 0 1 1 
Ina alpha-internexin 0 1 1 
Iqgap1 ras GTPase-activating-like protein IQGAP1 0 1 1 
Isy1 pre-mRNA-splicing factor ISY1 homolog 0 1 1 
Kars lysine--tRNA ligase 0 1 1 
Kdm1a lysine-specific histone demethylase 1A 0 1 1 
Keap1 kelch-like ECH-associated protein 1 0 1 1 
Kif20a kinesin-like protein KIF20A 0 1 1 
L1td1 LINE-1 type transposase domain-containing protein 1 0 1 1 
Lap3 cytosol aminopeptidase 0 1 1 
LOC100046151 0 0 1 1 
LOC100048062 0 0 1 1 
LOC638399 0 0 1 1 
Mcc mutated in colorectal cancers 0 1 1 
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Mcm3ap 80 kDa MCM3-associated protein 0 1 1 
Mrpl16 39S ribosomal protein L16, mitochondrial 0 1 1 
Naca nascent polypeptide-associated complex subunit alpha 1 2 1 
Nap1l1 nucleosome assembly protein 1-like 1 0 1 1 
Nkrf NF-kappa-B-repressing factor 0 1 1 
NOP10 H/ACA ribonucleoprotein complex subunit 3 0 1 1 
Npm1 nucleophosmin 0 1 1 
Nsa2 ribosome biogenesis protein NSA2 homolog 0 1 1 
Nsd1 histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific 0 1 1 
Orc4 origin recognition complex subunit 4 0 1 1 
Pabpn1 polyadenylate-binding protein 2 0 1 1 
Paf1 RNA polymerase II-associated factor 1 homolog 0 1 1 
Pcdh11x protocadherin 11 X-linked 0 1 1 
Pdia4 protein disulfide-isomerase A4 0 1 1 
Pkm pyruvate kinase isozymes M1/M2 0 1 1 
Plrg1 pleiotropic regulator 1 0 1 1 
Pnlip pancreatic triacylglycerol lipase 0 1 1 
Poldip3 polymerase delta-interacting protein 3 0 1 1 
Ppfibp2 liprin-beta-2 0 1 1 
Ppil1 peptidyl-prolyl cis-trans isomerase-like 1 0 1 1 
Pramef12 PRAME family member 12 0 1 1 
Prex1 phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein 0 1 1 
Prmt1 protein arginine N-methyltransferase 1 0 1 1 
Psmc6 26S protease regulatory subunit 10B 0 1 1 
Psmd2 26S proteasome non-ATPase regulatory subunit 2 0 1 1 
Rab13 ras-related protein Rab-13 0 1 1 
Racgap1 rac GTPase-activating protein 1 0 1 1 
Rad51l1 DNA repair protein RAD51 homolog 2 0 1 1 
Ralyl RNA-binding Raly-like protein 0 1 1 
Rbfox2 RNA binding protein fox-1 homolog 2 0 1 1 
Rbm14 RNA-binding protein 14 0 1 1 
Renbp N-acylglucosamine 2-epimerase 0 1 1 
Rgs7 regulator of G-protein signaling 7 0 1 1 
Rpl28 60S ribosomal protein L28 0 1 1 
Rpl31 60S ribosomal protein L31 0 1 1 
Rpl36a 60S ribosomal protein L36a 0 1 1 
Rpl36a-ps1 0 0 1 1 
Rplp1 60S acidic ribosomal protein P1 0 1 1 
RPS12 40S ribosomal protein S12 0 1 1 
Rps18 40S ribosomal protein S18 1 2 1 
Rps24 40S ribosomal protein S24 0 1 1 
RPS28 40S ribosomal protein S28 0 1 1 
Safb scaffold attachment factor B1 0 1 1 
Sh3d20 0 0 1 1 
Slc25a12 calcium-binding mitochondrial carrier protein Aralar1 0 1 1 
SMARCB1 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 
subfamily B member 1 0 1 1 
Snrpd3 small nuclear ribonucleoprotein Sm D3 0 1 1 
Snrpe small nuclear ribonucleoprotein E 0 1 1 
Snrpf small nuclear ribonucleoprotein F 0 1 1 
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Sntb2 beta-2-syntrophin 0 1 1 
Srbd1 S1 RNA-binding domain-containing protein 1 0 1 1 
Sumo2 small ubiquitin-related modifier 2 0 1 1 
Tex10 testis-expressed sequence 10 protein 0 1 1 
Tk1 thymidine kinase, cytosolic 0 1 1 
Tpt1 translationally-controlled tumor protein 0 1 1 
Tpx2 targeting protein for Xklp2 0 1 1 
Tspan11 tetraspanin-11 0 1 1 
Ttc17 tetratricopeptide repeat domain 17 0 1 1 
Tuba1a tubulin alpha-1A chain 0 1 1 
Tubb2b tubulin beta-2B chain 0 1 1 
Uba1 ubiquitin-like modifier-activating enzyme 1 0 1 1 
Ubap2l ubiquitin-associated protein 2-like 0 1 1 
Uncx homeobox protein unc-4 homolog 0 1 1 
Vdac3 voltage-dependent anion-selective channel protein 3 0 1 1 
Wdr65 WD repeat-containing protein 65 0 1 1 
Wdr72 WD repeat domain 72 0 1 1 
Xk membrane transport protein XK 0 1 1 
Yrdc yrdC domain-containing protein, mitochondrial 0 1 1 
Zc3h11a zinc finger CCCH domain-containing protein 11A 1 2 1 
Zc3h3 zinc finger CCCH domain-containing protein 3 0 1 1 
Zfyve26 zinc finger FYVE domain-containing protein 26 1 2 1 
 
Table III Mass-spec list of the Suv4-20h2 GST pulldown assays. The number of unique spectra that 
were identified for each protein in the mass-spec analysis is indicated (Scaffold analysis). 
gene name GST M5 M7 delta 
Suv420h2 histone-lysine N-methyltransferase SUV420H2 4 112 62 108 
Lmnb1 lamin-B1 1 82 75 81 
Top2a DNA topoisomerase 2-alpha 0 49 0 49 
Cbx5 chromobox protein homolog 5 0 41 0 41 
Hnrnpu heterogeneous nuclear ribonucleoprotein U 2 43 4 41 
CBX1 chromobox protein homolog 1 0 40 0 40 
Plec plectin 0 40 8 40 
CBX3 chromobox protein homolog 3 1 40 0 39 
Jup junction plakoglobin 4 37 13 33 
Mybbp1a myb-binding protein 1A 0 30 0 30 
Ahnak AHNAK nucleoprotein 4 34 13 30 
Krt31 keratin, type I cuticular Ha1 0 29 0 29 
Ddx21 nucleolar RNA helicase 2 0 28 0 28 
Nop58 nucleolar protein 58 0 23 0 23 
Ncl nucleolin 1 24 1 23 
Nop56 nucleolar protein 56 0 23 12 23 
5430421N2
1Rik 
type II hair keratin 1 20 2 19 
Eef2 elongation factor 2 0 19 8 19 
Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 4 23 12 19 
Ddx5 probable ATP-dependent RNA helicase DDX5 4 22 1 18 
Cltc clathrin heavy chain 1 0 18 3 18 
Vcl vinculin 0 18 4 18 
Acly ATP-citrate synthase 0 18 5 18 
Nup93 nuclear pore complex protein Nup93 0 16 0 16 
Fasn fatty acid synthase 0 16 3 16 
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Nolc1 nucleolar and coiled-body phosphoprotein 1 0 15 0 15 
Hsp90b1 endoplasmin 2 17 8 15 
Nup107 nuclear pore complex protein Nup107 0 14 0 14 
Tpr nuclear pore complex-associated protein Tpr 0 14 0 14 
Nedd4 E3 ubiquitin-protein ligase NEDD4 0 14 3 14 
Ddx3x ATP-dependent RNA helicase DDX3X 2 15 0 13 
Smarca5 SWI/SNF-related matrix-associated actin-dependent regulator of chromatin 
subfamily A member 5 
0 12 0 12 
Ranbp2 E3 SUMO-protein ligase RanBP2 0 12 3 12 
Vcp transitional endoplasmic reticulum ATPase 2 14 6 12 
Spna2 spectrin alpha chain, brain 0 12 6 12 
Vdac2 voltage-dependent anion-selective channel protein 2 3 14 1 11 
Myh9 myosin-9 0 11 3 11 
Atrx transcriptional regulator ATRX 0 10 0 10 
Ddost dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit 0 10 0 10 
Las1l protein LAS1 homolog 0 10 0 10 
Nup85 nuclear pore complex protein Nup85 0 10 0 10 
Nup98 nucleoporin 98 0 10 0 10 
Snrnp200 U5 small nuclear ribonucleoprotein 200 kDa helicase 0 10 0 10 
Ephx1 epoxide hydrolase 1 4 14 1 10 
Vars valyl-tRNA synthetase 0 10 2 10 
Col1a1 collagen alpha-1(I) chain 2 12 4 10 
Actn1 alpha-actinin-1 2 12 6 10 
Hnrnpul2 heterogeneous nuclear ribonucleoprotein U-like protein 2 0 9 1 9 
Trim28 transcription intermediary factor 1-beta 0 9 1 9 
Eef1b2 elongation factor 1-beta 3 12 3 9 
Spnb2 spectrin beta chain, brain 1 0 9 4 9 
Krt77 keratin, type II cytoskeletal 1b 4 13 6 9 
Nat10 N-acetyltransferase 10 0 8 0 8 
Orc1 origin recognition complex subunit 1 0 8 0 8 
Pwp2 periodic tryptophan protein 2 homolog 0 8 0 8 
Eprs bifunctional aminoacyl-tRNA synthetase 0 8 1 8 
Nup205 nucleoporin 205 0 8 1 8 
Canx calnexin 2 10 5 8 
Krt78 keratin Kb40 4 12 6 8 
Hist1h3e histone H3.2 1 9 9 8 
Rif1 telomere-associated protein RIF1 1 8 0 7 
Mcm3 DNA replication licensing factor MCM3 0 7 0 7 
Tcof1 treacle protein 0 7 0 7 
Vdac1 voltage-dependent anion-selective channel protein 1 3 10 1 7 
Eif3c eukaryotic translation initiation factor 3 subunit C 0 7 1 7 
Smc1a structural maintenance of chromosomes protein 1A 0 7 1 7 
Rpl5 60S ribosomal protein L5 2 8 0 6 
Mki67 antigen KI-67 0 6 0 6 
Ptbp1 polypyrimidine tract-binding protein 1 0 6 0 6 
Ruvbl1 ruvB-like 1 0 6 0 6 
Sf3b1 splicing factor 3B subunit 1 0 6 0 6 
Tmpo lamina-associated polypeptide 2 0 6 0 6 
Uqcrc1 cytochrome b-c1 complex subunit 1, mitochondrial 0 6 0 6 
Alb serum albumin 2 8 2 6 
Ndufs1 NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial 0 6 2 6 
Top2b DNA topoisomerase 2-beta 2 8 3 6 
Rrbp1 ribosome-binding protein 1 0 6 3 6 
Snd1 staphylococcal nuclease domain-containing protein 1 0 6 3 6 
Stt3a dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A 0 6 3 6 
Aldh18a1 delta-1-pyrroline-5-carboxylate synthase 0 6 4 6 
LOC10004
7183 
 
0 6 4 6 
Krt75 keratin, type II cytoskeletal 75 1 7 5 6 
Insrr insulin receptor-related protein 2 8 7 6 
Krt13 keratin, type I cytoskeletal 13 0 6 7 6 
Hnrnpl heterogeneous nuclear ribonucleoprotein L 2 7 0 5 
Ddx17 probable ATP-dependent RNA helicase DDX17 0 5 0 5 
Mcm5 DNA replication licensing factor MCM5 0 5 0 5 
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Numa1 nuclear mitotic apparatus protein 1 0 5 0 5 
Otc ornithine carbamoyltransferase, mitochondrial 0 5 0 5 
Pdcd11 protein RRP5 homolog 0 5 0 5 
Sf3a1 splicing factor 3A subunit 1 0 5 0 5 
Sf3b2 splicing factor 3b, subunit 2 0 5 0 5 
Wdr3 WD repeat-containing protein 3 0 5 0 5 
Ddx3y ATP-dependent RNA helicase DDX3Y 2 7 1 5 
Lyz1 lysozyme C-1 3 8 2 5 
Sfn 14-3-3 protein sigma 0 5 2 5 
Dnmt3b DNA (cytosine-5)-methyltransferase 3B 0 5 3 5 
Hnrnpa2b1 heterogeneous nuclear ribonucleoproteins A2/B1 4 9 6 5 
Fam161b protein FAM161B 1 5 0 4 
2610101N1
0Rik 
U2 snRNP-associated SURP motif-containing protein 0 4 0 4 
Acin1 apoptotic chromatin condensation inducer in the nucleus 0 4 0 4 
Ddx18 ATP-dependent RNA helicase DDX18 0 4 0 4 
Fads2 fatty acid desaturase 2 0 4 0 4 
Flnc filamin-C 0 4 0 4 
Krt33a keratin, type I cuticular Ha3-I 0 4 0 4 
Lama3 laminin subunit alpha-3 0 4 0 4 
LOC10004
6628 
 
0 4 0 4 
Nnt NAD(P) transhydrogenase, mitochondrial 0 4 0 4 
Nvl nuclear valosin-containing protein-like 0 4 0 4 
Prpf6 pre-mRNA-processing factor 6 0 4 0 4 
Rpl22 60S ribosomal protein L22 0 4 0 4 
Rpl23 60S ribosomal protein L23 0 4 0 4 
Tln1 talin-1 0 4 0 4 
Wdr36 WD repeat domain 36 0 4 0 4 
D1Pas1 putative ATP-dependent RNA helicase Pl10 
 
4 0 4 
Fscn1 fascin 2 6 1 4 
Hnrnph1 heterogeneous nuclear ribonucleoprotein H 2 6 1 4 
Hspb1 heat shock protein beta-1 0 4 1 4 
Actn4 alpha-actinin-4 0 4 2 4 
Dst dystonin 0 4 2 4 
Gemin5 gem-associated protein 5 0 4 2 4 
Hspa4 heat shock 70 kDa protein 4 0 4 2 4 
Odf2l outer dense fiber protein 2-like 0 4 2 4 
Bicd1 protein bicaudal D homolog 1 0 4 3 4 
Sarnp SAP domain-containing ribonucleoprotein 0 4 3 4 
Vps35 vacuolar protein sorting-associated protein 35 4 8 4 4 
Gucy2c heat-stable enterotoxin receptor 2 6 4 4 
Krt35 keratin, type I cuticular Ha5 2 6 4 4 
Plk2 serine/threonine-protein kinase PLK2 2 6 6 4 
2410002O2
2Rik 
UPF0533 protein C5orf44 homolog 1 4 0 3 
Fam98c uncharacterized protein LOC73833 1 4 0 3 
Rpl28-ps3 
 
1 4 0 3 
Shisa9 protein shisa-9 1 4 0 3 
Abcc2 canalicular multispecific organic anion transporter 1 0 3 0 3 
Alyref THO complex subunit 4 0 3 0 3 
Cacna2d4 voltage-dependent calcium channel subunit alpha-2/delta-4 0 3 0 3 
Dsg1a desmoglein-1-alpha 0 3 0 3 
E2f2 transcription factor E2F2 0 3 0 3 
Eed polycomb protein EED 0 3 0 3 
Eftud2 116 kDa U5 small nuclear ribonucleoprotein component 0 3 0 3 
Fam65b protein FAM65B 0 3 0 3 
Grpel1 grpE protein homolog 1, mitochondrial 0 3 0 3 
Hdac2 histone deacetylase 2 0 3 0 3 
Kif1b kinesin-like protein KIF1B 0 3 0 3 
Lgals3bp galectin-3-binding protein 0 3 0 3 
Nup160 nuclear pore complex protein Nup160 0 3 0 3 
P2rx3 P2X purinoceptor 3 0 3 0 3 
Pcnxl3 pecanex-like protein 3 0 3 0 3 
Pml protein PML 0 3 0 3 
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Smc3 structural maintenance of chromosomes protein 3 0 3 0 3 
Smg6 telomerase-binding protein EST1A 0 3 0 3 
Tnr tenascin-R 0 3 0 3 
Vezt vezatin 0 3 0 3 
Vps16 vacuolar protein sorting-associated protein 16 homolog 0 3 0 3 
Wdr46 WD repeat-containing protein 46 0 3 0 3 
Yes1 tyrosine-protein kinase Yes 0 3 0 3 
Arid5a AT-rich interactive domain-containing protein 5A 0 3 1 3 
Ddx58 probable ATP-dependent RNA helicase DDX58 0 3 1 3 
Gdf15 growth/differentiation factor 15 0 3 1 3 
Hinfp histone H4 transcription factor 0 3 1 3 
Sf3b3 splicing factor 3B subunit 3 0 3 1 3 
Slc25a13 calcium-binding mitochondrial carrier protein Aralar2 0 3 1 3 
Stag2 cohesin subunit SA-2 0 3 1 3 
Taf1 transcription initiation factor TFIID subunit 1 0 3 1 3 
Lrpprc leucine-rich PPR motif-containing protein, mitochondrial 1 4 2 3 
Herc2 E3 ubiquitin-protein ligase HERC2 0 3 2 3 
Rere arginine-glutamic acid dipeptide repeats protein 0 3 2 3 
Hnrnpab heterogeneous nuclear ribonucleoprotein A/B 4 7 3 3 
Fras1 extracellular matrix protein FRAS1 2 5 3 3 
Hnrnpd heterogeneous nuclear ribonucleoprotein D0 2 5 3 3 
Chrna10 neuronal acetylcholine receptor subunit alpha-10 0 3 3 3 
Dock9 dedicator of cytokinesis protein 9 0 3 3 3 
Erc1 ELKS/Rab6-interacting/CAST family member 1 0 3 3 3 
Hnrnpa0 heterogeneous nuclear ribonucleoprotein A0 0 3 3 3 
Pard6g partitioning defective 6 homolog gamma 0 3 3 3 
Prpf8 pre-mRNA-processing-splicing factor 8 0 3 3 3 
Ube2t ubiquitin-conjugating enzyme E2 T 0 3 3 3 
Vash1 vasohibin-1 1 4 4 3 
Mei4 UPF0623 protein 0 3 4 3 
 
Table VI. Mass-spec list of the PrSet7 GST pulldown assays. The number of unique spectra that were 
identified for each protein in the mass-spec analysis is indicated (Scaffold analysis). 
identified proteins (689) GST PrSet7 
histone-lysine N-methyltransferase SETD8 [Mus musculus] 0 63 
histone-lysine N-methyltransferase SUV420H2 [Mus musculus] 1 10 
plakoglobin [Mus musculus] 5 10 
unnamed protein product [Mus musculus] 0 5 
unnamed protein product [Mus musculus] 0 4 
keratin, type I cuticular Ha1 [Mus musculus] 0 4 
glutathione S-transferase P 1 [Mus musculus] 0 4 
unnamed protein product [Mus musculus] 2 5 
mCG121875 [Mus musculus] 0 3 
mCG13479, isoform CRA_a [Mus musculus] 0 3 
Hist2h4 protein [Mus musculus] 17 19 
mCG20427 [Mus musculus] 10 12 
mCG49945 [Mus musculus] 2 4 
fibronectin [Mus musculus] 2 4 
mCG116671 [Mus musculus] 2 4 
microtubule-actin crosslinking factor 1 [Mus musculus] 0 2 
mCG141708, isoform CRA_a [Mus musculus] 0 2 
Hnrpc protein [Mus musculus] 0 2 
APPENDIX 	   117	  
protein bicaudal D homolog 1 isoform 2 [Mus musculus] 0 2 
gi|148697763 0 2 
Voltage-dependent anion channel 2 [Mus musculus] 0 2 
60S ribosomal protein L8 [Homo sapiens] 0 2 
unnamed protein product [Mus musculus] 0 2 
RIKEN cDNA 9430010O03, isoform CRA_c [Mus musculus] 0 2 
60S ribosomal protein L13a [Mus musculus] 0 2 
unnamed protein product [Mus musculus] 0 2 
mCG113619 [Mus musculus] 0 2 
mCG9260 [Mus musculus] 0 2 
mCG120681 [Mus musculus] 0 2 
pre-rRNA-processing protein TSR1 homolog [Mus musculus] 0 2 
Hist1h3e protein [Mus musculus] 6 7 
RecName: Full=Histone deacetylase 6; Short=HD6; AltName: Full=Histone deacetylase mHDA2 0 1 
RIKEN cDNA 1810013C15, isoform CRA_b [Mus musculus] 1 2 
epidermal keratin type I [Mus musculus] 2 3 
myosin XVA isoform 1a [Mus musculus] 1 2 
Cd209f protein [Mus musculus] 0 1 
mCG1036780 [Mus musculus] 1 2 
unnamed protein product [Mus musculus] 1 2 
biorientation of chromosomes in cell division 1-like [Mus musculus] 0 1 
mCG121289, isoform CRA_a [Mus musculus] 0 1 
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit, isoform CRA_c [Mus musculus] 0 1 
mCG10523, isoform CRA_b [Mus musculus] 0 1 
lysozyme C-1 precursor [Mus musculus] 1 2 
L-2-hydroxyglutarate dehydrogenase [Mus musculus] 0 1 
gi|12850600 1 2 
histone deacetylase complex subunit SAP18 [Mus musculus] 1 2 
small proline-rich protein 2B [Mus musculus] 0 1 
expressed sequence AI841794 [Mus musculus] 0 1 
hypothetical protein LOC240067 [Mus musculus] 0 1 
gi|188497644 0 1 
1200009I06Rik protein [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
putative GTP-binding protein Parf [Mus musculus] 0 1 
RecName: Full=Putative 60S ribosomal protein L32' 0 1 
mCG117386 [Mus musculus] 0 1 
transmembrane channel-like gene family 6 [Mus musculus] 0 1 
mCG133345, isoform CRA_a [Mus musculus] 0 1 
mCG145367 [Mus musculus] 0 1 
low density lipoprotein-related protein 1B (deleted in tumors) [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
K+ channel [Mus musculus] 0 1 
low affinity cationic amino acid transporter 2 isoform 1 [Mus musculus] 0 1 
cornifin-A [Mus musculus] 0 1 
immunoglobulin mu heavy chain variable region [Mus musculus] 0 1 
mCG8461, isoform CRA_b [Mus musculus] 0 1 
ribosomal protein L26 [Mus musculus] 0 1 
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unnamed protein product [Mus musculus] 0 1 
PREDICTED: myosin light polypeptide 6-like [Mus musculus] 0 1 
mCG1230, isoform CRA_a [Mus musculus] 0 1 
vacuolar protein sorting 16 (yeast) [Mus musculus] 0 1 
Ribosomal protein, large, P0 [Mus musculus] 0 1 
complement component 1 Q subcomponent-binding protein, mitochondrial [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG141651 [Mus musculus] 0 1 
nucleoporin 205 [Mus musculus] 0 1 
myosin, heavy polypeptide 10, non-muscle [Mus musculus] 0 1 
keratin, type I cuticular Ha4 [Mus musculus] 0 1 
DNA segment, Chr 19, ERATO Doi 386, expressed [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
plakophilin 1 [Mus musculus] 0 1 
protease, serine, 23, isoform CRA_c [Mus musculus] 0 1 
mCG21742 [Mus musculus] 0 1 
PREDICTED: dedicator of cytokinesis protein 3-like [Mus musculus] 0 1 
vomeronasal 2, receptor, 122 isoform 2 [Mus musculus] 0 1 
mCG49140 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
arginine glutamic acid dipeptide (RE) repeats [Mus musculus] 0 1 
striated muscle-specific serine/threonine protein kinase [Mus musculus] 0 1 
mCG125596 [Mus musculus] 0 1 
unknown [Mus musculus] 0 1 
RecName: Full=Thyroid hormone receptor alpha; AltName: Full=Nuclear receptor subfamily 1 group A 
member 1; AltName: Full=c-erbA-1; AltName: Full=c-erbA-alpha 0 1 
mCG2257 [Mus musculus] 0 1 
mCG51125 [Mus musculus] 0 1 
DNA-directed RNA polymerases I, II, and III subunit RPABC1 [Mus musculus] 0 1 
RecName: Full=Forkhead box protein K2; AltName: Full=Cellular transcription factor ILF-1; AltName: 
Full=Interleukin enhancer-binding factor 1 0 1 
CD84-H1 [Mus musculus] 0 1 
chorion-specific transcription factor GCMb [Mus musculus] 0 1 
U6 snRNA-associated Sm-like protein LSm1 [Mus musculus] 0 1 
PREDICTED: 40S ribosomal protein S13-like [Mus musculus] 0 1 
RecName: Full=Filamin A-interacting protein 1-like; AltName: Full=Protein down-regulated in ovarian 
cancer 1 homolog; Short=DOC-1 0 1 
unnamed protein product [Mus musculus] 0 1 
Serpinb13 protein [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
E2F transcription factor 7, isoform CRA_b [Mus musculus] 0 1 
peptidylprolyl isomerase F (cyclophilin F), isoform CRA_c [Mus musculus] 0 1 
cDNA sequence, AY616753, isoform CRA_a [Mus musculus] 0 1 
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31 [Mus musculus] 0 1 
septin 9 [Mus musculus] 0 1 
C-C motif chemokine 27 isoform 1 [Mus musculus] 0 1 
immunoglobulin heavy chain [Mus musculus] 0 1 
Usherin precursor [Mus musculus] 0 1 
EF-hand calcium-binding domain-containing protein 7 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
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unnamed protein product [Mus musculus] 0 1 
RIKEN cDNA 1500010J02, isoform CRA_b [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
novel protein [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
prefoldin subunit 3 [Mus musculus] 0 1 
mCG117846 [Mus musculus] 0 1 
RIKEN cDNA C030014K22 [Mus musculus] 0 1 
ribosomal protein 10 [Mus musculus] 0 1 
breast cancer susceptibility [Mus musculus] 0 1 
Pwp2 protein [Mus musculus] 0 1 
utrophin [Mus musculus] 0 1 
gi|148674573 0 1 
Zfp641 protein [Mus musculus] 0 1 
Smage-3 protein [Mus musculus] 0 1 
tubulin, gamma complex associated protein 2, isoform CRA_a [Mus musculus] 0 1 
RecName: Full=60S ribosomal protein L3; AltName: Full=J1 protein 0 1 
ADAM33 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
atlastin-3 isoform 2 [Mus musculus] 0 1 
mCG1032915 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG140660 [Mus musculus] 0 1 
unknown [Mus musculus] 0 1 
mCG15386 [Mus musculus] 0 1 
beta,beta-carotene 9',10'-oxygenase [Mus musculus] 0 1 
mCG8513 [Mus musculus] 0 1 
transcription factor SOX-13 [Mus musculus] 0 1 
gi|74147627 0 1 
unnamed protein product [Mus musculus] 0 1 
solute carrier family 13, member 4 [Mus musculus] 0 1 
mCG130125, isoform CRA_b [Mus musculus] 0 1 
mCG129911 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
kallikrein related-peptidase 6 precursor [Mus musculus] 0 1 
mCG3093, isoform CRA_b [Mus musculus] 0 1 
serine/threonine-protein kinase receptor R3 precursor [Mus musculus] 0 1 
mCG130959 [Mus musculus] 0 1 
mCG140934 [Mus musculus] 0 1 
olfactory receptor 741 [Mus musculus] 0 1 
Rho GTPase activating protein 21 [Mus musculus] 0 1 
mCG1463, isoform CRA_a [Mus musculus] 0 1 
PDZ domain-containing protein 2 [Mus musculus] 0 1 
aldehyde oxidase 3 [Mus musculus] 0 1 
Tpd52 protein [Mus musculus] 0 1 
serum albumin precursor [Mus musculus] 0 1 
RNA/DNA-binding protein [Mus musculus] 0 1 
vomeronasal 1 receptor, G1 [Mus musculus] 0 1 
APPENDIX 	   120	  
DEAH (Asp-Glu-Ala-His) box polypeptide 9, isoform CRA_a [Mus musculus] 0 1 
mCG55273 [Mus musculus] 0 1 
coiled-coil domain containing 47 [Mus musculus] 0 1 
probable G-protein coupled receptor 162 [Mus musculus] 0 1 
mCG147147 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
olfactory receptor 1301 [Mus musculus] 0 1 
ankyrin repeat domain 36 [Mus musculus] 0 1 
Multimerin 1 [Mus musculus] 0 1 
ATP-binding cassette 1, sub-family A, member 1 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
cadherin-24 precursor [Mus musculus] 0 1 
Ckap5 protein [Mus musculus] 0 1 
CXXC finger 1 (PHD domain), isoform CRA_e [Mus musculus] 0 1 
ret proto-oncogene [Mus musculus] 0 1 
transcription factor TFIIIB component B'' homolog [Mus musculus] 0 1 
Stil protein [Mus musculus] 0 1 
mCG148436 [Mus musculus] 0 1 
RecName: Full=Serine/threonine-protein kinase 25; AltName: Full=Ste20-like kinase; AltName: Full=Sterile 
20/oxidant stress-response kinase 1; Short=SOK-1; Short=Ste20/oxidant stress response kinase 1 0 1 
galactose-3-O-sulfotransferase 2 [Mus musculus] 0 1 
mCG117370, isoform CRA_a [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
RIKEN cDNA 9130019O22 gene [Mus musculus] 0 1 
immunoglobulin heavy chain variable region (CDR3) [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG129641 [Mus musculus] 0 1 
paraneoplastic antigen-like protein 5 [Mus musculus] 0 1 
testis-specific serine/threonine-protein kinase 5 [Mus musculus] 0 1 
general transcription factor III C 1, isoform CRA_a [Mus musculus] 0 1 
RecName: Full=Protein chibby homolog 3 0 1 
vitamin K-dependent protein S precursor [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG133706, isoform CRA_a [Mus musculus] 0 1 
palladin [Mus musculus] 0 1 
ras-related protein Rab-32 [Mus musculus] 0 1 
mCG131439, isoform CRA_b [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
peroxisomal NADH pyrophosphatase NUDT12 [Mus musculus] 0 1 
gi|10946894 0 1 
RecName: Full=MAM domain-containing glycosylphosphatidylinositol anchor protein 1; Flags: Precursor 0 1 
mCG5769, isoform CRA_a [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
HMG box domain containing 3 isoform 1 [Mus musculus] 0 1 
GREB1-like protein [Mus musculus] 0 1 
ATPase family AAA domain-containing protein 2 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG145199 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
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IK cytokine [Mus musculus] 0 1 
centrosomal protein 135, isoform CRA_a [Mus musculus] 0 1 
Ccdc60 protein [Mus musculus] 0 1 
mitochondrial carnitine/acylcarnitine carrier protein [Mus musculus] 0 1 
Novel RhoGAP domain containing protein [Mus musculus] 0 1 
FYVE and coiled-coil domain-containing protein 1 [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide, isoform 
CRA_a [Mus musculus] 0 1 
mCG6975 [Mus musculus] 0 1 
mCG127343 [Mus musculus] 0 1 
serine/arginine-rich splicing factor 1 isoform 2 [Mus musculus] 0 1 
urotensin-2 precursor [Mus musculus] 0 1 
ephrin type-A receptor 6 [Mus musculus] 0 1 
Serine carboxypeptidase 1 [Mus musculus] 0 1 
fragile X mental retardation gene 1, autosomal homolog, isoform CRA_b [Mus musculus] 0 1 
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 [Mus 
musculus] 0 1 
EGF-like domain-containing protein C3orf50 homolog isoform a precursor [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
RecName: Full=Probable phospholipid-transporting ATPase VD; AltName: Full=ATPase class V type 10D 0 1 
O-6-methylguanine-DNA methyltransferase, isoform CRA_b [Mus musculus] 0 1 
kinesin 2, isoform CRA_b [Mus musculus] 0 1 
RecName: Full=Brain-specific angiogenesis inhibitor 2; Flags: Precursor 0 1 
mCG1031476 [Mus musculus] 0 1 
env precursor [Mus musculus] 0 1 
unnamed protein product [Mus musculus] 0 1 
mCG19193, isoform CRA_b [Mus musculus] 0 1 
RecName: Full=Porphobilinogen deaminase; Short=PBG-D; AltName: Full=Hydroxymethylbilane synthase; 
Short=HMBS; AltName: Full=Pre-uroporphyrinogen synthase 0 1 
expressed sequence C79407 [Mus musculus] 0 1 
cyclin-F [Mus musculus] 0 1 
erythroid cell-specific and testis-specific protein 1(ERT-1) [Mus musculus] 0 1 
mCG4144 [Mus musculus] 0 1 
hypothetical protein LOC380768 [Mus musculus] 0 1 
interferon alpha 6T [Mus musculus] 0 1 
YTH domain containing 1 [Mus musculus] 0 1 
tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 [Mus musculus] 0 1 
anti-DNA immunoglobulin heavy chain IgG [Mus musculus] 0 1 
prosaposin [Mus musculus] 0 1 
immunoglobulin light chain V region [Mus musculus] 0 1 
metastasis associated 1, isoform CRA_a [Mus musculus] 0 1 
hypothetical protein LOC214763 [Mus musculus] 0 1 
novel protein similar to protein phosphatase 1, regulatory (inhibitor) subunit 2 Ppp1r2 [Mus musculus] 0 1 
Rho guanine nucleotide exchange factor (GEF) 5 [Mus musculus] 0 1 
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